In	IN	case	O
this	DT	det	O
study	NN	nmod	O
we	PRP	nsubj	O
separated	VBD	ROOT	O
weakly	RB	advmod	O
acidic	JJ	amod	O
phenolic	JJ	amod	O
components	NNS	dobj	O
from	IN	case	O
other	JJ	amod	O
neutral	JJ	amod	O
,	,	punct	O
acidic	JJ	conj	O
and	CC	cc	O
basic	JJ	conj	O
components	NNS	nmod	O
of	IN	case	O
tobacco	NN	compound	B-Simple_chemical
smoke	NN	compound	I-Simple_chemical
condensate	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
TSC	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
observed	VBD	conj	O
that	IN	mark	O
phenolic	JJ	amod	B-Simple_chemical
fraction	NN	nsubj	I-Simple_chemical
of	IN	case	O
TSC	NN	nmod	B-Simple_chemical
significantly	RB	advmod	O
increased	VBD	ccomp	O
the	DT	det	O
number	NN	dobj	O
of	IN	case	O
colonies	NNS	nmod	O
of	IN	case	O
promotion	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	amod	O
JB6	NN	compound	B-Cell
Cl41	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
that	WDT	nsubj	O
showed	VBD	acl:relcl	O
anchorage	JJ	amod	O
-	HYPH	punct	O
independent	JJ	amod	O
growth	NN	dobj	O
on	IN	case	O
soft	JJ	amod	O
agar	NN	nmod	O
in	IN	case	O
response	NN	nmod	O
to	TO	case	O
BPDE	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
an	DT	det	O
ultimate	JJ	amod	O
carcinogen	NN	dobj	O
produced	VBN	acl	O
by	IN	case	O
metabolic	JJ	amod	O
activation	NN	nmod	O
of	IN	case	O
the	DT	det	O
PAH	NN	compound	B-Simple_chemical
benzo	NN	nmod	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
a	DT	det	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
pyrene	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
.	.	punct	O

BPDE	NN	compound	B-Simple_chemical
treatment	NN	nsubj	O
caused	VBD	ROOT	O
induction	NN	dobj	O
of	IN	case	O
both	CC	cc:preconj	O
AP	NN	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	conj	I-Gene_or_gene_product
activity	NN	dep	O
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
luciferase	NN	compound	B-Gene_or_gene_product
reporter	NN	compound	O
assay	NN	nmod	O
and	CC	cc	O
only	RB	advmod	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
induction	NN	nsubjpass	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
BPDE	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
significantly	RB	advmod	O
attenuated	VBN	conj	O
by	IN	case	O
TSC	NN	compound	B-Simple_chemical
phenolic	JJ	amod	I-Simple_chemical
fraction	NN	nmod	I-Simple_chemical
whereas	IN	mark	O
AP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
induction	NN	nsubj	O
remains	VBZ	advcl	O
unaltered	JJ	xcomp	O
.	.	punct	O

These	DT	det	O
assays	NNS	nsubj	O
yielded	VBD	ROOT	O
mainly	RB	advmod	O
the	DT	det	O
viral	JJ	amod	B-Organism
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
,	,	punct	O
in	IN	case	O
particular	JJ	nmod	O
,	,	punct	O
the	DT	det	O
associated	VBN	amod	O
cellular	JJ	amod	B-Cell
p53	NN	appos	B-Gene_or_gene_product
as	IN	case	O
endogenous	JJ	amod	O
substrates	NNS	nmod	O
.	.	punct	O

Blockade	NN	nsubj	O
of	IN	case	O
angiogenesis	NN	nmod	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
approach	NN	ROOT	O
for	IN	case	O
cancer	NN	compound	B-Cancer
treatment	NN	nmod	O
and	CC	cc	O
prevention	NN	conj	O
.	.	punct	O

Remarkably	RB	advmod	O
,	,	punct	O
lymphomas	NNS	nsubj	B-Cancer
arising	VBG	acl	O
in	IN	case	O
Trp53	NN	compound	B-Gene_or_gene_product
(	-LRB-	punct	O
515C	NN	compound	O
/	:	punct	O
515C	NN	appos	O
)	-RRB-	punct	O
mice	NNS	nmod	O
(	-LRB-	punct	O
encoding	VBG	acl	O
p53R172P	NNS	advmod	B-Gene_or_gene_product
)	-RRB-	punct	O
retain	VBP	ROOT	O
stable	JJ	amod	O
genomes	NNS	dobj	O
.	.	punct	O

Tumors	NNS	nsubjpass	B-Cancer
of	IN	case	O
H4	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
were	VBD	auxpass	O
well	RB	advmod	O
perfused	VBN	ROOT	O
,	,	punct	O
unlike	IN	case	O
tumors	NNS	nmod	B-Cancer
of	IN	case	O
H5	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
which	WDT	nsubj	O
were	VBD	cop	O
highly	RB	advmod	O
necrotic	JJ	acl:relcl	O
.	.	punct	O

Angiogenesis	NN	nsubj	O
has	VBZ	aux	O
become	VBN	ROOT	O
an	DT	det	O
attractive	JJ	amod	O
target	NN	attr	O
for	IN	case	O
drug	NN	compound	O
therapy	NN	nmod	O
because	IN	case	O
of	IN	mwe	O
its	PRP$	nmod:poss	O
key	JJ	amod	O
role	NN	advcl	O
in	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
.	.	punct	O

The	DT	det	O
Interferon	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
inducible	JJ	amod	O
gene	NN	compound	O
IFI16	NN	nsubjpass	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
HIN200	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
,	,	punct	O
is	VBZ	auxpass	O
activated	VBN	ROOT	O
by	IN	case	O
oxidative	JJ	amod	O
stress	NN	nmod	O
and	CC	cc	O
cell	NN	compound	B-Cell
density	NN	conj	O
,	,	punct	O
in	IN	case	O
addition	NN	nmod	O
to	TO	case	O
Interferons	NNS	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
it	PRP	nsubjpass	O
is	VBZ	auxpass	O
implicated	VBN	conj	O
in	IN	case	O
the	DT	det	O
regulation	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	nmod	O
and	CC	cc	O
vessel	NN	compound	B-Multi-tissue_structure
formation	NN	conj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

With	IN	ROOT	O
a	DT	det	O
median	JJ	amod	O
follow	NN	amod	O
-	HYPH	punct	O
up	NN	pobj	O
of	IN	prep	O
8	CD	pobj	O
.	.	punct	O
4	CD	nummod	O
months	NNS	npadvmod	O
,	,	punct	O
the	DT	det	O
overall	RB	amod	O
best	JJS	amod	O
response	NN	compound	O
rate	NN	nsubj	O
is	VBZ	ROOT	O
37	CD	nummod	O
%	NN	attr	O
(	-LRB-	punct	O
2	CD	nummod	O
complete	JJ	amod	O
clinical	JJ	amod	O
response	NN	appos	O
/	:	punct	O
complete	JJ	amod	O
clinical	JJ	amod	O
response	NN	conj	O
unconfirmed	JJ	amod	O
and	CC	cc	O
9	CD	nummod	O
partial	JJ	amod	O
response	NN	conj	O
)	-RRB-	punct	O
,	,	punct	O
with	IN	case	O
22	CD	nummod	O
%	NN	nmod	O
achieving	VBG	acl	O
stable	JJ	amod	O
disease	NN	dobj	O
.	.	punct	O

BMSVTs	NNS	nsubj	B-Cell
exhibited	VBD	ROOT	O
a	DT	det	O
partially	RB	advmod	O
transformed	VBN	amod	O
phenotype	NN	dobj	O
,	,	punct	O
demonstrating	VBG	advcl	O
growth	NN	compound	O
factor	NN	compound	O
independence	NN	dobj	O
,	,	punct	O
altered	JJ	amod	O
antigen	NN	compound	O
expression	NN	conj	O
and	CC	cc	O
forming	VBG	conj	O
tiny	JJ	amod	O
,	,	punct	O
infrequent	NN	amod	O
colonies	NNS	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	dobj	O
inactivating	VBG	amod	O
mutations	NNS	nmod	O
in	IN	case	O
CK1delta	NN	compound	B-Gene_or_gene_product
impair	VBP	compound	O
SV40	NN	nmod:npmod	B-Organism
-	HYPH	punct	O
induced	VBN	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
mouse	NN	compound	B-Organism
mammary	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Magnolol	NNP	nsubj	B-Simple_chemical
,	,	punct	O
a	DT	det	O
substance	NN	appos	O
purified	VBN	acl	O
from	IN	prep	O
the	DT	det	O
bark	NN	pobj	B-Tissue
of	IN	prep	O
Magnolia	NNP	compound	B-Organism
officialis	NN	pobj	I-Organism
,	,	punct	O
inhibits	VBZ	ROOT	O
cell	NN	compound	B-Cell
proliferation	NN	dobj	O
and	CC	cc	O
induces	VBZ	conj	O
apoptosis	NN	dobj	O
in	IN	case	O
a	DT	det	O
variety	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

With	IN	case	O
the	DT	det	O
recent	JJ	amod	O
ability	NN	nmod	O
to	TO	case	O
clone	NN	compound	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
to	TO	mark	O
carry	VB	conj	O
them	PRP	dobj	O
in	IN	prep	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
culture	NN	pobj	O
,	,	punct	O
it	PRP	nsubj	O
has	VBZ	aux	O
been	VBN	cop	O
possible	JJ	ROOT	O
to	TO	mark	O
further	RB	advmod	O
delineate	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
capillary	JJ	amod	B-Tissue
growth	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
that	IN	mark	O
orally	RB	advmod	B-Organism_subdivision
administered	VBN	amod	O
artemisinin	NN	nsubj	B-Simple_chemical
inhibited	VBD	ccomp	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	dobj	I-Multi-tissue_structure
and	CC	cc	O
lung	NN	compound	B-Organ
metastasis	NN	conj	O
and	CC	cc	O
prolonged	JJ	amod	O
survival	NN	conj	O
without	IN	mark	O
retarding	VBG	advcl	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
.	.	punct	O

The	DT	det	O
ACIS	NN	compound	O
index	NN	nsubj	O
,	,	punct	O
using	VBG	acl	O
a	DT	det	O
cutoff	NN	compound	O
point	NN	dobj	O
defined	VBN	acl	O
by	IN	agent	O
the	DT	det	O
median	JJ	amod	O
value	NN	pobj	O
,	,	punct	O
<	ADD	appos	O
or	CC	cc	O
=	JJ	conj	O
3	CD	nummod	O
%	NN	conj	O
versus	CC	cc	O
>	NN	conj	O
3	CD	nummod	O
%	NN	conj	O
,	,	punct	O
was	VBD	aux	O
related	JJ	ROOT	O
to	IN	case	O
5	CD	nummod	O
-	HYPH	punct	O
year	NN	compound	O
DM	NN	compound	O
rates	NNS	dobj	O
in	IN	case	O
univariate	JJ	amod	O
analyses	NNS	nmod	O
(	-LRB-	punct	O
32	CD	nummod	O
.	.	punct	O
6	CD	nummod	O
%	NN	npadvmod	O
vs	CC	cc	O
.	.	punct	O
45	CD	ROOT	O
.	.	punct	O
8	CD	nummod	O
%	NN	ROOT	O
;	:	punct	O
P	NN	nsubj	O
=	JJ	dep	O
0	CD	dobj	O
.	.	punct	O
057	CD	ROOT	O
)	-RRB-	punct	O
and	CC	cc	O
MVA	NN	nsubj	O
(	-LRB-	punct	O
P	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
06	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

E	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nsubj	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
Ca	NN	ROOT	B-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
+	CC	cc	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
-	:	punct	O
dependent	JJ	amod	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
adhesion	NN	compound	O
molecule	NN	appos	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
mainly	RB	advmod	O
expressed	VBN	acl:relcl	O
in	IN	case	O
epithelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
activities	NNS	nsubj	O
provide	VBP	ROOT	O
an	DT	det	O
explanation	NN	dobj	O
for	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
properties	NNS	nmod	O
of	IN	case	O
EGF	NN	nmod	B-Gene_or_gene_product
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubj	O
of	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product
expression	NN	nmod	O
on	IN	case	O
morphology	NN	nmod	O
and	CC	cc	O
motility	NN	conj	O
are	VBP	cop	O
separable	JJ	ROOT	O
since	IN	mark	O
cells	NNS	nsubj	B-Cell
transfected	VBN	acl	O
with	IN	case	O
a	DT	det	O
truncated	JJ	amod	O
form	NN	nmod	O
of	IN	case	O
5T4	NN	compound	B-Gene_or_gene_product
cDNA	NN	nmod	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
cytoplasmic	JJ	amod	B-Organism_substance
domain	NN	nsubjpass	O
is	VBZ	auxpass	O
deleted	VBN	acl:relcl	O
reveal	VBP	advcl	O
that	IN	mark	O
the	DT	det	O
latter	JJ	nsubj	O
is	VBZ	cop	O
necessary	JJ	ccomp	O
to	TO	mark	O
abrogate	VB	xcomp	O
actin	NN	compound	B-Gene_or_gene_product
/	:	punct	O
cadherin	NN	appos	B-Gene_or_gene_product
-	HYPH	punct	O
containing	VBG	amod	O
contacts	NNS	dobj	O
but	CC	cc	O
does	VBZ	aux	O
not	RB	neg	O
influence	VB	conj	O
the	DT	det	O
effects	NNS	dobj	O
on	IN	case	O
motility	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
defined	VBD	ROOT	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Myc	NNP	nmod	I-Gene_or_gene_product
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
sensitivity	NN	nmod	O
to	TO	case	O
vinblastine	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
VLB	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
using	VBG	acl	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
:	:	punct	O
LoVo	NN	compound	B-Cell
wild	JJ	amod	O
-	HYPH	punct	O
type	NN	dobj	O
or	CC	cc	O
transfected	VBN	conj	O
with	IN	case	O
a	DT	det	O
plasmid	NN	nmod	O
containing	VBG	acl	O
the	DT	det	O
human	JJ	amod	B-Organism
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
gene	NN	dobj	O
in	IN	case	O
antisense	JJ	amod	O
orientation	NN	nmod	O
(	-LRB-	punct	O
LoVo	NN	compound	B-Cell
-	:	punct	I-Cell
mycANS	NN	appos	I-Cell
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
ephrin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B1	NN	nsubj	I-Gene_or_gene_product
promotes	VBZ	acl:relcl	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
in	IN	case	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
because	IN	mark	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	compound	O
heralds	VBZ	compound	O
cell	NN	compound	B-Cell
body	NN	compound	I-Cell
migration	NN	advcl	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
aimed	VBD	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
role	NN	dobj	O
of	IN	case	O
aberrations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
genes	NNS	nmod	O
in	IN	case	O
the	DT	det	O
pathogenesis	NN	nmod	O
of	IN	case	O
CRC	NN	nmod	B-Cancer
in	IN	case	O
the	DT	det	O
Kashmir	NN	compound	O
valley	NN	nmod	O
,	,	punct	O
and	CC	cc	O
to	TO	mark	O
correlate	VB	conj	O
it	PRP	dobj	O
with	IN	case	O
various	JJ	amod	O
clinicopathological	JJ	amod	O
variables	NNS	nmod	O
.	.	punct	O

Glioma	NN	compound	B-Cell
tumor	NN	compound	I-Cell
stem	NN	nsubj	I-Cell
-	HYPH	punct	I-Cell
like	JJ	case	I-Cell
cells	NNS	nsubj	I-Cell
promote	VBP	ROOT	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	dobj	O
and	CC	cc	O
vasculogenesis	NN	conj	O
via	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
stromal	JJ	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
derived	VBN	amod	I-Gene_or_gene_product
factor	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
.	.	punct	O

Restored	VBN	amod	O
DCC	NN	compound	B-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
the	DT	det	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	nmod	I-Cell
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
netrin	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
induced	VBD	amod	O
apoptosis	NN	nmod	O
.	.	punct	O

This	DT	det	O
review	NN	compound	O
article	NN	nsubj	O
focuses	VBZ	ROOT	O
on	IN	prep	O
recent	JJ	amod	O
developments	NNS	pobj	O
in	IN	prep	O
the	DT	det	O
use	NN	pobj	O
of	IN	case	O
angiogenesis	NN	compound	O
inhibitors	NNS	nmod	O
for	IN	case	O
the	DT	det	O
treatment	NN	nmod	O
of	IN	case	O
breast	NN	nmod	B-Cancer
,	,	punct	O
lung	NN	conj	B-Cancer
,	,	punct	O
and	CC	cc	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	conj	I-Cancer
.	.	punct	O

Emodin	NN	nsubj	B-Simple_chemical
also	RB	advmod	O
induced	VBD	ROOT	O
differentiation	NN	dobj	O
of	IN	case	O
HER	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	intj	I-Gene_or_gene_product
/	:	punct	O
neu	NN	npadvmod	B-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
by	IN	mark	O
exhibiting	VBG	advcl	O
a	DT	det	O
morphological	JJ	amod	O
maturation	NN	compound	O
property	NN	dobj	O
of	IN	case	O
large	JJ	amod	O
lacy	JJ	compound	O
nuclei	NNS	nmod	B-Cellular_component
surrounded	VBN	acl	O
by	IN	case	O
sizable	JJ	amod	O
flat	JJ	compound	B-Organism_substance
cytoplasm	NN	nmod	I-Organism_substance
and	CC	cc	O
by	IN	mark	O
showing	VBG	advcl	O
a	DT	det	O
measurable	JJ	amod	O
production	NN	dobj	O
of	IN	case	O
large	JJ	amod	O
lipid	NN	compound	B-Simple_chemical
droplets	NNS	nmod	O
,	,	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
marker	NN	acl:relcl	O
of	IN	case	O
mature	JJ	amod	B-Cell
breast	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
report	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
murine	JJ	amod	B-Organism
bone	NN	compound	B-Multi-tissue_structure
marrow	NN	nsubj	I-Multi-tissue_structure
contains	VBZ	ccomp	O
endothelial	JJ	amod	B-Cell
progenitors	NNS	dobj	I-Cell
,	,	punct	O
which	WDT	nsubj	O
arise	VBP	acl:relcl	O
from	IN	case	O
a	DT	det	O
cell	NN	nmod	B-Cell
with	IN	case	O
self	NN	npadvmod	O
-	HYPH	punct	O
renewing	VBG	amod	O
capacity	NN	nmod	O
,	,	punct	O
and	CC	cc	O
can	MD	aux	O
integrate	VB	conj	O
into	IN	case	O
tumor	NN	compound	B-Tissue
microvasculature	NN	nmod	I-Tissue
,	,	punct	O
albeit	IN	mark	O
at	IN	case	O
a	DT	det	O
very	RB	advmod	O
low	JJ	amod	O
frequency	NN	nmod	O
.	.	punct	O

Inhibition	NN	nsubj	O
of	IN	case	O
either	CC	cc:preconj	O
PARP	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
caspase	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
blocked	VBD	ROOT	O
magnolol	NN	amod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
apoptosis	NN	dobj	O
,	,	punct	O
supporting	VBG	advcl	O
the	DT	det	O
involvement	NN	dobj	O
of	IN	case	O
the	DT	det	O
caspases	NNS	nmod	B-Gene_or_gene_product
and	CC	cc	O
PARP	NN	conj	B-Gene_or_gene_product
.	.	punct	O

By	IN	mark	O
ruling	VBG	advcl	O
out	RP	prt	O
cell	NN	compound	B-Cell
fusion	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
clearly	RB	advmod	O
demonstrate	VBP	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
an	DT	det	O
adult	JJ	amod	O
hemangioblast	NN	nmod	B-Cell
,	,	punct	O
but	CC	cc	O
the	DT	det	O
differentiation	NN	nsubj	O
of	IN	case	O
marrow	JJ	compound	B-Cell
stem	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
toward	IN	case	O
the	DT	det	O
endothelial	JJ	amod	B-Cell
lineage	NN	nmod	I-Cell
is	VBZ	cop	O
an	DT	det	O
extremely	RB	advmod	O
rare	JJ	amod	O
event	NN	conj	O
.	.	punct	O

There	EX	expl	O
is	VBZ	ROOT	O
also	RB	advmod	O
an	DT	det	O
implicit	JJ	amod	O
assumption	NN	attr	O
that	IN	mark	O
a	DT	det	O
mechanistic	JJ	amod	O
understanding	NN	nsubj	O
,	,	punct	O
although	IN	mark	O
fundamentally	RB	advmod	O
reductionist	NN	advcl	O
,	,	punct	O
will	MD	aux	O
nonetheless	RB	advmod	O
lead	VB	ccomp	O
to	TO	prep	O
a	DT	det	O
more	RBR	advmod	O
profound	JJ	amod	O
teleological	JJ	amod	O
understanding	NN	pobj	O
of	IN	prep	O
the	DT	det	O
need	NN	pobj	O
for	IN	case	O
altered	JJ	amod	O
metabolism	NN	nmod	O
in	IN	case	O
invasive	JJ	amod	O
cancers	NNS	nmod	B-Cancer
.	.	punct	O

Neoplastic	JJ	amod	O
progression	NN	nsubjpass	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
overexpression	NN	nmod	O
of	IN	case	O
the	DT	det	O
stromelysin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
and	CC	cc	O
BM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
SPARC	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
our	PRP$	nmod:poss	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
induction	NN	nsubj	O
of	IN	case	O
de	FW	amod	O
novo	FW	dep	O
lipid	NN	compound	B-Simple_chemical
synthesis	NN	nmod	O
by	IN	case	O
androgen	NN	nmod	B-Simple_chemical
requires	VBZ	ccomp	O
the	DT	det	O
transcriptional	JJ	amod	O
up	RP	dep	O
-	HYPH	punct	O
regulation	NN	dobj	O
of	IN	case	O
HK2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
PFKFB2	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
phosphorylation	NN	conj	O
of	IN	case	O
PFKFB2	NN	nmod	B-Gene_or_gene_product
generated	VBN	acl	O
by	IN	case	O
the	DT	det	O
PI3K	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	DT	nmod	B-Gene_or_gene_product
signalling	NN	compound	O
pathway	NN	nmod	O
to	TO	mark	O
supply	VB	xcomp	O
the	DT	det	O
source	NN	dobj	O
for	IN	case	O
lipogenesis	NN	nmod	O
from	IN	case	O
glucose	NN	nmod	B-Simple_chemical
in	IN	case	O
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Osteonectin	NNP	nsubj	B-Gene_or_gene_product
is	VBZ	ROOT	O
one	CD	attr	O
of	IN	prep	O
the	DT	det	O
major	JJ	amod	O
non	JJ	amod	O
-	HYPH	punct	O
collagenous	JJ	amod	O
proteins	NNS	pobj	O
of	IN	case	O
bone	NN	nmod	B-Tissue
.	.	punct	O

Apoptotic	JJ	amod	O
cells	NNS	nsubj	B-Cell
were	VBD	cop	O
more	RBR	advmod	O
numerous	JJ	ROOT	O
in	IN	case	O
RM	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
-	HYPH	punct	I-Cancer
IL12	NN	compound	I-Cancer
tumors	NNS	dobj	I-Cancer
:	:	punct	O
10	CD	dep	O
.	.	punct	O
3	CD	nummod	O
%	NN	ROOT	O
vs	CC	cc	O
.	.	punct	O
1	LS	ROOT	O
.	.	punct	O
5	CD	nummod	O
%	NN	ROOT	O
in	IN	case	O
control	NN	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
001	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

An	DT	det	O
image	NN	amod	O
analysis	NN	compound	O
system	NN	nsubjpass	O
was	VBD	auxpass	O
also	RB	advmod	O
used	VBN	ROOT	O
to	TO	mark	O
quantify	VB	xcomp	O
the	DT	det	O
proportion	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
nuclei	NNS	nmod	B-Cellular_component
with	IN	case	O
MDM2	NN	compound	B-Gene_or_gene_product
staining	NN	nmod	O
(	-LRB-	punct	O
ACIS	NN	compound	O
index	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
staining	VBG	compound	O
intensity	NN	conj	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
HMGA2	NN	compound	B-Gene_or_gene_product
knockdown	NN	nsubj	O
by	IN	case	O
short	JJ	amod	O
hairpin	NN	compound	O
HMGA2	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
HepG2	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
leads	VBZ	ROOT	O
to	TO	case	O
progressive	VB	amod	O
telomere	RB	compound	B-Cellular_component
shortening	VBG	nmod	O
and	CC	cc	O
a	DT	det	O
concurrent	JJ	amod	O
decrease	NN	conj	O
of	IN	case	O
steady	JJ	amod	O
-	HYPH	punct	O
state	NN	compound	O
hTERT	NN	compound	B-Gene_or_gene_product
mRNA	NN	compound	O
levels	NNS	nmod	O
,	,	punct	O
attenuating	VBG	xcomp	O
their	PRP$	nmod:poss	O
ability	NN	dobj	O
to	TO	aux	O
form	VB	acl	O
colonies	NNS	dobj	O
in	IN	prep	O
soft	JJ	amod	O
agar	NN	pobj	O
.	.	punct	O

Retinal	JJ	amod	B-Multi-tissue_structure
microangiopathies	NNS	nsubj	O
overlying	VBG	ROOT	O
pigment	NN	amod	B-Tissue
epithelial	JJ	amod	I-Tissue
detachment	NN	dobj	O
in	IN	prep	O
age	NN	npadvmod	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	pobj	O
.	.	punct	O

A	DT	det	O
reduction	NN	nsubj	O
in	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
collagen	NN	compound	B-Gene_or_gene_product
XII	NN	nmod	I-Gene_or_gene_product
might	MD	aux	O
have	VB	ROOT	O
profound	JJ	amod	O
effects	NNS	dobj	O
on	IN	case	O
the	DT	det	O
stability	NN	nmod	O
of	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
of	IN	case	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
The	DT	det	O
expression	NN	nsubjpass	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
in	IN	case	O
normal	JJ	amod	O
endometrial	JJ	amod	B-Multi-tissue_structure
glands	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
cancer	NN	compound	B-Cell
cell	NN	compound	I-Cell
lines	NNS	conj	I-Cell
was	VBD	auxpass	O
examined	VBN	dep	O
by	IN	case	O
RT	NN	nmod	O
-	HYPH	punct	O
PCR	NN	dep	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
.	.	punct	O

MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
increased	VBN	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
,	,	punct	O
but	CC	cc	O
no	DT	neg	O
expression	NN	nsubjpass	O
of	IN	case	O
MMP	NN	nmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
9	CD	nsubjpass	I-Gene_or_gene_product
was	VBD	auxpass	O
seen	VBN	conj	O
.	.	punct	O

The	DT	det	O
mechanism	NN	nsubj	O
proposed	VBN	acl	O
is	VBZ	cop	O
a	DT	det	O
stimulation	NN	ROOT	O
of	IN	case	O
angiogenesis	NN	nmod	O
for	IN	case	O
distant	JJ	amod	B-Cancer
dormant	JJ	amod	I-Cancer
micrometastases	NNS	nmod	I-Cancer
.	.	punct	O

Nude	JJ	compound	B-Organism
mice	NNS	nsubjpass	I-Organism
bearing	VBG	acl	O
ovarian	JJ	amod	B-Cancer
cancers	NNS	dobj	I-Cancer
were	VBD	auxpass	O
treated	VBN	ROOT	O
with	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
p	NN	compound	O
/	,	punct	O
liposome	NN	nmod	B-Simple_chemical
.	.	punct	O

Depletion	NN	nsubj	O
of	IN	case	O
polyphenol	NN	nmod	B-Simple_chemical
with	IN	case	O
polyvinylpyrrolidone	NN	nmod	B-Simple_chemical
abolished	VBD	ROOT	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	dobj	O
of	IN	case	O
GSE	NN	nmod	B-Organism_substance
,	,	punct	O
suggesting	VBG	advcl	O
a	DT	det	O
water	NN	nmod:npmod	O
-	HYPH	punct	O
soluble	JJ	amod	O
fraction	NN	nsubj	O
of	IN	case	O
polyphenol	NN	nmod	B-Simple_chemical
in	IN	case	O
GSE	NN	nmod	B-Organism_substance
is	VBZ	cop	O
responsible	JJ	ccomp	O
for	IN	case	O
the	DT	det	O
antiangiogenic	JJ	amod	O
activity	NN	nmod	O
.	.	punct	O

Photodynamic	JJ	amod	O
therapy	NN	ROOT	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
for	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
secondary	JJ	amod	O
to	TO	case	O
pathologic	JJ	amod	O
myopia	NN	nmod	O
:	:	punct	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
study	NN	dep	O
.	.	punct	O

In	IN	case	O
contrast	NN	nmod	O
,	,	punct	O
the	DT	det	O
incidence	NN	nsubj	O
and	CC	cc	O
density	NN	conj	O
of	IN	case	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptors	NNS	nmod	I-Gene_or_gene_product
in	IN	case	O
peritumoral	JJ	amod	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
was	VBD	cop	O
low	JJ	ROOT	O
in	IN	case	O
well	RB	advmod	O
-	HYPH	punct	O
differentiated	VBN	amod	O
gastrointestinal	JJ	amod	B-Cancer
and	CC	cc	O
bronchial	JJ	conj	B-Cancer
carcinoids	NNS	nmod	I-Cancer
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
the	DT	det	O
high	JJ	amod	O
density	NN	nmod	O
of	IN	case	O
such	JJ	amod	O
receptors	NNS	nmod	O
in	IN	case	O
the	DT	det	O
carcinoid	JJ	amod	B-Tissue
tumor	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
.	.	punct	O

These	DT	det	O
observations	NNS	nsubj	O
provide	VBP	ROOT	O
evidence	NN	dobj	O
that	IN	mark	O
enhanced	VBN	amod	O
proliferation	NN	nsubj	O
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
compromises	NNS	ccomp	O
teratocarcinoma	VBP	compound	B-Cell
cell	NN	compound	I-Cell
differentiation	NN	dobj	O
by	IN	case	O
a	DT	det	O
mechanism	NN	nmod	O
that	WDT	nsubj	O
transiently	RB	advmod	O
suppresses	VBZ	acl:relcl	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
induction	NN	dobj	O
and	CC	cc	O
implies	VBZ	conj	O
a	DT	det	O
central	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
in	IN	case	O
RA	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
differentiation	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
postulate	VBP	ROOT	O
that	IN	mark	O
endoscopic	JJ	amod	O
observation	NN	nsubj	O
is	VBZ	cop	O
valuable	JJ	ccomp	O
in	IN	mark	O
investigating	VBG	advcl	O
the	DT	det	O
development	NN	dobj	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
,	,	punct	O
and	CC	cc	O
microvascular	JJ	amod	B-Tissue
structure	NN	nsubj	O
and	CC	cc	O
lectin	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
pattern	NN	conj	O
may	MD	aux	O
be	VB	cop	O
useful	JJ	conj	O
to	TO	mark	O
demonstrate	VB	xcomp	O
the	DT	det	O
mechanism	NN	dobj	O
of	IN	case	O
growth	NN	nmod	O
of	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
magnolol	NN	nsubj	B-Simple_chemical
initiates	VBZ	ccomp	O
apoptosis	NN	dobj	O
via	IN	case	O
the	DT	dep	O
cytochrome	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
c	NN	compound	I-Gene_or_gene_product
/	:	punct	O
caspase	NN	nmod	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
PARP	NN	compound	B-Gene_or_gene_product
/	:	punct	O
AIF	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
PTEN	NN	compound	B-Gene_or_gene_product
/	:	punct	O
Akt	NNP	compound	B-Gene_or_gene_product
/	:	punct	O
caspase	NN	conj	B-Gene_or_gene_product
9	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
PARP	NN	compound	B-Gene_or_gene_product
pathways	NNS	conj	O
and	CC	cc	O
necrosis	NN	conj	O
via	IN	case	O
PARP	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

Since	IN	mark	O
other	JJ	amod	O
DNA	NN	compound	B-Cellular_component
tumor	NN	compound	B-Cancer
viruses	NNS	nsubjpass	O
,	,	punct	O
such	JJ	case	O
as	IN	mwe	O
simian	JJ	amod	B-Organism
virus	NN	nmod	I-Organism
40	CD	nummod	I-Organism
and	CC	cc	O
adenovirus	NN	conj	B-Organism
,	,	punct	O
have	VBP	aux	O
previously	RB	advmod	O
been	VBN	auxpass	O
shown	VBN	advcl	O
to	TO	mark	O
interact	VB	xcomp	O
with	IN	case	O
cellular	JJ	amod	B-Cell
protein	NN	compound	O
p53	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
investigated	VBD	ROOT	O
whether	IN	mark	O
infection	NN	nsubj	O
of	IN	case	O
cells	NNS	nmod	B-Cell
by	IN	case	O
HCMV	NN	nmod	B-Organism
would	MD	aux	O
modulate	VB	ccomp	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
.	.	punct	O

OBJECTIVE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
investigate	VB	dep	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nmod	O
in	IN	case	O
autogenous	JJ	amod	B-Multi-tissue_structure
bone	NN	compound	I-Multi-tissue_structure
graft	NN	nmod	I-Multi-tissue_structure
on	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Somatic	JJ	amod	B-Cell
cell	NN	compound	I-Cell
hybrids	NNS	nsubj	I-Cell
between	IN	case	O
LTA	NN	nmod	B-Cell
and	CC	cc	O
NIH	NN	compound	B-Cell
3T3	NN	compound	I-Cell
cells	NNS	conj	I-Cell
are	VBP	cop	O
tumorigenic	JJ	ROOT	O
,	,	punct	O
metastatic	JJ	conj	O
and	CC	cc	O
ras	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
responsive	JJ	conj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
most	RBS	advmod	O
current	JJ	amod	O
anti	NN	compound	O
-	HYPH	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product
agents	NNS	nsubj	O
often	RB	advmod	O
cause	VBP	ROOT	O
some	DT	det	O
side	JJ	amod	O
effects	NNS	dobj	O
when	WRB	advmod	O
given	VBN	advcl	O
chronically	RB	advmod	O
.	.	punct	O

Diallyl	NN	compound	B-Simple_chemical
trisulfide	NN	nsubj	I-Simple_chemical
(	-LRB-	punct	O
DATS	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
inhibits	VBZ	ROOT	O
mouse	NN	compound	B-Organism
colon	NN	compound	B-Cancer
tumor	NN	dobj	I-Cancer
in	IN	case	O
mouse	NN	compound	B-Organism
CT	NN	compound	B-Cell
-	:	punct	I-Cell
26	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
allograft	NN	xcomp	O
model	NN	dobj	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

The	DT	det	O
expression	NN	nsubj	O
of	IN	case	O
Cbl	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
plasma	NN	compound	B-Cellular_component
membrane	NN	compound	I-Cellular_component
targets	NNS	ROOT	O
both	CC	cc:preconj	O
Hck	NNP	dobj	B-Gene_or_gene_product
and	CC	cc	O
itself	PRP	conj	O
for	IN	case	O
ubiquitination	NN	nmod	O
and	CC	cc	O
degradation	NN	conj	O
,	,	punct	O
requiring	VBG	advcl	O
an	DT	det	O
intact	JJ	amod	O
RING	NN	compound	O
finger	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
is	VBZ	cop	O
possible	JJ	ROOT	O
that	IN	mark	O
the	DT	det	O
suppressive	JJ	amod	O
effect	NN	nsubj	O
of	IN	case	O
GA	NN	nmod	B-Simple_chemical
on	IN	case	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
/	SYM	punct	O
9	CD	dep	B-Gene_or_gene_product
might	MD	aux	O
involve	VB	ccomp	O
the	DT	det	O
inhibition	NN	dobj	O
of	IN	case	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
.	.	punct	O

Systemic	JJ	amod	O
administration	NN	nsubj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
or	CC	cc	O
LPS	NN	conj	B-Simple_chemical
in	IN	case	O
adult	JJ	amod	O
mice	NNS	nmod	B-Organism
resulted	VBD	ROOT	O
in	IN	case	O
cyclosporine	NN	compound	B-Simple_chemical
A	NN	nmod:npmod	I-Simple_chemical
-	HYPH	punct	O
sensitive	JJ	amod	O
reactivation	NN	nmod	O
of	IN	case	O
the	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product
promoter	NN	nmod	O
and	CC	cc	O
endogenous	JJ	amod	O
gene	NN	compound	O
expression	NN	conj	O
in	IN	case	O
a	DT	det	O
subset	NN	nmod	O
of	IN	case	O
organs	NNS	nmod	B-Organ
,	,	punct	O
including	VBG	prep	O
the	DT	det	O
heart	NN	pobj	B-Organ
and	CC	cc	O
brain	NN	conj	B-Organ
.	.	punct	O

Thus	RB	advmod	O
,	,	punct	O
such	PDT	predet	O
a	DT	det	O
resonating	NN	amod	O
cross	NN	compound	O
-	HYPH	punct	O
talk	NN	nsubj	O
can	MD	aux	O
amplify	VB	ROOT	O
Hedgehog	JJ	compound	B-Gene_or_gene_product
signaling	NN	dobj	O
,	,	punct	O
resulting	VBG	advcl	O
in	IN	case	O
molecular	JJ	amod	O
chatter	NN	nmod	O
that	WDT	nsubj	O
overall	RB	advmod	O
promotes	VBZ	acl:relcl	O
tumor	NN	compound	B-Cancer
progression	NN	dobj	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
inhibition	NN	nsubj	O
of	IN	case	O
PARP	NN	compound	B-Gene_or_gene_product
activity	NN	nmod	O
,	,	punct	O
but	CC	cc	O
not	RB	neg	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
activity	NN	conj	O
,	,	punct	O
completely	RB	advmod	O
prevented	VBD	ROOT	O
magnolol	NN	compound	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
necrosis	NN	dobj	O
,	,	punct	O
suggesting	VBG	advcl	O
the	DT	det	O
notion	NN	dobj	O
that	IN	mark	O
it	PRP	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
depletion	NN	nmod	O
of	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
ATP	NN	compound	B-Simple_chemical
levels	NNS	nmod	O
due	JJ	case	O
to	TO	mwe	O
PARP	NN	compound	B-Gene_or_gene_product
activation	NN	nmod	O
.	.	punct	O

In	IN	case	O
summary	NN	nmod	O
,	,	punct	O
these	DT	det	O
novel	JJ	amod	O
studies	NNS	nsubj	O
identify	VBP	ROOT	O
and	CC	cc	O
characterize	VBP	conj	O
a	DT	det	O
marked	JJ	amod	O
glucose	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
modulated	VBN	amod	O
activation	NN	compound	O
response	NN	dobj	O
of	IN	case	O
the	DT	det	O
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
hexokinase	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
to	TO	case	O
hypoxic	JJ	amod	O
conditions	NNS	nmod	O
within	IN	case	O
highly	RB	advmod	O
glycolytic	JJ	amod	O
hepatoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
a	DT	det	O
property	NN	appos	O
that	WDT	nsubj	O
may	MD	aux	O
help	VB	acl:relcl	O
assure	VB	dobj	O
that	IN	mark	O
such	JJ	amod	O
cells	NNS	nsubj	B-Cell
exhibit	VBP	ccomp	O
a	DT	det	O
growth	NN	compound	O
and	CC	cc	O
survival	NN	conj	O
advantage	NN	dobj	O
over	IN	case	O
their	PRP$	nmod:poss	O
parental	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
of	IN	case	O
origin	NN	nmod	O
.	.	punct	O

The	DT	det	O
efficacy	NN	nsubjpass	O
of	IN	case	O
the	DT	det	O
antitumor	NN	compound	B-Cancer
activity	NN	nmod	O
of	IN	case	O
1	CD	nummod	B-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
acetoxychavicol	NN	compound	I-Simple_chemical
acetate	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
ACA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
reported	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
a	DT	det	O
suppressor	NN	xcomp	O
of	IN	case	O
chemically	RB	advmod	O
induced	VBN	amod	O
carcinogenesis	NN	nmod	O
,	,	punct	O
was	VBD	auxpass	O
evaluated	VBN	ROOT	O
in	IN	case	O
Ehrlich	NN	nmod	B-Cell
ascites	VBZ	ccomp	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

Angiogenesis	NN	nsubj	O
is	VBZ	cop	O
essential	JJ	ROOT	O
for	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
metastasis	NN	conj	O
.	.	punct	O

In	IN	case	O
all	DT	det	O
cases	NNS	nmod	O
,	,	punct	O
the	DT	det	O
somatostatin	NN	compound	B-Gene_or_gene_product
receptors	NNS	nsubj	I-Gene_or_gene_product
were	VBD	aux	O
localized	JJ	ROOT	O
in	IN	case	O
veins	NNS	nmod	B-Multi-tissue_structure
,	,	punct	O
particularly	RB	advmod	O
in	IN	case	O
the	DT	det	O
smooth	NN	amod	B-Tissue
-	HYPH	punct	I-Tissue
muscle	NN	compound	I-Tissue
cell	NN	compound	I-Tissue
layer	NN	appos	I-Tissue
.	.	punct	O

In	IN	case	O
a	DT	det	O
multivariate	JJ	amod	O
analysis	NN	nmod	O
D2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	nummod	I-Gene_or_gene_product
+	CC	cc	O
was	VBD	cop	O
the	DT	det	O
strongest	JJS	amod	O
predictor	NN	ROOT	O
for	IN	case	O
ALNM	NN	nmod	O
with	IN	case	O
an	DT	det	O
odds	NNS	compound	O
ratio	NN	nmod	O
of	IN	case	O
3	CD	nmod	O
.	.	punct	O
489	CD	nummod	O
and	CC	cc	O
a	DT	det	O
P	NN	compound	O
-	HYPH	punct	O
value	NN	nsubj	O
of	IN	case	O
P	NN	nmod	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
0003	CD	ROOT	O
,	,	punct	O
followed	VBN	acl	O
only	RB	advmod	O
by	IN	case	O
T	NN	compound	O
-	HYPH	punct	O
stage	NN	nmod	O
and	CC	cc	O
grading	VBG	conj	O
with	IN	prep	O
odds	NNS	compound	O
ratios	NNS	pobj	O
of	IN	prep	O
3	CD	pobj	O
.	.	punct	O
167	CD	nummod	O
and	CC	cc	O
1	CD	conj	O
.	.	punct	O
953	CD	dep	O
and	CC	cc	O
P	NN	conj	O
-	HYPH	punct	O
values	NNS	dep	O
P	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
0003	CD	ROOT	O
and	CC	cc	O
P	NN	nsubj	O
=	JJ	conj	O
0	CD	dobj	O
.	.	punct	O
0352	CD	dobj	O
.	.	punct	O

Nitric	JJ	amod	B-Gene_or_gene_product
oxide	NN	compound	I-Gene_or_gene_product
synthase	NN	compound	I-Gene_or_gene_product
inhibition	NN	nsubj	O
results	VBZ	ROOT	O
in	IN	case	O
synergistic	JJ	amod	O
anti	JJ	compound	O
-	HYPH	punct	O
tumour	NN	compound	B-Cancer
activity	NN	nmod	O
with	IN	case	O
melphalan	NN	nmod	B-Simple_chemical
and	CC	cc	O
tumour	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
alpha	NN	conj	I-Gene_or_gene_product
-	HYPH	punct	O
based	VBN	amod	O
isolated	VBN	amod	O
limb	NN	compound	B-Organism_subdivision
perfusions	NNS	conj	O
.	.	punct	O

CONCLUSION	NN	dep	O
:	:	punct	O
Loss	NN	nsubj	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
FBXW7	NN	appos	B-Gene_or_gene_product
appears	VBZ	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
EOGC	NN	nmod	B-Cancer
and	CC	cc	O
conventional	JJ	amod	O
gastric	JJ	amod	B-Organ
carcinogenesis	NN	conj	O
,	,	punct	O
and	CC	cc	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
overexpression	NN	nsubj	O
is	VBZ	cop	O
likely	JJ	conj	O
to	TO	mark	O
be	VB	cop	O
an	DT	det	O
important	JJ	amod	O
oncogenic	JJ	amod	O
consequence	NN	xcomp	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product
/	:	punct	O
FBXW7	NN	compound	B-Gene_or_gene_product
loss	NN	nmod	O
.	.	punct	O

The	DT	det	O
vascular	JJ	amod	B-Multi-tissue_structure
anomalies	NNS	nsubj	O
seem	VBP	ROOT	O
to	TO	mark	O
precede	VB	xcomp	O
the	DT	det	O
development	NN	dobj	O
of	IN	prep	O
histologic	JJ	amod	B-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
in	IN	prep	O
some	DT	det	O
instances	NNS	pobj	O
.	.	punct	O

Anti	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
endosialin	NN	nsubj	I-Gene_or_gene_product
was	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
preventing	VBG	advcl	O
pericyte	NN	compound	B-Cell
tube	NN	compound	B-Tissue
formation	NN	dobj	O
in	IN	case	O
culture	NN	nmod	B-Cell
and	CC	cc	O
inhibited	VBD	conj	O
migration	NN	dobj	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
their	PRP$	poss	O
potency	NN	nsubj	O
toward	IN	prep	O
individual	JJ	amod	O
targets	NNS	pobj	O
can	MD	aux	O
vary	VB	ROOT	O
.	.	punct	O

A	DT	det	O
lesion	NN	nsubjpass	B-Pathological_formation
was	VBD	auxpass	O
considered	VBN	ROOT	O
subfoveal	JJ	oprd	O
if	IN	mark	O
it	PRP	nsubj	O
extended	VBD	advcl	O
underneath	IN	prep	O
the	DT	det	O
geometric	JJ	amod	O
center	NN	pobj	O
of	IN	prep	O
the	DT	det	O
FAZ	NN	pobj	B-Tissue
.	.	punct	O

Increased	VBN	amod	O
apoptosis	NN	nsubjpass	O
of	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
decreased	VBD	amod	O
angiogenesis	NN	conj	O
in	IN	case	O
tumor	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
.	.	punct	O

Following	VBG	ROOT	O
i	LS	dobj	O
.	.	punct	O
v	LS	ROOT	O
.	.	punct	O
infusion	NN	nsubjpass	O
with	IN	case	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
alanine	NN	nmod	I-Simple_chemical
,	,	punct	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	dep	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
lactate	NN	conj	I-Simple_chemical
and	CC	cc	O
glutamate	NN	conj	B-Amino_acid
,	,	punct	O
evidence	NN	conj	O
of	IN	case	O
oxidation	NN	nmod	O
via	IN	case	O
the	DT	det	O
TCA	NN	compound	B-Simple_chemical
cycle	NN	nmod	O
,	,	punct	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
in	IN	case	O
H4	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
dominant	JJ	amod	O
negative	JJ	amod	O
mutant	NN	nsubj	O
of	IN	case	O
Rac1	NN	nmod	B-Gene_or_gene_product
completely	RB	advmod	O
inhibited	VBD	ROOT	O
ephrin	NN	amod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B1	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	dobj	O
and	CC	cc	O
focal	JJ	amod	B-Cellular_component
complex	NN	compound	I-Cellular_component
assembly	NN	conj	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
Abdominal	JJ	amod	O
surgery	NN	nsubj	O
can	MD	aux	O
lead	VB	appos	O
to	TO	case	O
intra	JJ	amod	O
-	HYPH	punct	O
abdominal	JJ	amod	O
adhesions	NNS	nmod	O
with	IN	case	O
significant	JJ	amod	O
morbidity	NN	nmod	O
and	CC	cc	O
mortality	NN	conj	O
.	.	punct	O

LVI	NN	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	ROOT	O
with	IN	case	O
axillary	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
(	-LRB-	punct	O
ALNM	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
a	DT	det	O
long	JJ	amod	O
-	HYPH	punct	O
term	NN	compound	O
prognostic	JJ	amod	O
factor	NN	conj	O
.	.	punct	O

After	IN	prep	O
seizures	NNS	pobj	O
,	,	punct	O
blood	NN	compound	B-Multi-tissue_structure
-	HYPH	punct	I-Multi-tissue_structure
brain	NN	compound	I-Multi-tissue_structure
barrier	NN	amod	I-Multi-tissue_structure
breakdown	NN	nsubjpass	O
and	CC	cc	O
inflammation	NN	conj	O
is	VBZ	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
brain	NN	nmod	B-Organ
,	,	punct	O
albeit	IN	mark	O
on	IN	case	O
a	DT	det	O
lower	JJR	amod	O
scale	NN	advcl	O
than	IN	case	O
that	DT	nmod	O
observed	VBN	acl	O
after	IN	prep	O
stroke	NN	pobj	O
.	.	punct	O

Since	IN	mark	O
all	PDT	det:predet	O
these	DT	det	O
cells	NNS	nsubj	B-Cell
lack	VBP	advcl	O
any	DT	det	O
mRNA	NN	dobj	O
for	IN	case	O
collagen	NN	nmod	B-Gene_or_gene_product
,	,	punct	I-Gene_or_gene_product
XII	NN	appos	I-Gene_or_gene_product
,	,	punct	O
it	PRP	nsubj	O
seems	VBZ	ROOT	O
likely	JJ	xcomp	O
that	IN	mark	O
the	DT	det	O
synthesis	NN	nsubjpass	O
is	VBZ	auxpass	O
blocked	VBN	ccomp	O
at	IN	case	O
the	DT	det	O
transcriptional	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

Grape	NN	compound	B-Organism_substance
seed	NN	compound	I-Organism_substance
extract	NN	nsubjpass	I-Organism_substance
(	-LRB-	punct	O
GSE	NN	appos	B-Organism_substance
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
widely	RB	advmod	O
used	VBN	amod	O
dietary	JJ	amod	O
supplement	NN	appos	O
,	,	punct	O
is	VBZ	auxpass	O
known	VBN	ROOT	O
to	TO	mark	O
have	VB	xcomp	O
antitumor	NN	compound	B-Cancer
activity	NN	dobj	O
.	.	punct	O

Artemisinin	NN	nsubj	B-Simple_chemical
inhibits	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
lymphangiogenesis	NN	dobj	O
by	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
C	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Sequencing	NN	nsubj	O
of	IN	case	O
exons	NNS	nmod	O
5	CD	nummod	O
through	IN	case	O
8	CD	nmod	O
of	IN	case	O
the	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
revealed	VBD	ROOT	O
no	DT	neg	O
mutations	NNS	dobj	O
,	,	punct	O
nor	CC	cc	O
were	VBD	conj	O
mutations	NNS	nsubj	O
detected	VBN	acl	O
in	IN	case	O
the	DT	det	O
N	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
or	CC	cc	O
K	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	conj	I-Gene_or_gene_product
protooncogenes	NNS	nmod	O
in	IN	case	O
four	CD	nmod	O
of	IN	case	O
the	DT	det	O
carcinomas	NNS	nmod	B-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
respective	JJ	amod	O
metastatic	JJ	amod	O
deposits	NNS	conj	B-Cancer
.	.	punct	O

No	DT	neg	O
significant	JJ	amod	O
association	NN	nsubjpass	O
was	VBD	auxpass	O
demonstrated	VBN	ROOT	O
between	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
B	NNP	nmod	I-Gene_or_gene_product
,	,	punct	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	conj	I-Gene_or_gene_product
,	,	punct	O
flt	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
,	,	punct	O
KDR	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
flt	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
with	IN	case	O
patient	NN	compound	B-Organism
sex	NN	nmod	O
,	,	punct	O
patient	NN	compound	B-Organism
age	NN	conj	O
,	,	punct	O
or	CC	cc	O
tumor	NN	compound	B-Cancer
size	NN	conj	O
(	-LRB-	punct	O
P	NN	dep	O
greater	JJR	amod	O
than	IN	case	O
0	CD	nmod	O
.	.	punct	O
05	CD	dep	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
also	RB	advmod	O
found	VBD	ROOT	O
an	DT	det	O
increase	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
and	CC	cc	O
lung	NN	compound	B-Organ
metastasis	NN	conj	O
count	NN	acl	O
in	IN	case	O
TB4	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
Tg	NN	compound	O
mice	NNS	nmod	O
as	IN	mark	O
compared	VBN	advcl	O
to	TO	case	O
wildtype	JJ	compound	O
mice	NNS	nmod	B-Organism
.	.	punct	O

Increased	VBN	amod	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	compound	O
protein	NN	compound	O
expression	NN	nsubj	O
may	MD	aux	O
contribute	VB	ROOT	O
to	TO	case	O
the	DT	det	O
increased	VBN	amod	O
uptake	NN	nmod	O
of	IN	case	O
2	CD	nummod	B-Simple_chemical
-	SYM	punct	I-Simple_chemical
[	-LRB-	punct	I-Simple_chemical
18F	NN	nummod	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
-	:	punct	I-Simple_chemical
fluoro	NNS	compound	I-Simple_chemical
-	:	punct	I-Simple_chemical
2	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
deoxy	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
D	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
glucose	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
FDG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
by	IN	case	O
these	DT	det	O
tumors	NNS	nmod	B-Cancer
observed	VBN	acl	O
by	IN	case	O
positron	NN	compound	O
emission	NN	compound	O
tomography	NN	nmod	O
(	-LRB-	punct	O
PET	NN	appos	O
)	-RRB-	punct	O
imaging	NN	acl	O
.	.	punct	O

This	DT	nsubj	O
implies	VBZ	ROOT	O
that	IN	mark	O
enhancing	VBG	nsubj	O
Nrf2	NN	compound	B-Gene_or_gene_product
activity	NN	dobj	O
is	VBZ	cop	O
a	DT	det	O
promising	JJ	amod	O
method	NN	ccomp	O
for	IN	prep	O
thwarting	VBG	pcomp	O
cancer	NN	dobj	B-Cancer
.	.	punct	O

Transfection	NN	nsubj	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
alone	RB	advmod	O
,	,	punct	O
led	VBD	ROOT	O
to	TO	case	O
the	DT	det	O
immortalization	NN	nmod	O
of	IN	case	O
two	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
three	CD	nummod	O
cultures	NNS	nmod	O
of	IN	case	O
bone	NN	compound	B-Cell
marrow	NN	nmod:npmod	I-Cell
-	HYPH	punct	I-Cell
derived	VBN	amod	I-Cell
ECs	NNS	nmod	I-Cell
(	-LRB-	punct	O
BMECs	NNS	appos	B-Cell
)	-RRB-	punct	O
.	.	punct	O

Increasing	VBG	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
EMT	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
specific	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
the	DT	det	O
migration	NN	nmod	O
of	IN	case	O
cells	NNS	nmod	B-Cell
from	IN	case	O
a	DT	det	O
primary	JJ	amod	O
tumor	NN	nmod	B-Cancer
into	IN	case	O
the	DT	det	O
circulation	NN	nmod	O
and	CC	cc	O
may	MD	aux	O
provide	VB	conj	O
a	DT	det	O
rationale	NN	dobj	O
for	IN	mark	O
developing	VBG	acl	O
more	RBR	advmod	O
effective	JJ	amod	O
cancer	NN	compound	B-Cancer
therapies	NNS	dobj	O
.	.	punct	O

One	CD	nummod	O
hTERT	NN	compound	B-Gene_or_gene_product
transduced	VBD	amod	O
BMEC	NN	compound	B-Cell
culture	NN	nsubj	O
underwent	VBD	ROOT	O
a	DT	det	O
long	JJ	amod	O
proliferative	JJ	amod	O
lag	NN	dobj	O
before	IN	mark	O
resuming	VBG	advcl	O
proliferation	NN	dobj	O
.	.	punct	O

Thus	RB	advmod	O
the	DT	det	O
results	NNS	nsubj	O
obtained	VBN	acl	O
by	IN	case	O
31P	NN	nmod	B-Simple_chemical
and	CC	cc	O
13C	NN	conj	B-Simple_chemical
MRS	NN	conj	O
correlated	VBD	ROOT	O
with	IN	case	O
the	DT	det	O
differentiation	NN	compound	O
state	NN	nmod	O
of	IN	case	O
H4	NN	nmod	B-Cell
and	CC	cc	O
H5	NN	conj	B-Cell
spheroids	NNS	dep	I-Cell
and	CC	cc	O
tumors	NNS	conj	B-Cancer
.	.	punct	O

Treatment	NN	nsubj	O
with	IN	case	O
suberoylanilide	NN	amod	B-Simple_chemical
hydroxamide	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
SAHA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
histone	NN	compound	B-Gene_or_gene_product
deacetylase	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
HDAC	NN	compound	B-Gene_or_gene_product
)	-RRB-	punct	O
inhibitor	NN	appos	O
,	,	punct	O
causes	VBZ	ROOT	O
dose	NN	nmod:npmod	O
-	HYPH	punct	O
dependent	JJ	amod	O
hTERT	NN	compound	B-Gene_or_gene_product
reporter	NN	compound	O
activation	NN	dobj	O
,	,	punct	O
mimicking	VBG	advcl	O
HMGA2	NN	compound	B-Gene_or_gene_product
overexpression	NN	dobj	O
.	.	punct	O

As	IN	mark	O
reported	VBN	advcl	O
previously	RB	advmod	O
(	-LRB-	punct	O
Namba	NNP	dep	O
et	FW	dep	O
al	FW	conj	O
.	NNP	punct	O
,	,	punct	O
1985	CD	appos	O
;	:	punct	O
Namba	NNP	conj	O
,	,	punct	O
1985	CD	appos	O
)	-RRB-	punct	O
,	,	punct	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
fibroblasts	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
transformed	VBN	ROOT	O
into	IN	case	O
immortal	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
with	IN	case	O
abnormal	JJ	amod	O
karyotypes	NNS	nmod	O
by	IN	case	O
Co	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
60	CD	nummod	I-Simple_chemical
gamma	NN	compound	O
-	HYPH	punct	O
ray	NN	compound	O
irradiation	NN	nmod	O
.	.	punct	O

The	DT	det	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
oncogene	NN	nsubj	O
encodes	VBZ	ROOT	O
for	IN	case	O
a	DT	det	O
transcriptional	JJ	amod	O
factor	NN	nmod	O
involved	VBN	acl	O
in	IN	case	O
many	JJ	amod	O
cellular	JJ	amod	B-Cell
processes	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
proliferation	NN	nmod	O
,	,	punct	O
differentiation	NN	conj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nummod	O
male	JJ	amod	O
wistar	NN	compound	B-Organism
rats	NNS	nsubj	I-Organism
randomly	RB	advmod	O
divided	VBN	appos	O
into	IN	prep	O
four	CD	nummod	O
groups	NNS	pobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
address	VBP	ROOT	O
the	DT	det	O
mechanism	NN	dobj	O
by	IN	case	O
which	WDT	nmod	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
phosphorylation	NN	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	acl:relcl	O
by	IN	case	O
dopamine	NN	nmod	B-Simple_chemical
.	.	punct	O

Glutamine	NN	compound	B-Amino_acid
consumption	NN	nsubj	O
in	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
was	VBD	cop	O
higher	JJR	ROOT	O
than	IN	case	O
with	IN	case	O
glutamine	NN	nmod	B-Amino_acid
alone	RB	advmod	O
.	.	punct	O

Two	CD	nsubjpass	O
of	IN	case	O
them	PRP	nmod	O
were	VBD	auxpass	O
selected	VBN	ROOT	O
for	IN	case	O
high	JJ	nmod	O
or	CC	cc	O
low	JJ	conj	O
osteonectin	NN	dep	B-Gene_or_gene_product
expression	NN	dep	O
and	CC	cc	O
tested	VBN	conj	O
in	FW	compound	O
vivo	FW	advmod	O
in	IN	case	O
spontaneous	JJ	amod	O
and	CC	cc	O
artificial	JJ	conj	O
metastasis	NN	compound	O
assays	NNS	nmod	O
.	.	punct	O

All	DT	det	O
slides	NNS	nsubjpass	O
were	VBD	auxpass	O
screened	VBN	ROOT	O
for	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
LVI	NN	nmod	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
association	NN	dobj	O
between	IN	case	O
tumour	NN	compound	B-Cancer
location	NN	nmod	O
,	,	punct	O
tumour	NN	compound	B-Cancer
grade	NN	compound	O
and	CC	cc	O
node	NN	conj	B-Multi-tissue_structure
status	NN	conj	O
and	CC	cc	O
the	DT	det	O
methylation	NN	compound	O
status	NN	conj	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	:	nsubj	O
=	JJ	advcl	O
0	CD	dobj	O
.	.	punct	O
05	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

At	IN	prep	O
this	DT	det	O
time	NN	pobj	O
,	,	punct	O
the	DT	det	O
cells	NNS	poss	B-Cell
'	POS	case	O
growth	NN	nsubjpass	O
is	VBZ	auxpass	O
arrested	VBN	ROOT	O
at	IN	prep	O
very	RB	advmod	O
high	JJ	amod	O
density	NN	pobj	O
,	,	punct	O
and	CC	cc	O
no	DT	neg	O
differentiated	VBN	amod	O
morphologic	JJ	amod	O
characteristics	NNS	nsubjpass	O
are	VBP	auxpass	O
observed	VBN	conj	O
.	.	punct	O

Historically	RB	advmod	O
,	,	punct	O
PDT	NN	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
limited	VBN	ROOT	O
by	IN	case	O
a	DT	det	O
lack	NN	nmod	O
of	IN	case	O
suitable	JJ	amod	O
photosensitive	JJ	amod	O
dyes	NNS	nmod	O
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
assess	VB	dep	O
the	DT	det	O
safety	NN	dobj	O
and	CC	cc	O
effectiveness	NN	conj	O
of	IN	case	O
photodynamic	JJ	amod	O
therapy	NN	nmod	O
(	-LRB-	punct	O
PDT	NN	appos	O
)	-RRB-	punct	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
for	IN	case	O
subfoveal	JJ	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
(	-LRB-	punct	O
CNV	NN	appos	O
)	-RRB-	punct	O
secondary	JJ	amod	O
to	TO	case	O
pathologic	JJ	amod	O
myopia	NN	nmod	O
(	-LRB-	punct	O
PM	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

We	PRP	nsubj	O
undertook	VBD	ROOT	O
this	DT	det	O
study	NN	dobj	O
to	TO	mark	O
test	VB	xcomp	O
the	DT	det	O
hypothesis	NN	dobj	O
that	IN	mark	O
Fas	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
FasL	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
apoptosis	NN	nsubj	O
plays	VBZ	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
IL	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
tumor	NN	compound	B-Cancer
regression	NN	nmod	O
.	.	punct	O

This	DT	det	O
work	NN	nsubj	O
illustrates	VBZ	ROOT	O
alternate	JJ	amod	O
means	NNS	dobj	O
to	TO	aux	O
regulate	VB	xcomp	O
Src	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
family	NN	compound	O
kinases	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
suggests	VBZ	conj	O
that	IN	mark	O
Cbl	NN	nsubj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
able	JJ	ccomp	O
to	TO	mark	O
suppress	VB	xcomp	O
many	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
activated	VBN	acl:relcl	O
in	IN	case	O
various	JJ	amod	O
proliferative	JJ	amod	O
syndromes	NNS	nmod	O
including	VBG	case	O
cancer	NN	nmod	B-Cancer
.	.	punct	O

Angiogenesis	NN	ROOT	O
:	:	punct	O
initiation	NN	dep	O
and	CC	cc	O
control	NN	conj	O
.	.	punct	O

[	-LRB-	punct	O
Intraepithelial	JJ	amod	B-Cancer
neoplasm	NN	ROOT	I-Cancer
of	IN	case	O
the	DT	det	O
uterine	NN	amod	B-Multi-tissue_structure
cervix	NNS	nmod	I-Multi-tissue_structure
and	CC	cc	O
angiogenesis	NN	conj	O
:	:	punct	O
morphologic	JJ	amod	O
study	NN	dep	O
]	-RRB-	punct	O

CONCLUSION	NN	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
observations	NNS	nsubj	O
suggest	VBP	appos	O
that	IN	mark	O
DCC	NN	compound	B-Gene_or_gene_product
/	:	punct	O
netrin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
signaling	NN	nsubj	O
may	MD	aux	O
commit	VB	ccomp	O
cells	NNS	dobj	B-Cell
to	TO	case	O
the	DT	det	O
transition	NN	nmod	O
of	IN	case	O
endometrial	JJ	amod	B-Multi-tissue_structure
gland	NN	compound	I-Multi-tissue_structure
architecture	NN	nmod	O
or	CC	cc	O
function	NN	conj	O
from	IN	case	O
a	DT	det	O
proliferating	VBG	nmod	O
to	TO	case	O
a	DT	det	O
secretory	JJ	amod	O
phase	NN	nmod	O
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
establish	VBP	ROOT	O
a	DT	det	O
novel	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
SHP	NN	compound	B-Gene_or_gene_product
-	CC	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
phosphatase	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
the	DT	det	O
dopamine	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
mediated	VBN	amod	O
regulation	NN	nmod	O
of	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
phosphorylation	NN	nmod	O
.	.	punct	O

Overexpression	NN	nsubj	O
of	IN	prep	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ski	NNP	pobj	I-Gene_or_gene_product
inhibited	VBD	ROOT	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	dobj	O
in	IN	case	O
OCUM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
2MLN	CD	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

After	IN	case	O
MNNG	NN	compound	B-Simple_chemical
administration	NN	nmod	O
,	,	punct	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
investigated	VBN	ROOT	O
by	IN	case	O
endoscopic	JJ	amod	O
observation	NN	nmod	O
,	,	punct	O
visualization	NN	appos	O
of	IN	case	O
microvascular	JJ	amod	B-Tissue
structure	NN	nmod	O
,	,	punct	O
and	CC	cc	O
estimation	NN	conj	O
of	IN	case	O
lectin	NN	compound	B-Gene_or_gene_product
binding	NN	compound	O
sites	NNS	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
WAP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
mice	NNS	nsubj	B-Organism
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
WAP	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	O
mutCK1delta	NN	nmod:npmod	B-Gene_or_gene_product
/	:	punct	O
WAP	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
T	NNP	nmod:npmod	I-Gene_or_gene_product
bi	IN	advmod	O
-	HYPH	punct	O
transgenic	JJ	amod	O
mice	NNS	conj	O
developed	VBD	ROOT	O
breast	NN	compound	B-Cancer
cancer	NN	dobj	I-Cancer
.	.	punct	O

The	DT	det	O
ST3	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
BM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	conj	I-Gene_or_gene_product
/	SYM	punct	O
SPARC	NN	compound	B-Gene_or_gene_product
transcripts	NNS	nsubjpass	O
were	VBD	auxpass	O
overexpressed	VBN	ROOT	O
in	IN	case	O
primary	JJ	amod	O
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
and	CC	cc	O
their	PRP$	nmod:poss	O
liver	NN	compound	B-Organ
metastases	NNS	conj	O
compared	VBN	prep	O
to	TO	case	O
non	JJ	advmod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
mucosa	NN	nmod	B-Multi-tissue_structure
.	.	punct	O

In	IN	mark	O
order	NN	mwe	O
to	TO	dep	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
coordinated	VBN	amod	O
regulation	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
and	CC	cc	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
matrix	NN	conj	B-Cellular_component
interactions	NNS	nmod	O
during	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
studied	VBN	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
syndecan	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
malignant	JJ	amod	B-Cell
mammary	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
genetically	RB	advmod	O
manipulated	VBD	acl	O
for	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
expression	NN	nmod	O
.	.	punct	O

Staining	NN	nsubj	O
of	IN	case	O
the	DT	det	O
normal	JJ	amod	O
mammary	JJ	amod	B-Tissue
epithelium	NN	nmod	I-Tissue
,	,	punct	O
if	IN	mark	O
present	JJ	advcl	O
,	,	punct	O
was	VBD	cop	O
much	RB	advmod	O
lower	JJR	ROOT	O
than	IN	mark	O
observed	VBN	advcl	O
in	IN	case	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
from	IN	case	O
the	DT	det	O
same	JJ	amod	O
patient	NN	nmod	B-Organism
.	.	punct	O

This	DT	nsubj	O
creates	VBZ	ROOT	O
a	DT	det	O
network	NN	dobj	O
of	IN	prep	O
Hedgehog	NNP	compound	B-Gene_or_gene_product
signaling	NN	pobj	O
that	WDT	nsubj	O
determines	VBZ	relcl	O
the	DT	det	O
malignant	JJ	amod	O
behavior	NN	dobj	O
of	IN	case	O
the	DT	det	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

A	DT	det	O
number	NN	nsubjpass	O
of	IN	case	O
signaling	NN	compound	O
cascades	NNS	nmod	O
have	VBP	aux	O
been	VBN	auxpass	O
shown	VBN	ROOT	O
to	TO	mark	O
play	VB	xcomp	O
important	JJ	amod	O
roles	NNS	dobj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	compound	I-Cancer
development	NN	nmod	O
and	CC	cc	O
progression	NN	conj	O
,	,	punct	O
including	VBG	case	O
the	DT	det	O
androgen	NN	compound	B-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
AR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
phosphatidylinositol	NN	compound	B-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kinase	NN	dep	I-Gene_or_gene_product
/	:	punct	O
Akt	DT	compound	B-Gene_or_gene_product
signaling	NN	compound	O
pathways	NNS	conj	O
.	.	punct	O

It	PRP	nsubj	O
activated	VBD	ROOT	O
multicaspases	NNS	dobj	O
,	,	punct	O
and	CC	cc	O
increased	VBD	conj	O
the	DT	det	O
activities	NNS	dobj	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
8	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
caspase	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	dep	I-Gene_or_gene_product
in	IN	case	O
both	DT	cc:preconj	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	dep	I-Cell
and	CC	cc	O
SaOS	NNP	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Levels	NNS	nsubjpass	O
of	IN	case	O
uPA	NN	compound	B-Gene_or_gene_product
,	,	punct	O
urokinase	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
plasminogen	NN	compound	I-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
uPAR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
plasminogen	NN	compound	B-Gene_or_gene_product
activator	NN	compound	I-Gene_or_gene_product
inhibitor	NN	conj	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
PAI	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
were	VBD	auxpass	O
measured	VBN	ROOT	O
semiquantitatively	RB	advmod	O
in	IN	case	O
paraffin	NN	amod	O
sections	NNS	nmod	B-Cancer
of	IN	case	O
tumours	NNS	nmod	B-Cancer
from	IN	case	O
147	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
NSCLC	NN	nmod	B-Cancer
.	.	punct	O

We	PRP	nsubj	O
now	RB	advmod	O
report	VBP	ROOT	O
that	IN	mark	O
six	CD	nummod	O
different	JJ	amod	O
genes	NNS	nsubjpass	O
of	IN	case	O
the	DT	det	O
cluster	NN	compound	O
HOX	NN	nmod	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
are	VBP	auxpass	O
sequentially	RB	advmod	O
induced	VBN	ccomp	O
by	IN	case	O
RA	NN	nmod	B-Simple_chemical
in	IN	case	O
a	DT	det	O
similar	JJ	amod	O
temporal	JJ	amod	O
pattern	NN	nmod	O
,	,	punct	O
beginning	VBG	advcl	O
with	IN	case	O
genes	NNS	nmod	O
at	IN	case	O
the	DT	det	O
3	CD	nummod	O
'	``	punct	O
end	NN	nmod	O
of	IN	case	O
the	DT	det	O
cluster	NN	nmod	O
.	.	punct	O

BACKGROUND	NN	dep	O
:	:	punct	O
Recent	JJ	amod	O
data	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
anti	JJ	amod	O
-	HYPH	punct	O
tumor	NN	compound	B-Cancer
activities	NNS	nsubj	O
of	IN	case	O
interleukin	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
12	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
IL	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
12	CD	nmod	I-Gene_or_gene_product
)	-RRB-	punct	O
involve	VBP	ccomp	O
the	DT	det	O
induction	NN	dobj	O
of	IN	case	O
apoptosis	NN	nmod	O
.	.	punct	O

The	DT	det	O
nature	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
substrates	NNS	nmod	O
was	VBD	auxpass	O
confirmed	VBN	ROOT	O
by	IN	case	O
proteolysis	NN	compound	O
techniques	NNS	nmod	O
.	.	punct	O

When	WRB	advmod	O
stably	RB	advmod	O
over	RB	advmod	O
-	HYPH	punct	O
expressed	VBN	advcl	O
in	IN	case	O
maximal	JJ	amod	O
transformed	VBN	amod	O
SV	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
52	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
CK1delta	NN	compound	B-Gene_or_gene_product
mutants	NNS	nsubj	O
induced	VBD	ROOT	O
reversion	NN	dobj	O
to	TO	case	O
a	DT	det	O
minimal	JJ	amod	O
transformed	VBN	amod	O
phenotype	NN	nmod	O
by	IN	case	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
interference	NN	nmod	O
with	IN	case	O
endogenous	JJ	amod	O
wtCK1delta	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
transformed	VBN	amod	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
,	,	punct	O
RA	NN	nmod:npmod	B-Simple_chemical
-	:	punct	O
induced	VBN	amod	O
expression	NN	nsubjpass	O
of	IN	case	O
these	DT	det	O
homeobox	NN	compound	B-Gene_or_gene_product
genes	NNS	nmod	O
is	VBZ	auxpass	O
delayed	VBN	ROOT	O
.	.	punct	O

MATERIALS	NNS	nsubjpass	O
AND	CC	cc	O
METHODS	NNS	conj	O
:	:	punct	O
Human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
carcinoma	NN	nsubjpass	I-Cancer
(	-LRB-	punct	O
HT29	NN	appos	B-Cell
)	-RRB-	punct	O
and	CC	cc	O
murine	JJ	amod	B-Organism
squamous	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
(	-LRB-	punct	O
SCCVII	NN	compound	B-Cell
)	-RRB-	punct	O
clonal	JJ	amod	O
cell	NN	compound	B-Cell
lines	NNS	conj	I-Cell
expressing	VBG	acl	O
varying	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
were	VBD	auxpass	O
established	VBN	dep	O
and	CC	cc	O
their	PRP$	nmod:poss	O
response	NN	conj	O
to	TO	case	O
vandetanib	NN	nmod	B-Simple_chemical
was	VBD	auxpass	O
assessed	VBN	ROOT	O
in	IN	case	O
tissue	NN	compound	B-Tissue
culture	NN	nmod	O
and	CC	cc	O
as	IN	case	O
solid	JJ	amod	B-Cancer
tumors	NNS	conj	I-Cancer
.	.	punct	O

The	DT	det	O
PCR	NN	compound	O
products	NNS	nsubj	O
were	VBD	cop	O
then	RB	advmod	O
subject	JJ	ROOT	O
to	TO	case	O
XhoI	NN	compound	B-Gene_or_gene_product
digestion	NN	nmod	O
and	CC	cc	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
sequencing	NN	compound	O
analysis	NN	conj	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
may	MD	aux	O
have	VB	ROOT	O
chemotherapeutic	JJ	amod	O
implications	NNS	dobj	O
for	IN	mark	O
using	VBG	advcl	O
emodin	NN	dobj	B-Simple_chemical
to	TO	mark	O
target	VB	xcomp	O
HER	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
/	:	punct	O
neu	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
overexpressing	VBG	amod	O
cancer	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
number	NN	nsubj	O
of	IN	case	O
therapies	NNS	nmod	O
applied	VBN	acl	O
,	,	punct	O
including	VBG	case	O
initial	JJ	amod	O
surgery	NN	nmod	O
,	,	punct	O
was	VBD	cop	O
5	CD	nummod	O
(	-LRB-	punct	O
range	NN	dep	O
3	CD	compound	O
-	SYM	punct	O
7	CD	nummod	O
therapies	NNS	ROOT	O
)	-RRB-	punct	O
.	.	punct	O

Experiments	NNS	nsubj	O
with	IN	case	O
a	DT	det	O
temperature	NN	nmod:npmod	O
-	HYPH	punct	O
sensitive	JJ	amod	O
mutant	NN	nmod	O
of	IN	case	O
Rous	JJ	amod	B-Organism
sarcoma	NN	compound	I-Organism
virus	NN	nmod	I-Organism
demonstrated	VBD	ROOT	O
that	IN	mark	O
a	DT	det	O
single	JJ	amod	O
oncogene	NN	compound	O
product	NN	nsubj	O
is	VBZ	cop	O
sufficient	JJ	ccomp	O
to	TO	mark	O
inhibit	VB	xcomp	O
the	DT	det	O
synthesis	NN	dobj	O
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
thrombospondin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
normal	JJ	amod	O
prostate	NN	nmod	B-Organ
but	CC	cc	O
not	RB	neg	O
in	IN	case	O
prostate	NN	compound	B-Cancer
tumours	NNS	conj	I-Cancer
in	IN	case	O
a	DT	det	O
rat	NN	compound	B-Organism
model	NN	nmod	O
.	.	punct	O

In	IN	case	O
human	JJ	amod	B-Organism
colon	NN	compound	B-Cancer
carcinoma	NN	nsubj	I-Cancer
Colo205	NN	dep	I-Cancer
and	CC	cc	O
HT29	NN	conj	B-Cancer
xenografts	NNS	advmod	I-Cancer
grown	VBN	acl	O
in	IN	case	O
human	JJ	amod	B-Organism
endosialin	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
transgenic	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
endosialin	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
was	VBD	auxpass	O
largely	RB	advmod	O
confined	VBN	ROOT	O
to	TO	case	O
NG2	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
perivascular	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
not	RB	cc	O
CD31	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
positive	JJ	amod	O
endothelial	JJ	amod	B-Cell
cells	NNS	conj	I-Cell
.	.	punct	O

In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
the	DT	det	O
hypothesis	NN	compound	O
predicts	VBZ	ROOT	O
that	IN	mark	O
early	JJ	amod	O
detection	NN	nsubj	O
,	,	punct	O
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
designed	VBN	acl:relcl	O
to	TO	mark	O
find	VB	xcomp	O
more	JJR	amod	O
patients	NNS	dobj	B-Organism
without	IN	case	O
involved	VBN	amod	O
lymph	NN	compound	B-Multi-tissue_structure
nodes	NNS	nmod	I-Multi-tissue_structure
,	,	punct	O
may	MD	aux	O
not	RB	neg	O
be	VB	cop	O
a	DT	det	O
synergistic	JJ	amod	O
strategy	NN	ccomp	O
with	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
works	VBZ	acl:relcl	O
best	RB	advmod	O
with	IN	case	O
positive	JJ	amod	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
patients	NNS	nmod	B-Organism
.	.	punct	O

Capillary	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nsubjpass	O
and	CC	cc	O
proliferation	NN	conj	O
are	VBP	auxpass	O
proposed	VBN	ROOT	O
as	IN	case	O
sensitive	JJ	amod	O
quantifiable	JJ	amod	O
bioassays	NNS	nmod	O
to	TO	mark	O
explore	VB	xcomp	O
the	DT	det	O
functional	JJ	amod	O
domains	NNS	dobj	O
of	IN	case	O
the	DT	det	O
EGF	NN	compound	B-Gene_or_gene_product
molecule	NN	nmod	O
.	.	punct	O

To	TO	mark	O
better	RBR	advmod	O
understand	VB	advcl	O
the	DT	det	O
activity	NN	dobj	O
of	IN	case	O
cediranib	NN	nmod	B-Simple_chemical
against	IN	case	O
VEGFR	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
associated	VBN	amod	O
signaling	NN	compound	O
events	NNS	conj	O
compared	VBN	case	O
with	IN	case	O
its	PRP$	nmod:poss	O
activity	NN	nmod	O
against	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
receptor	NN	nmod:npmod	O
-	HYPH	punct	O
specific	JJ	amod	O
ligands	NNS	dobj	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
E	NNP	dep	I-Gene_or_gene_product
and	CC	cc	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C156S	NN	conj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
relationship	NN	nsubj	O
between	IN	case	O
this	DT	det	O
unique	JJ	amod	O
type	NN	nmod	O
of	IN	case	O
EBV	NN	nmod	B-Organism
and	CC	cc	O
NPC	NN	conj	B-Cancer
has	VBZ	ROOT	O
yet	RB	advmod	O
to	TO	mark	O
be	VB	auxpass	O
established	VBN	xcomp	O
.	.	punct	O

Our	PRP$	nmod:poss	O
initial	JJ	amod	O
investigations	NNS	nsubj	O
show	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
naturally	RB	advmod	O
occurring	VBG	amod	O
organoselenium	NN	compound	O
compound	NN	compound	O
selenomethionine	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
SM	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
synthetic	JJ	amod	O
1	CD	nmod	B-Simple_chemical
,	,	punct	I-Simple_chemical
4	CD	nummod	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
phenylenebis	NN	conj	I-Simple_chemical
(	-LRB-	punct	I-Simple_chemical
methylene	NN	appos	I-Simple_chemical
)	-RRB-	punct	I-Simple_chemical
selenocyanate	NN	conj	I-Simple_chemical
(	-LRB-	punct	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	appos	I-Simple_chemical
)	-RRB-	punct	O
can	MD	aux	O
inhibit	VB	ccomp	O
human	JJ	amod	B-Organism
prostate	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cell	NN	compound	I-Cell
viability	NN	dobj	O
;	:	punct	O
however	RB	advmod	O
,	,	punct	O
in	IN	case	O
contrast	NN	dep	O
to	TO	case	O
SM	NN	nmod	B-Simple_chemical
,	,	punct	O
p	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
XSC	NN	nsubj	I-Simple_chemical
is	VBZ	cop	O
active	JJ	parataxis	O
at	IN	case	O
physiologically	RB	advmod	O
relevant	JJ	amod	O
doses	NNS	nmod	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
investigated	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
TS	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
DPD	NN	conj	B-Gene_or_gene_product
in	IN	case	O
cervical	JJ	amod	B-Multi-tissue_structure
lymph	NN	compound	I-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastases	NNS	nmod	O
and	CC	cc	O
its	PRP$	nmod:poss	O
relationship	NN	conj	O
with	IN	case	O
primary	JJ	amod	B-Cancer
OSCC	NN	nmod	I-Cancer
,	,	punct	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
the	DT	det	O
interaction	NN	conj	O
between	IN	case	O
these	DT	det	O
enzymes	NNS	nmod	O
and	CC	cc	O
Kangai	NN	compound	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
KAI1	NN	compound	B-Gene_or_gene_product
/	:	punct	O
CD82	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
which	WDT	nsubj	O
is	VBZ	cop	O
a	DT	det	O
metastasis	NN	compound	O
suppressor	NN	compound	O
protein	NN	acl:relcl	O
.	.	punct	O

Apparently	RB	advmod	O
,	,	punct	O
several	JJ	amod	O
in	FW	amod	O
vivo	FW	dep	O
phosphorylation	NN	compound	O
sites	NNS	nsubjpass	O
were	VBD	auxpass	O
recognized	VBN	ROOT	O
in	FW	compound	O
vitro	FW	advmod	O
in	IN	case	O
both	CC	cc:preconj	O
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nmod	I-Gene_or_gene_product
and	CC	cc	O
p53	NN	conj	B-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
the	DT	det	O
presence	NN	nsubjpass	O
of	IN	case	O
some	DT	det	O
artifactual	JJ	amod	O
sites	NNS	nmod	O
could	MD	aux	O
not	RB	neg	O
be	VB	auxpass	O
completely	RB	advmod	O
excluded	VBN	conj	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
advance	VBP	ROOT	O
our	PRP$	nmod:poss	O
understanding	NN	dobj	O
of	IN	case	O
the	DT	det	O
functions	NNS	nmod	O
of	IN	case	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	case	O
this	DT	det	O
location	NN	nmod	O
,	,	punct	O
it	PRP	nsubj	O
interacts	VBZ	ROOT	O
with	IN	case	O
other	JJ	amod	O
proteins	NNS	nmod	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
adhesion	NN	nmod	I-Cellular_component
to	TO	mark	O
activate	VB	acl	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signalling	NN	amod	O
events	NNS	dobj	O
associated	VBN	acl	O
with	IN	case	O
cell	NN	compound	B-Cell
adhesion	NN	nmod	O
.	.	punct	O

To	TO	mark	O
examine	VB	advcl	O
whether	IN	mark	O
IFI16	NN	compound	B-Gene_or_gene_product
induction	NN	nsubjpass	O
might	MD	aux	O
be	VB	auxpass	O
extended	VBN	ccomp	O
to	TO	case	O
other	JJ	amod	O
proinflammatory	JJ	amod	O
cytokines	NNS	nmod	O
such	JJ	case	O
as	IN	mwe	O
tumor	NN	compound	B-Gene_or_gene_product
necrosis	NN	compound	I-Gene_or_gene_product
factor	NN	dep	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TNF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
strategy	NN	dobj	O
of	IN	case	O
the	DT	det	O
RNA	NN	compound	O
interference	NN	nmod	O
to	TO	mark	O
knock	VB	advcl	O
down	RP	prt	O
IFI16	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
,	,	punct	O
and	CC	cc	O
analyze	VB	conj	O
the	DT	det	O
capability	NN	dobj	O
of	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
to	TO	mark	O
stimulate	VB	acl	O
intercellular	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecule	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ICAM	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
or	CC	cc	O
CD54	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	dobj	O
in	IN	case	O
the	DT	det	O
absence	NN	nmod	O
of	IN	case	O
functional	JJ	amod	O
IFI16	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

Membrane	NNP	npadvmod	O
-	HYPH	punct	O
anchored	VBN	amod	O
Cbl	NN	nsubj	B-Gene_or_gene_product
suppresses	VBZ	ROOT	O
Hck	NN	compound	B-Gene_or_gene_product
protein	NN	compound	O
-	HYPH	punct	O
tyrosine	NN	compound	B-Amino_acid
kinase	NN	nmod:npmod	O
mediated	JJ	amod	O
cellular	JJ	amod	B-Cell
transformation	NN	dobj	O
.	.	punct	O

Antiapoptotic	JJ	amod	O
effect	NN	ROOT	O
of	IN	case	O
coagulation	NN	compound	B-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
VIIa	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Role	NN	ROOT	O
of	IN	case	O
the	DT	det	O
interferon	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
inducible	JJ	amod	O
IFI16	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
in	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
ICAM	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
by	IN	case	O
TNF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
alpha	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Apoptosis	NN	nsubjpass	O
,	,	punct	O
characterized	VBN	acl	O
by	IN	case	O
nuclear	JJ	amod	B-Cellular_component
condensation	NN	nmod	O
,	,	punct	O
membrane	NN	compound	B-Cellular_component
blebbing	NN	conj	O
,	,	punct	O
cell	NN	compound	B-Cell
shrinkage	NN	conj	O
and	CC	cc	O
a	DT	det	O
significant	JJ	amod	O
induction	NN	nsubjpass	O
of	IN	case	O
caspase	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
like	IN	dep	I-Gene_or_gene_product
protease	NN	compound	I-Gene_or_gene_product
activity	NN	nmod	O
at	IN	case	O
8	CD	nummod	O
h	NN	nmod	O
in	IN	case	O
a	DT	det	O
time	NN	compound	O
-	HYPH	punct	O
course	NN	amod	O
study	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
.	.	punct	O

BMSVTs	NNS	nsubj	B-Cell
immortalized	VBN	acl	O
with	IN	case	O
hTERT	NN	nmod	B-Gene_or_gene_product
formed	VBD	ROOT	O
large	JJ	amod	O
colonies	NNS	dobj	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	cc	O
small	JJ	amod	O
transient	JJ	amod	O
tumours	NNS	conj	B-Cancer
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
strongly	RB	advmod	O
support	VBP	ROOT	O
an	DT	det	O
enhanced	VBN	amod	O
role	NN	dobj	O
for	IN	case	O
this	DT	det	O
pathway	NN	nmod	O
in	IN	case	O
clear	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
by	IN	mark	O
regulating	VBG	advcl	O
angiogenesis	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
lymphangiogenesis	NN	conj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
MDM2	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
quantified	VBN	acl	O
by	IN	case	O
image	NN	compound	O
analysis	NN	nmod	O
was	VBD	auxpass	O
weakly	RB	advmod	O
associated	VBN	dep	O
with	IN	case	O
DM	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
a	DT	det	O
proteoglycan	JJ	amod	O
decorin	NN	nsubj	B-Gene_or_gene_product
(	-LRB-	punct	O
DCN	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
up	RB	advmod	O
-	:	punct	O
regulates	VBZ	ccomp	O
the	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
expression	NN	dobj	O
with	IN	case	O
activation	NN	nmod	O
of	IN	case	O
VEGF	NN	nmod	B-Gene_or_gene_product
regulating	VBG	acl	O
transcription	NN	compound	O
factors	NNS	dobj	O
Sp1	NN	dep	B-Gene_or_gene_product
,	,	punct	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
1alpha	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF1alpha	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
signal	NN	compound	B-Gene_or_gene_product
transducer	NN	conj	I-Gene_or_gene_product
and	CC	cc	I-Gene_or_gene_product
activator	NN	conj	I-Gene_or_gene_product
of	IN	case	I-Gene_or_gene_product
transcription	NN	nmod	I-Gene_or_gene_product
3	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Stat3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
via	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
EGFR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
mitogen	NN	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
activated	VBN	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
extracellular	JJ	amod	I-Gene_or_gene_product
signal	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
regulated	VBN	amod	I-Gene_or_gene_product
kinase	NN	conj	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
ERK1	NN	dep	B-Gene_or_gene_product
/	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
protein	NN	compound	B-Gene_or_gene_product
kinase	NN	compound	I-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	O
AKT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
pathways	NNS	dobj	O
in	IN	case	O
DCN	NN	compound	B-Gene_or_gene_product
transfected	VBN	amod	O
mouse	NN	compound	B-Organism
cerebral	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
(	-LRB-	punct	I-Cell
MCE	NN	compound	I-Cell
)	-RRB-	punct	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
suggest	VBP	ROOT	O
that	IN	mark	O
point	NN	compound	O
mutations	NNS	nsubjpass	O
in	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
ras	NN	conj	B-Gene_or_gene_product
are	VBP	auxpass	O
not	RB	neg	O
associated	VBN	ccomp	O
with	IN	case	O
pituitary	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
,	,	punct	O
however	RB	advmod	O
,	,	punct	O
point	NN	compound	O
mutations	NNS	nsubj	O
of	IN	case	O
the	DT	det	O
H	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
may	MD	aux	O
be	VB	cop	O
important	JJ	parataxis	O
in	IN	case	O
the	DT	det	O
formation	NN	nmod	O
and	CC	cc	O
or	CC	cc	O
growth	NN	conj	O
of	IN	case	O
pituitary	JJ	amod	B-Cancer
metastases	NNS	nmod	I-Cancer
.	.	punct	O

Focal	JJ	amod	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
kinase	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
pp125FAK	NN	dep	B-Gene_or_gene_product
or	CC	cc	O
FAK	NN	conj	B-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
protein	NN	compound	B-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
kinase	NN	ROOT	I-Gene_or_gene_product
which	WDT	nsubjpass	O
is	VBZ	auxpass	O
associated	VBN	acl:relcl	O
with	IN	case	O
intracellular	JJ	amod	B-Immaterial_anatomical_entity
signalling	NN	amod	O
cascades	NNS	nmod	O
which	WDT	nsubjpass	O
are	VBP	auxpass	O
initiated	VBN	acl:relcl	O
when	WRB	advmod	O
the	DT	det	O
integrin	NN	compound	B-Gene_or_gene_product
family	NN	nsubj	O
of	IN	case	O
cell	NN	compound	B-Gene_or_gene_product
adhesion	NN	compound	I-Gene_or_gene_product
molecules	NNS	nmod	I-Gene_or_gene_product
engage	VBP	advcl	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	compound	I-Cellular_component
molecules	NNS	dobj	O
.	.	punct	O

Syndecan	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nsubj	O
in	IN	case	O
mammary	JJ	amod	B-Cell
epithelial	JJ	amod	I-Cell
tumor	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
is	VBZ	cop	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	ROOT	O
.	.	punct	O

Presence	NN	nsubjpass	O
of	IN	case	O
subfoveal	JJ	amod	O
CNV	NN	nmod	O
at	IN	case	O
6	CD	nummod	O
and	CC	cc	O
12	CD	conj	O
months	NNS	nmod	O
of	IN	case	O
follow	NN	compound	O
-	HYPH	punct	O
up	NN	nmod	O
was	VBD	auxpass	O
determined	VBN	ROOT	O
by	IN	case	O
review	NN	nmod	O
of	IN	case	O
fluorescein	NN	compound	B-Simple_chemical
angiograms	NNS	nmod	O
.	.	punct	O

In	IN	case	O
the	DT	det	O
HT29	NN	compound	B-Cancer
tumor	NN	compound	I-Cancer
model	NN	nmod	O
,	,	punct	O
treatment	NN	compound	O
response	NN	nsubjpass	O
to	TO	case	O
vandetanib	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
50	CD	compound	O
mg	NN	dep	O
/	:	punct	O
kg	NN	nmod	O
/	:	punct	O
day	NN	dobj	O
,	,	punct	O
Monday	NNP	compound	O
-	HYPH	punct	O
Friday	NNP	appos	O
for	IN	prep	O
2	CD	nummod	O
weeks	NNS	pobj	O
)	-RRB-	punct	O
was	VBD	auxpass	O
greatest	JJS	ROOT	O
in	IN	case	O
xenografts	NNS	nmod	B-Cancer
derived	VBN	acl	O
from	IN	case	O
the	DT	det	O
highest	JJS	amod	O
VEGF	NNP	dep	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
.	.	punct	O

Angiotensin	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
(	-LRB-	punct	O
Ang	NN	appos	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
potent	JJ	amod	O
vasoconstrictor	NN	ROOT	O
that	WDT	nsubj	O
increases	VBZ	acl:relcl	O
concomitant	JJ	dobj	O
with	IN	case	O
sFlt	JJ	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
during	IN	case	O
pregnancy	NN	nmod	O
.	.	punct	O

The	DT	det	O
median	JJ	amod	O
response	NN	compound	O
duration	NN	nsubj	O
was	VBD	cop	O
8	CD	ROOT	O
.	.	punct	O
2	CD	nummod	O
months	NNS	ROOT	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Higher	JJR	amod	O
expression	NN	nsubj	O
of	IN	case	O
the	DT	det	O
glucose	NN	compound	B-Simple_chemical
transporter	NN	compound	O
Glut	NN	compound	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
by	IN	case	O
breast	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
healthy	JJ	amod	B-Tissue
breast	NN	compound	I-Tissue
tissue	NN	nmod	I-Tissue
is	VBZ	cop	O
common	JJ	appos	O
.	.	punct	O

Thymidylate	NN	compound	B-Gene_or_gene_product
synthase	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
TS	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
dihydropyrimidine	NN	compound	B-Gene_or_gene_product
dehydrogenase	NN	conj	I-Gene_or_gene_product
(	-LRB-	punct	O
DPD	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
are	VBP	cop	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
fluorouracil	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	appos	I-Simple_chemical
)	-RRB-	punct	O
metabolizing	JJ	compound	O
enzymes	NNS	ROOT	O
and	CC	cc	O
are	VBP	auxpass	O
involved	VBN	conj	O
in	IN	case	O
the	DT	det	O
sensitivity	NN	nmod	O
of	IN	case	O
carcinoma	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
to	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NNP	nmod	I-Simple_chemical
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
its	PRP$	nmod:poss	O
receptors	NNS	conj	O
are	VBP	cop	O
key	JJ	amod	O
regulators	NNS	ROOT	O
of	IN	case	O
the	DT	det	O
process	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
,	,	punct	O
which	WDT	nsubj	O
makes	VBZ	acl:relcl	O
them	PRP	nsubj	O
attractive	JJ	amod	O
therapeutic	JJ	amod	O
targets	NNS	dobj	O
.	.	punct	O

In	IN	case	O
transfected	VBN	amod	O
MDCK	NN	compound	B-Cell
canine	NN	compound	I-Cell
kidney	NN	compound	I-Cell
epithelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
5T4	NN	compound	B-Gene_or_gene_product
over	IN	compound	O
-	HYPH	punct	O
expression	NN	nsubj	O
also	RB	advmod	O
results	VBZ	ROOT	O
in	IN	case	O
increased	VBN	amod	O
motility	NN	nmod	O
,	,	punct	O
but	CC	cc	O
disruption	NN	nsubjpass	O
of	IN	case	O
cell	NN	compound	B-Cell
-	HYPH	punct	O
cell	NN	compound	B-Cell
contacts	NNS	nmod	O
,	,	punct	O
either	CC	appos	O
by	IN	mark	O
culturing	VBG	advcl	O
cells	NNS	dobj	B-Cell
in	IN	case	O
low	JJ	amod	O
calcium	NN	compound	B-Simple_chemical
medium	NN	nmod	O
or	CC	cc	O
by	IN	case	O
addition	NN	conj	O
of	IN	case	O
HGF	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
SF	NN	conj	B-Gene_or_gene_product
,	,	punct	O
is	VBZ	auxpass	O
needed	VBN	conj	O
.	.	punct	O

None	NN	nsubj	O
of	IN	case	O
the	DT	det	O
tumors	NNS	nmod	B-Cancer
or	CC	cc	O
the	DT	det	O
healthy	JJ	amod	B-Tissue
breast	NN	conj	I-Tissue
in	IN	case	O
the	DT	det	O
tissues	NNS	nmod	B-Tissue
studied	VBN	acl	O
expressed	VBD	ROOT	O
Glut	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
3	CD	dobj	I-Gene_or_gene_product
or	CC	cc	O
Glut	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
5	CD	conj	I-Gene_or_gene_product
.	.	punct	O

Rat	NN	compound	B-Organism
tissues	NNS	nsubjpass	B-Tissue
known	VBN	acl	O
to	TO	mark	O
express	VB	xcomp	O
these	DT	det	O
glucose	NN	compound	B-Simple_chemical
transporters	NNS	nsubjpass	O
were	VBD	auxpass	O
used	VBN	ROOT	O
as	IN	case	O
controls	NNS	nmod	O
.	.	punct	O

No	DT	dep	O
[	-LRB-	punct	B-Simple_chemical
13C	NN	nsubjpass	I-Simple_chemical
]	-RRB-	punct	I-Simple_chemical
glucose	NN	compound	I-Simple_chemical
utilization	NN	nsubjpass	O
was	VBD	auxpass	O
detected	VBN	ROOT	O
in	IN	case	O
H4	NN	compound	B-Cell
spheroids	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
uptake	NN	nsubj	O
of	IN	case	O
alanine	NN	nmod	B-Amino_acid
and	CC	cc	O
accumulation	NN	conj	O
of	IN	case	O
labeled	VBN	amod	O
lactate	NN	nmod	B-Simple_chemical
,	,	punct	O
glutamate	NN	conj	B-Amino_acid
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
indicated	VBD	conj	O
oxidation	NN	dobj	O
via	IN	case	O
the	DT	det	O
tricarboxylic	JJ	amod	B-Simple_chemical
acid	NN	compound	I-Simple_chemical
(	-LRB-	punct	O
TCA	NN	compound	B-Simple_chemical
)	-RRB-	punct	O
cycle	NN	nmod	O
.	.	punct	O

Analysis	NN	nsubj	O
of	IN	case	O
VLB	NN	compound	B-Simple_chemical
cytotoxicity	NN	nmod	O
demonstrated	VBD	ROOT	O
a	DT	det	O
3	CD	nummod	O
-	HYPH	punct	O
fold	JJ	amod	O
increase	NN	dobj	O
in	IN	case	O
VLB	NN	compound	B-Simple_chemical
sensitivity	NN	nmod	O
in	IN	case	O
LoVo	NN	compound	B-Cell
-	HYPH	punct	I-Cell
mycANS	CD	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Pharmacological	JJ	amod	O
inhibition	NN	nsubj	O
of	IN	case	O
the	DT	det	O
proteasome	NN	nmod	O
prevents	VBZ	ROOT	O
the	DT	det	O
degradation	NN	dobj	O
of	IN	case	O
Hck	NNP	compound	B-Gene_or_gene_product
correlating	NN	nmod	O
with	IN	case	O
an	DT	det	O
increase	NN	nmod	O
in	IN	case	O
the	DT	det	O
phosphotyrosine	NN	compound	B-Amino_acid
levels	NNS	nmod	O
within	IN	case	O
the	DT	det	O
cells	NNS	nmod	B-Cell
.	.	punct	O

Trough	NN	compound	O
celecoxib	NN	compound	B-Simple_chemical
levels	NNS	nsubj	O
achieved	VBD	ROOT	O
targeted	VBN	amod	O
"	``	punct	O
antiangiogenic	JJ	amod	O
"	''	punct	O
levels	NNS	dobj	O
.	.	punct	O

Taken	VBN	advcl	O
together	RB	advmod	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
indicates	VBZ	ROOT	O
that	IN	mark	O
GSE	NN	nsubj	B-Organism_substance
is	VBZ	cop	O
a	DT	det	O
well	RB	advmod	O
-	HYPH	punct	O
tolerated	VBN	amod	O
and	CC	cc	O
inexpensive	JJ	conj	O
natural	JJ	amod	O
VEGF	NN	compound	B-Gene_or_gene_product
inhibitor	NN	ccomp	O
and	CC	cc	O
could	MD	aux	O
potentially	RB	advmod	O
be	VB	cop	O
useful	JJ	conj	O
in	IN	case	O
cancer	NN	compound	B-Cancer
prevention	NN	nmod	O
or	CC	cc	O
treatment	NN	conj	O
.	.	punct	O

Here	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
demonstrate	VBP	ROOT	O
that	IN	mark	O
D2	NN	compound	B-Gene_or_gene_product
dopamine	NN	compound	I-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
(	-LRB-	punct	O
D2DR	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
colocalizes	VBZ	ccomp	O
with	IN	case	O
VEGFR	NN	nmod	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

The	DT	det	O
results	NNS	nsubj	O
in	IN	case	O
steady	JJ	amod	O
state	NN	nmod	O
reveal	VBP	ROOT	O
that	IN	mark	O
both	DT	det	O
substrates	NNS	ccomp	O
glucose	NN	nsubjpass	B-Simple_chemical
and	CC	cc	O
glutamine	NN	conj	B-Amino_acid
are	VBP	auxpass	O
continuously	RB	advmod	O
wasted	VBN	dep	O
by	IN	case	O
tumour	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
excreting	VBG	xcomp	O
two	CD	nummod	O
moles	NNS	dobj	O
of	IN	prep	O
lactate	NN	pobj	B-Simple_chemical
per	IN	case	O
mol	NN	nmod	O
of	IN	case	O
glucose	NN	nmod	B-Simple_chemical
and	CC	cc	O
one	CD	nummod	O
mol	NN	conj	O
of	IN	case	O
glutamate	NN	nmod	B-Amino_acid
and	CC	cc	O
ammonia	NN	conj	B-Simple_chemical
per	IN	case	O
mol	NN	nmod	O
of	IN	case	O
glutamine	NN	nmod	B-Amino_acid
consumed	VBN	acl	O
into	IN	case	O
the	DT	det	O
medium	NN	nmod	O
.	.	punct	O

An	DT	det	O
immunohistochemical	JJ	amod	O
study	NN	ROOT	O
.	.	punct	O

The	DT	det	O
experimental	JJ	amod	O
studies	NNS	nsubjpass	O
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
were	VBD	auxpass	O
performed	VBN	ROOT	O
to	TO	mark	O
investigate	VB	xcomp	O
the	DT	det	O
effects	NNS	dobj	O
of	IN	case	O
carcinostatic	JJ	amod	O
agents	NNS	nmod	O
in	IN	case	O
the	DT	det	O
adhesion	NN	nmod	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
to	TO	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod:npmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
receptor	NN	compound	O
phosphorylation	NN	nsubj	O
is	VBZ	cop	O
the	DT	det	O
crucial	JJ	amod	O
step	NN	ROOT	O
for	IN	mark	O
initiating	VBG	advcl	O
downstream	JJ	amod	O
signaling	NN	compound	O
pathways	NNS	dobj	O
that	WDT	nsubj	O
lead	VBP	acl:relcl	O
to	TO	case	O
angiogenesis	NN	nmod	O
or	CC	cc	O
related	JJ	amod	O
pathophysiological	JJ	amod	O
outcomes	NNS	conj	O
.	.	punct	O

The	DT	det	O
present	JJ	amod	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
vandetanib	NN	compound	B-Simple_chemical
therapy	NN	nsubj	O
effectively	RB	advmod	O
counteracted	VBD	ccomp	O
the	DT	det	O
aggressive	JJ	amod	O
feature	NN	dobj	O
of	IN	case	O
tumor	NN	compound	B-Cancer
growth	NN	nmod	O
resulting	VBG	acl	O
from	IN	case	O
VEGF	NNP	nmod	B-Gene_or_gene_product
over	IN	advmod	O
-	HYPH	punct	O
expressing	VBG	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
such	JJ	amod	O
tumors	NNS	nsubjpass	B-Cancer
may	MD	aux	O
be	VB	auxpass	O
particularly	RB	advmod	O
well	RB	advmod	O
suited	VBN	ccomp	O
for	IN	case	O
anti	JJ	amod	O
-	HYPH	punct	O
VEGF	NNP	compound	B-Gene_or_gene_product
interventions	NNS	nmod	O
.	.	punct	O

Various	JJ	amod	O
cellular	JJ	amod	B-Cell
kinases	NNS	nsubj	O
,	,	punct	O
among	IN	case	O
them	PRP	nmod	O
members	NNS	dep	O
of	IN	case	O
the	DT	det	O
CK1	NN	compound	B-Gene_or_gene_product
family	NN	nmod	O
,	,	punct	O
play	VBP	ROOT	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
modulating	VBG	advcl	O
the	DT	det	O
transforming	NN	amod	O
activity	NN	dobj	O
of	IN	case	O
SV40	NN	nmod	B-Organism
,	,	punct	O
including	VBG	case	O
the	DT	det	O
transforming	NN	amod	O
activity	NN	nmod	O
of	IN	case	O
T	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ag	NN	nmod	I-Gene_or_gene_product
,	,	punct	O
the	DT	det	O
major	JJ	amod	O
transforming	VBG	amod	O
protein	NN	appos	O
of	IN	case	O
SV40	NN	nmod	B-Organism
,	,	punct	O
itself	PRP	appos	O
.	.	punct	O

Moreover	RB	advmod	O
,	,	punct	O
the	DT	det	O
downregulation	NN	nsubj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
by	IN	case	O
an	DT	det	O
antisense	JJ	amod	O
strategy	NN	nmod	O
might	MD	aux	O
represent	VB	ROOT	O
a	DT	det	O
useful	JJ	amod	O
goal	NN	dobj	O
for	IN	mark	O
improving	VBG	advcl	O
the	DT	det	O
efficacy	NN	dobj	O
of	IN	case	O
this	DT	det	O
anti	JJ	amod	O
-	HYPH	punct	O
neoplastic	JJ	amod	O
drug	NN	compound	O
family	NN	nmod	O
.	.	punct	O

EXPERIMENTAL	JJ	compound	O
DESIGN	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
assessed	VBD	ROOT	O
response	NN	dobj	O
,	,	punct	O
toxicity	NN	conj	O
,	,	punct	O
and	CC	cc	O
biomarkers	NNS	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
to	TO	case	O
low	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
cyclophosphamide	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
50	CD	compound	O
mg	NN	compound	O
p	NN	dep	O
.	.	punct	O
o	NN	ROOT	O
.	.	punct	O
o	LS	ROOT	O
.	.	punct	O
d	LS	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
dose	NN	compound	O
celecoxib	NN	conj	B-Simple_chemical
(	-LRB-	punct	O
400	CD	compound	O
mg	NN	compound	O
p	NN	nmod	O
.	.	punct	O
o	NN	ROOT	O
.	.	punct	O
b	LS	ROOT	O
.	.	punct	O
i	LS	ROOT	O
.	.	punct	O
d	XX	ROOT	O
.	.	punct	O
)	-RRB-	punct	O
in	IN	case	O
adult	JJ	amod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
relapsed	JJ	amod	O
or	CC	cc	O
refractory	JJ	conj	O
aggressive	JJ	amod	O
non	NN	amod	B-Cancer
-	HYPH	punct	I-Cancer
Hodgkin	NNP	poss	I-Cancer
'	POS	case	I-Cancer
s	NNS	compound	I-Cancer
lymphoma	NN	nmod	I-Cancer
in	IN	case	O
a	DT	det	O
multicenter	NN	amod	O
phase	NN	compound	O
II	CD	nummod	O
prospective	JJ	amod	O
study	NN	nmod	O
.	.	punct	O

Antibodies	NNS	nsubj	O
developed	VBD	ROOT	O
to	TO	case	O
human	JJ	amod	B-Organism
endosialin	NN	nmod	B-Gene_or_gene_product
were	VBD	auxpass	O
used	VBN	ccomp	O
to	TO	mark	O
investigate	VB	xcomp	O
endosialin	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
and	CC	cc	O
function	NN	conj	O
in	IN	case	O
human	JJ	amod	B-Organism
prenatal	JJ	amod	B-Cell
brain	NN	compound	I-Cell
pericytes	NNS	nmod	I-Cell
and	CC	cc	O
pericytes	NNS	conj	B-Cell
residing	VBG	acl	O
in	IN	prep	O
tumors	NNS	pobj	B-Cancer
.	.	punct	O

OBJECTIVE	NN	nsubj	O
:	:	punct	O
We	PRP	nsubj	O
transfected	VBD	ROOT	O
ovarian	JJ	amod	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	dobj	I-Cell
and	CC	cc	O
administered	VBN	conj	O
recombinant	JJ	amod	O
plasmid	NN	dobj	O
encoding	VBG	acl	O
hPNAS	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	dobj	I-Gene_or_gene_product
to	TO	mark	O
nude	JJ	xcomp	B-Organism
mice	NNS	dobj	I-Organism
bearing	VBG	acl	O
ovarian	JJ	amod	B-Cancer
cancer	NN	dobj	I-Cancer
,	,	punct	O
aiming	VBG	advcl	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nmod	I-Gene_or_gene_product
against	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	FW	compound	O
vitro	FW	advmod	O
and	CC	amod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
the	DT	det	O
mechanism	NN	nsubj	O
by	IN	case	O
which	WDT	nmod	O
E7	NN	nsubj	B-Gene_or_gene_product
contributes	VBZ	acl:relcl	O
to	TO	case	O
cellular	JJ	amod	B-Cell
transformation	NN	nmod	O
is	VBZ	cop	O
unknown	JJ	ROOT	O
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
Crk	NN	nsubj	B-Gene_or_gene_product
plays	VBZ	ccomp	O
a	DT	det	O
critical	JJ	amod	O
role	NN	dobj	O
in	IN	case	O
Rac1	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	O
induced	VBN	amod	O
membrane	NN	compound	B-Cellular_component
ruffling	NN	nmod	O
and	CC	cc	O
Rap1	NN	compound	B-Gene_or_gene_product
-	:	punct	O
mediated	VBN	amod	O
nascent	JJ	amod	B-Cellular_component
focal	JJ	amod	I-Cellular_component
complex	NN	compound	I-Cellular_component
stabilization	NN	conj	O
contributing	VBG	acl	O
to	TO	case	O
ephrin	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
B1	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
human	JJ	amod	B-Organism
aortic	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	compound	I-Cell
migration	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Of	IN	case	O
the	DT	det	O
13	CD	nummod	O
treated	JJ	amod	O
patients	NNS	nmod	B-Organism
,	,	punct	O
10	CD	appos	O
(	-LRB-	punct	O
77	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	dep	O
a	DT	det	O
radiologically	RB	advmod	O
demonstrated	VBN	amod	O
partial	JJ	amod	O
response	NN	dobj	O
and	CC	cc	O
3	CD	conj	O
(	-LRB-	punct	O
23	CD	nummod	O
%	NN	appos	O
)	-RRB-	punct	O
had	VBD	conj	O
stable	JJ	amod	O
disease	NN	dobj	O
.	.	punct	O

It	PRP	nsubj	O
suggests	VBZ	ROOT	O
that	IN	mark	O
TB4	NN	nsubj	B-Gene_or_gene_product
could	MD	aux	O
be	VB	cop	O
a	DT	det	O
hypoxia	NN	compound	O
responsive	JJ	amod	O
regulator	NN	ccomp	O
to	TO	mark	O
control	VB	acl	O
tumor	NN	compound	B-Cell
cell	NN	compound	I-Cell
migration	NN	dobj	O
in	IN	case	O
angiogenesis	NN	nmod	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
metastasis	NN	conj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
examined	VBN	ROOT	O
the	DT	det	O
ability	NN	dobj	O
of	IN	case	O
the	DT	det	O
purine	NN	compound	B-Simple_chemical
analogue	NN	nmod	I-Simple_chemical
8	CD	nummod	I-Simple_chemical
-	:	punct	I-Simple_chemical
aminoadenosine	NN	dep	I-Simple_chemical
to	TO	aux	O
acutely	RB	advmod	O
reduce	VB	acl	O
glucose	NN	compound	B-Simple_chemical
consumption	NN	dobj	O
by	IN	mark	O
regulating	VBG	advcl	O
localization	NN	dobj	O
and	CC	cc	O
expression	NN	conj	O
of	IN	case	O
key	JJ	amod	O
glucose	NN	compound	B-Gene_or_gene_product
transporters	NNS	nmod	I-Gene_or_gene_product
.	.	punct	O

By	IN	mark	O
using	VBG	advcl	O
immunohistochemistry	NN	dobj	O
,	,	punct	O
Western	NN	compound	O
blot	NN	conj	O
,	,	punct	O
and	CC	cc	O
real	JJ	amod	O
-	HYPH	punct	O
time	NN	compound	O
PCR	NN	conj	O
the	DT	det	O
expression	NN	compound	O
patterns	NNS	nsubjpass	O
of	IN	prep	O
TSP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	dep	I-Gene_or_gene_product
,	,	punct	O
TSP	NN	appos	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
CD36	NN	conj	B-Gene_or_gene_product
,	,	punct	O
CD47	NN	conj	B-Gene_or_gene_product
,	,	punct	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
MMP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	conj	I-Gene_or_gene_product
were	VBD	auxpass	O
investigated	VBN	ROOT	O
in	IN	case	O
normal	JJ	amod	O
rat	NN	compound	B-Organism
prostate	NN	compound	B-Tissue
tissue	NN	nmod	I-Tissue
and	CC	cc	O
five	CD	nummod	O
malignant	JJ	amod	B-Tissue
Dunning	NN	compound	I-Tissue
sublines	NNS	compound	I-Tissue
tissue	NN	conj	I-Tissue
.	.	punct	O

The	DT	det	O
CD47	NN	compound	B-Gene_or_gene_product
receptor	NN	nsubj	I-Gene_or_gene_product
did	VBD	aux	O
slightly	RB	advmod	O
increase	VB	ROOT	O
with	IN	case	O
malignancy	NN	nmod	O
except	IN	case	O
for	IN	case	O
H3327	NN	nmod	B-Cancer
.	.	punct	O

c	LS	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ski	NNP	nsubj	I-Gene_or_gene_product
,	,	punct	O
originally	RB	advmod	O
identified	VBN	acl	O
as	IN	prep	O
a	DT	det	O
proto	NN	compound	O
-	HYPH	punct	O
oncogene	NN	compound	O
product	NN	pobj	O
,	,	punct	O
is	VBZ	cop	O
an	DT	det	O
important	JJ	amod	O
negative	JJ	amod	O
regulator	NN	ROOT	O
of	IN	case	O
transforming	VBG	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TGF	NN	compound	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
family	NN	compound	O
signaling	NN	nmod	O
through	IN	case	O
interaction	NN	nmod	O
with	IN	case	O
Smad2	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
Smad3	NN	conj	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
Smad4	NN	conj	B-Gene_or_gene_product
.	.	punct	O

We	PRP	nsubj	O
found	VBD	ROOT	O
a	DT	det	O
decrease	NN	dobj	O
in	IN	case	O
corneal	NN	compound	B-Multi-tissue_structure
neovascularization	NN	nmod	O
in	IN	case	O
spironolactone	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
rats	NNS	nmod	B-Organism
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
PBS	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
group	NN	advcl	O
,	,	punct	O
although	IN	mark	O
the	DT	det	O
difference	NN	nsubj	O
was	VBD	cop	O
not	RB	neg	O
statistically	RB	advmod	O
significant	JJ	advcl	O
.	.	punct	O

Correlation	NN	nsubj	O
between	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	nummod	I-Gene_or_gene_product
+	CC	cc	O
LVI	NN	conj	O
and	CC	cc	O
menopausal	JJ	amod	O
-	HYPH	punct	O
status	NN	nmod	O
,	,	punct	O
HER2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
status	NN	conj	O
and	CC	cc	O
histological	JJ	amod	O
type	NN	conj	O
was	VBD	cop	O
not	RB	neg	O
significant	JJ	ROOT	O
,	,	punct	O
while	IN	mark	O
there	EX	expl	O
was	VBD	advcl	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
of	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	nmod	I-Gene_or_gene_product
and	CC	cc	O
so	RB	advmod	O
called	VBN	conj	O
"	``	punct	O
triple	JJ	amod	O
negative	JJ	amod	O
"	''	punct	O
tumors	NNS	oprd	B-Cancer
(	-LRB-	punct	O
ER	NN	appos	B-Gene_or_gene_product
/	:	punct	O
PR	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
HER2neu	NNS	compound	B-Gene_or_gene_product
-	HYPH	punct	O
negative	JJ	conj	O
)	-RRB-	punct	O
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
immunoreactivity	NN	compound	O
assay	NN	nsubj	O
of	IN	case	O
cytoskeletal	JJ	amod	B-Cellular_component
F	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
actin	NN	nmod	I-Gene_or_gene_product
demonstrated	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
GA	NN	compound	B-Simple_chemical
treatment	NN	nmod	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Our	PRP$	nmod:poss	O
promising	NN	amod	O
results	NNS	nsubjpass	O
on	IN	case	O
the	DT	det	O
potential	JJ	amod	O
antitumor	JJ	compound	B-Cancer
effects	NNS	nmod	O
of	IN	case	O
hPNAS	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
4	CD	nmod	I-Gene_or_gene_product
on	IN	case	O
ovarian	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
in	FW	compound	O
vitro	FW	advmod	O
and	CC	advmod	O
in	FW	compound	O
vivo	FW	advmod	O
may	MD	aux	O
be	VB	auxpass	O
explained	VBN	appos	O
,	,	punct	O
in	IN	case	O
part	NN	nmod	O
,	,	punct	O
by	IN	case	O
the	DT	det	O
induction	NN	nmod	O
of	IN	case	O
apoptosis	NN	nmod	O
and	CC	cc	O
inhibition	NN	conj	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

Further	JJ	amod	O
prospective	JJ	amod	O
studies	NNS	nsubjpass	O
are	VBP	auxpass	O
needed	VBN	ROOT	O
to	TO	mark	O
prove	VB	xcomp	O
the	DT	det	O
clinical	JJ	amod	O
impact	NN	dobj	O
of	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

Our	PRP$	nmod:poss	O
study	NN	nsubj	O
reveals	VBZ	ROOT	O
a	DT	det	O
novel	JJ	amod	O
link	NN	dobj	O
between	IN	case	O
HMGA2	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
the	DT	det	O
regulation	NN	conj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	compound	B-Gene_or_gene_product
reverse	JJ	compound	I-Gene_or_gene_product
transcriptase	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
the	DT	det	O
catalytic	JJ	amod	O
subunit	NN	appos	O
of	IN	case	O
telomerase	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
which	WDT	nsubj	O
offers	VBZ	acl:relcl	O
critical	JJ	amod	O
insight	NN	dobj	O
into	IN	mark	O
how	WRB	advmod	O
HMGA2	NN	nsubj	B-Gene_or_gene_product
contributes	VBZ	advcl	O
to	TO	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

This	DT	det	O
restriction	NN	compound	O
enzyme	NN	compound	O
site	NN	compound	O
polymorphism	NN	nsubjpass	O
along	IN	case	O
with	IN	case	O
the	DT	det	O
sequence	NN	compound	O
variations	NNS	nmod	O
were	VBD	auxpass	O
also	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
50	CD	nummod	O
biopsy	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
in	IN	case	O
the	DT	det	O
throat	NN	compound	B-Organism_subdivision
washings	NNS	conj	O
of	IN	case	O
6	CD	compound	O
out	IN	advmod	O
of	IN	advmod	O
20	CD	nummod	O
healthy	JJ	amod	O
individuals	NNS	nmod	B-Organism
that	WDT	dobj	O
we	PRP	nsubj	O
examined	VBD	acl:relcl	O
,	,	punct	O
indicating	VBG	xcomp	O
that	IN	mark	O
the	DT	det	O
EBV	NN	compound	B-Organism
strain	NN	nsubj	O
predominantly	RB	advmod	O
existing	VBG	nsubj	O
in	IN	case	O
these	DT	det	O
biopsy	NN	compound	B-Tissue
tissues	NNS	nmod	I-Tissue
was	VBD	cop	O
different	JJ	ccomp	O
from	IN	case	O
strains	NNS	nmod	O
of	IN	case	O
B95	NN	nmod	B-Organism
-	SYM	punct	I-Organism
8	CD	nummod	I-Organism
,	,	punct	O
Jijoye	NN	conj	B-Organism
or	CC	cc	O
nude	JJ	conj	B-Organism
mouse	NN	compound	I-Organism
passaged	JJ	amod	O
cells	NNS	conj	B-Cell
(	-LRB-	punct	O
C15	NN	appos	B-Cell
)	-RRB-	punct	O
with	IN	case	O
an	DT	det	O
African	JJ	amod	O
origin	NN	nmod	O
,	,	punct	O
but	CC	cc	O
closely	RB	advmod	O
resembled	VBD	amod	O
other	JJ	amod	O
nude	JJ	amod	B-Organism
mouse	NN	compound	I-Organism
passaged	JJ	amod	O
CAO	NN	compound	B-Cell
cells	NNS	conj	I-Cell
which	WDT	nsubjpass	O
were	VBD	auxpass	O
originally	RB	advmod	O
derived	VBN	acl:relcl	O
from	IN	prep	O
China	NNP	pobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
infusion	NN	nsubj	O
of	IN	case	O
Ang	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
significantly	RB	advmod	O
increases	VBZ	ccomp	O
circulating	VBG	amod	O
levels	NNS	dobj	O
of	IN	case	O
sFlt	NN	nmod	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
in	IN	case	O
pregnant	JJ	amod	O
mice	NNS	nmod	B-Organism
,	,	punct	O
thereby	RB	advmod	O
demonstrating	VBG	advcl	O
that	IN	mark	O
Ang	NN	nsubj	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
is	VBZ	cop	O
a	DT	det	O
regulator	NN	ccomp	O
of	IN	case	O
sFlt	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
secretion	NN	nmod	O
in	FW	compound	O
vivo	FW	advmod	O
.	.	punct	O

Molecular	JJ	amod	O
mechanisms	NNS	nsubjpass	O
of	IN	case	O
pituitary	JJ	amod	B-Organ
tumorigenesis	NN	nmod	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
Polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
single	JJ	dobj	O
stranded	JJ	xcomp	O
conformational	JJ	amod	O
polymorphism	NN	dobj	O
with	IN	case	O
DNA	NN	compound	O
sequencing	NN	nmod	O
to	TO	mark	O
identify	VB	xcomp	O
potential	JJ	amod	O
mutations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
ras	NN	compound	B-Gene_or_gene_product
protooncogenes	NNS	nmod	O
and	CC	cc	O
the	DT	det	O
tumor	NN	compound	B-Cancer
suppressor	NN	compound	O
gene	NN	compound	O
p53	NN	conj	B-Gene_or_gene_product
in	IN	case	O
invasive	JJ	amod	B-Cancer
pituitary	JJ	amod	I-Cancer
adenomas	NNS	nmod	I-Cancer
and	CC	cc	O
carcinomas	NNS	conj	B-Cancer
.	.	punct	O

The	DT	det	O
rats	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
divided	VBN	ROOT	O
into	IN	case	O
4	CD	nummod	O
groups	NNS	nmod	O
.	.	punct	O

We	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
paired	JJ	amod	O
tumour	NN	dobj	B-Cancer
and	CC	cc	O
normal	JJ	amod	O
-	HYPH	punct	O
tissue	NN	compound	B-Tissue
specimens	NNS	conj	I-Tissue
of	IN	case	O
86	CD	nummod	O
CRC	NN	compound	B-Cancer
patients	NNS	nmod	B-Organism
for	IN	case	O
the	DT	det	O
occurrence	NN	nmod	O
of	IN	case	O
aberrations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
mutation	NN	compound	O
cluster	NN	compound	O
region	NN	nmod	O
(	-LRB-	punct	O
MCR	NN	appos	O
)	-RRB-	punct	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
exon	NN	conj	O
3	CD	nummod	O
of	IN	case	O
the	DT	det	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
by	IN	case	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
single	JJ	amod	O
-	HYPH	punct	O
strand	NN	compound	O
conformation	NN	compound	O
polymorphism	NN	nmod	O
(	-LRB-	punct	O
PCR	NN	compound	O
-	:	punct	O
SSCP	NN	appos	O
)	-RRB-	punct	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
PCR	NN	compound	O
-	HYPH	punct	O
direct	JJ	amod	O
sequencing	NN	conj	O
.	.	punct	O

This	DT	det	O
study	NN	nsubj	O
establishes	VBZ	ROOT	O
the	DT	det	O
potential	NN	dobj	O
of	IN	prep	O
metabolic	JJ	amod	O
targeting	NN	pobj	O
as	IN	prep	O
a	DT	det	O
broader	JJR	amod	O
means	NNS	pobj	O
to	TO	aux	O
kill	VB	acl	O
and	CC	cc	O
sensitize	VB	conj	O
myeloma	NN	dobj	B-Cancer
and	CC	cc	O
identifies	VBZ	conj	O
a	DT	det	O
compound	NN	dobj	O
that	WDT	nsubj	O
can	MD	aux	O
achieve	VB	relcl	O
this	DT	det	O
goal	NN	dobj	O
.	.	punct	O

Thirty	CD	nummod	O
uterine	JJ	amod	B-Multi-tissue_structure
cervix	NNS	compound	I-Multi-tissue_structure
specimens	NNS	nsubjpass	I-Multi-tissue_structure
sampled	VBN	acl	O
following	VBG	case	O
conization	NN	nmod	O
or	CC	cc	O
total	JJ	amod	O
hysterectomy	NN	conj	O
were	VBD	auxpass	O
studied	VBN	ROOT	O
using	VBG	xcomp	O
histology	NN	dobj	O
,	,	punct	O
histoenzymology	NN	conj	O
(	-LRB-	punct	O
vessel	NN	compound	B-Multi-tissue_structure
phosphatase	NN	compound	O
alkaline	NN	compound	O
activity	NN	appos	O
)	-RRB-	punct	O
,	,	punct	O
and	CC	cc	O
immunohistochemistry	NN	conj	O
(	-LRB-	punct	O
demonstration	NN	dep	O
of	IN	case	O
laminin	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
type	NN	compound	B-Gene_or_gene_product
IV	CD	nummod	I-Gene_or_gene_product
collagen	NN	conj	I-Gene_or_gene_product
in	IN	case	O
epithelium	NN	nmod	B-Tissue
and	CC	cc	O
vessel	NN	conj	B-Cellular_component
basement	NN	compound	I-Cellular_component
membranes	NNS	dep	I-Cellular_component
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
p53	NN	compound	B-Gene_or_gene_product
protein	NN	nsubj	O
suppresses	VBZ	ROOT	O
tumorigenesis	NN	dobj	O
by	IN	mark	O
initiating	VBG	advcl	O
cellular	JJ	amod	B-Cell
functions	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	nmod	O
and	CC	cc	O
apoptosis	NN	conj	O
in	IN	case	O
response	NN	dep	O
to	TO	case	O
DNA	NN	compound	B-Cellular_component
damage	NN	nmod	O
.	.	punct	O

As	IN	case	O
a	DT	det	O
result	NN	nmod	O
,	,	punct	O
GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
inhibit	VB	ROOT	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
proliferation	NN	dobj	O
and	CC	cc	O
migration	NN	conj	O
as	RB	cc	O
well	RB	mwe	O
as	IN	mwe	O
sprout	NN	compound	B-Tissue
formation	NN	conj	O
from	IN	case	O
aorta	NN	compound	B-Multi-tissue_structure
ring	NN	nmod	I-Multi-tissue_structure
.	.	punct	O

To	TO	mark	O
define	VB	advcl	O
these	DT	det	O
roles	NNS	dobj	O
more	RBR	advmod	O
clearly	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
examined	VBD	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
DCC	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
its	PRP$	nmod:poss	O
ligand	NN	conj	O
,	,	punct	O
netrin	NN	appos	B-Gene_or_gene_product
-	,	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
in	IN	case	O
the	DT	det	O
normal	JJ	amod	O
endometrium	NN	nmod	B-Multi-tissue_structure
and	CC	cc	O
in	IN	case	O
endometrial	JJ	amod	B-Cancer
cancer	NN	conj	I-Cancer
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
TS	NN	nsubj	B-Gene_or_gene_product
and	CC	cc	O
CD82	NN	conj	B-Gene_or_gene_product
may	MD	aux	O
be	VB	cop	O
of	IN	case	O
great	JJ	amod	O
value	NN	ccomp	O
in	IN	mark	O
assessing	VBG	advcl	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	dobj	O
of	IN	case	O
OSCC	NN	nmod	B-Cancer
,	,	punct	O
and	CC	cc	O
could	MD	aux	O
be	VB	auxpass	O
taken	VBN	conj	O
as	IN	case	O
new	JJ	amod	O
targets	NNS	nmod	O
for	IN	case	O
therapy	NN	nmod	O
of	IN	case	O
metastatic	JJ	amod	O
OSCC	NN	nmod	B-Cancer
.	.	punct	O

Clinical	JJ	amod	O
evaluations	NNS	nsubj	O
performed	VBN	acl	O
at	IN	case	O
all	DT	det	O
study	NN	compound	O
visits	NNS	nmod	O
included	VBD	ROOT	O
measurement	NN	dobj	O
of	IN	case	O
best	RBS	advmod	O
-	HYPH	punct	O
corrected	VBN	amod	O
Snellen	NNP	amod	O
visual	JJ	amod	O
acuity	NN	nmod	O
,	,	punct	O
slit	NNS	compound	O
-	HYPH	punct	O
lamp	NN	compound	O
biomicroscopy	NN	conj	O
,	,	punct	O
and	CC	cc	O
fundus	VB	compound	B-Multi-tissue_structure
fluorescein	NN	compound	B-Simple_chemical
angiography	NN	conj	O
.	.	punct	O

The	DT	det	O
effects	NNS	nsubjpass	O
of	IN	case	O
exogenous	JJ	amod	O
DCC	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
together	RB	advmod	O
with	IN	case	O
the	DT	det	O
respective	JJ	amod	O
expression	NN	compound	O
vector	NN	compound	O
transfection	NN	nmod	O
.	.	punct	O

The	DT	det	O
genes	NNS	nsubj	O
regulated	VBN	acl	O
by	IN	case	O
Nrf2	NN	nmod	B-Gene_or_gene_product
are	VBP	cop	O
very	RB	advmod	O
important	JJ	ROOT	O
for	IN	case	O
cellular	JJ	amod	B-Cell
protection	NN	nmod	O
of	IN	case	O
the	DT	det	O
genome	NN	nmod	B-Cellular_component
from	IN	case	O
xenobiotic	JJ	amod	O
and	CC	cc	O
oxidative	JJ	conj	O
stresses	NNS	nmod	O
and	CC	cc	O
,	,	punct	O
consequently	RB	advmod	O
,	,	punct	O
for	IN	mark	O
preventing	VBG	advcl	O
carcinogenesis	NN	dobj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Forty	CD	compound	O
-	HYPH	punct	O
one	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
41	CD	nummod	O
eyes	NNS	appos	B-Organ
)	-RRB-	punct	O
with	IN	case	O
a	DT	det	O
clinical	JJ	amod	O
diagnosis	NN	nmod	O
of	IN	case	O
exudative	JJ	amod	O
ARMD	NN	nmod	O
with	IN	case	O
PED	NN	nmod	B-Pathological_formation
underwent	VBD	appos	O
simultaneous	JJ	amod	O
fluorescein	NN	dobj	B-Simple_chemical
and	CC	cc	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
angiography	NN	conj	O
,	,	punct	O
also	RB	advmod	O
under	IN	case	O
high	JJ	amod	O
(	-LRB-	punct	O
10	CD	nummod	O
degrees	NNS	dep	O
)	-RRB-	punct	O
magnification	NN	nmod	O
.	.	punct	O

Vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B	NN	compound	I-Gene_or_gene_product
and	CC	cc	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
C	NN	conj	I-Gene_or_gene_product
expression	NN	ROOT	O
in	IN	case	O
renal	JJ	amod	B-Cancer
cell	NN	compound	I-Cancer
carcinomas	NNS	nmod	I-Cancer
:	:	punct	O
regulation	NN	dep	O
by	IN	case	O
the	DT	det	O
von	NN	compound	B-Gene_or_gene_product
Hippel	NNP	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Lindau	NN	compound	I-Gene_or_gene_product
gene	NN	nmod	O
and	CC	cc	O
hypoxia	NN	conj	O
.	.	punct	O

Recent	JJ	amod	O
evidence	NN	nsubj	O
suggests	VBZ	ROOT	O
the	DT	det	O
existence	NN	dobj	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
precursors	NNS	nmod	I-Cell
in	IN	case	O
adult	JJ	amod	O
bone	NN	compound	B-Cell
marrow	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
but	CC	cc	O
it	PRP	nsubj	O
is	VBZ	cop	O
unclear	JJ	conj	O
whether	IN	mark	O
those	DT	det	O
precursors	NNS	nsubj	O
have	VBP	ccomp	O
a	DT	det	O
role	NN	dobj	O
in	IN	case	O
tumor	NN	compound	B-Cancer
neovascularization	NN	nmod	O
.	.	punct	O

Both	CC	cc:preconj	O
STX243	NN	nsubj	B-Simple_chemical
and	CC	cc	O
STX140	NN	conj	B-Simple_chemical
were	VBD	cop	O
capable	JJ	ROOT	O
of	IN	mark	O
retarding	VBG	advcl	O
the	DT	det	O
growth	NN	dobj	O
of	IN	case	O
MDA	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
MB	NNP	compound	I-Cancer
-	:	punct	I-Cancer
231	CD	nummod	I-Cancer
xenograft	NN	compound	I-Cancer
tumours	NNS	nmod	I-Cancer
(	-LRB-	punct	O
72	CD	nummod	O
and	CC	cc	O
63	CD	conj	O
%	NN	dep	O
,	,	punct	O
respectively	RB	advmod	O
)	-RRB-	punct	O
,	,	punct	O
whereas	IN	dep	O
no	DT	neg	O
inhibition	NN	nsubjpass	O
was	VBD	auxpass	O
observed	VBN	parataxis	O
for	IN	case	O
animals	NNS	nmod	O
treated	VBN	acl	O
with	IN	case	O
2	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
MeOE2	NN	nmod	I-Simple_chemical
.	.	punct	O

Consequently	RB	advmod	O
,	,	punct	O
mitochondrial	JJ	amod	B-Cellular_component
integrity	NN	nsubjpass	O
is	VBZ	auxpass	O
compromised	VBN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
caspase	NN	nmod:npmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
9	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	amod	O
cascade	NN	nsubjpass	O
is	VBZ	auxpass	O
activated	VBN	conj	O
in	IN	case	O
treated	VBN	amod	O
tumor	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

Our	PRP$	nmod:poss	O
data	NNS	nsubj	O
align	NN	ROOT	O
osteonectin	NN	dobj	B-Gene_or_gene_product
with	IN	case	O
other	JJ	amod	O
matrix	NN	compound	B-Cellular_component
-	HYPH	punct	O
components	NNS	nmod	O
and	CC	cc	O
adhesion	NN	compound	O
molecules	NNS	conj	O
in	IN	mark	O
affecting	VBG	advcl	O
potential	JJ	amod	O
metastatic	JJ	amod	O
spreading	NN	dobj	O
of	IN	case	O
transformed	VBN	amod	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

The	DT	det	O
development	NN	nsubjpass	O
of	IN	case	O
carcinoma	NN	nmod	B-Cancer
was	VBD	auxpass	O
examined	VBN	ROOT	O
in	IN	case	O
male	JJ	amod	O
Wistar	NNP	compound	B-Organism
rats	NNS	nmod	I-Organism
(	-LRB-	punct	O
n	NN	dep	O
=	JJ	amod	O
120	CD	dep	O
)	-RRB-	punct	O
exposed	VBN	acl	O
to	TO	case	O
N	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
methyl	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
'	''	punct	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitro	NN	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
N	NNP	compound	I-Simple_chemical
-	HYPH	punct	I-Simple_chemical
nitrosoguanidine	NN	nmod	I-Simple_chemical
(	-LRB-	punct	O
MNNG	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
in	IN	case	O
the	DT	det	O
drinking	VBG	amod	O
water	NN	nmod	B-Simple_chemical
(	-LRB-	punct	O
83	CD	nummod	O
micrograms	NNS	compound	O
/	:	punct	O
ml	NN	appos	O
)	-RRB-	punct	O
for	IN	case	O
16	CD	nummod	O
weeks	NNS	nmod	O
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
we	PRP	nsubj	O
need	VBP	ROOT	O
to	TO	mark	O
determine	VB	xcomp	O
whether	IN	mark	O
it	PRP	nsubj	O
happens	VBZ	ccomp	O
in	IN	case	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
shown	VBN	ROOT	O
that	IN	mark	O
large	JJ	amod	B-Gene_or_gene_product
T	NN	compound	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
antigen	NN	nsubj	I-Gene_or_gene_product
showed	VBD	ccomp	O
associated	VBN	amod	O
kinase	NN	compound	O
activity	NN	dobj	O
,	,	punct	O
although	IN	mark	O
none	NN	nsubj	O
of	IN	case	O
our	PRP$	nmod:poss	O
results	NNS	nmod	O
could	MD	aux	O
unambiguously	RB	advmod	O
demonstrate	VB	advcl	O
an	DT	det	O
intrinsic	JJ	amod	O
kinase	NN	compound	O
activity	NN	dobj	O
of	IN	case	O
this	DT	det	O
protein	NN	nmod	O
.	.	punct	O

TUNEL	NN	compound	O
assay	NN	nsubjpass	O
and	CC	cc	O
microvessel	NN	compound	B-Tissue
density	NN	conj	O
was	VBD	auxpass	O
assessed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
apoptosis	NN	dobj	O
and	CC	cc	O
angiogenesis	NN	conj	O
.	.	punct	O

Bevacizumab	NNP	nsubj	B-Simple_chemical
is	VBZ	ROOT	O
a	DT	det	O
humanized	JJ	amod	O
immunoglobulin	NN	compound	B-Gene_or_gene_product
G1	NN	compound	I-Gene_or_gene_product
monoclonal	JJ	amod	B-Gene_or_gene_product
antibody	NN	attr	I-Gene_or_gene_product
to	TO	case	I-Gene_or_gene_product
vascular	JJ	amod	I-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
that	WDT	nsubjpass	O
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	acl:relcl	O
to	TO	mark	O
have	VB	xcomp	O
activity	NN	dobj	O
in	IN	case	O
malignant	JJ	amod	B-Cancer
gliomas	NNS	nmod	I-Cancer
when	WRB	advmod	O
combined	VBN	advcl	O
with	IN	prep	O
irinotecan	NN	pobj	B-Simple_chemical
.	.	punct	O

We	PRP	nsubj	O
have	VBP	aux	O
modelled	VBN	ROOT	O
multiple	JJ	amod	O
stages	NNS	dobj	O
of	IN	case	O
malignant	JJ	amod	O
transformation	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
(	-LRB-	punct	O
ECs	NNS	appos	B-Cell
)	-RRB-	punct	O
by	IN	mark	O
overexpressing	VBG	advcl	O
the	DT	det	O
catalytic	JJ	amod	O
subunit	NN	dobj	O
of	IN	case	O
human	JJ	amod	B-Organism
telomerase	NN	nmod	B-Gene_or_gene_product
(	-LRB-	punct	O
hTERT	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
together	RB	advmod	O
with	IN	case	O
SV40	NN	compound	B-Organism
T	NN	compound	B-Gene_or_gene_product
antigen	NN	advcl	I-Gene_or_gene_product
(	-LRB-	punct	O
SV40T	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
oncogenic	JJ	amod	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	conj	I-Gene_or_gene_product
.	.	punct	O

Angiogenic	JJ	compound	O
factors	NNS	nsubj	O
,	,	punct	O
in	IN	case	O
particular	JJ	amod	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
the	DT	det	O
angiopoietins	NNS	conj	B-Gene_or_gene_product
,	,	punct	O
Ang	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	appos	I-Gene_or_gene_product
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
2	CD	conj	I-Gene_or_gene_product
,	,	punct	O
have	VBP	aux	O
recently	RB	advmod	O
generated	VBN	ROOT	O
significant	JJ	amod	O
interest	NN	dobj	O
,	,	punct	O
especially	RB	advmod	O
in	IN	case	O
oncology	NN	nmod	O
.	.	punct	O

Besides	IN	case	O
TGFbeta	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
RTK	NN	conj	B-Gene_or_gene_product
/	:	punct	O
Ras	NN	compound	B-Gene_or_gene_product
signaling	NN	conj	O
,	,	punct	O
autocrine	JJ	amod	O
factors	NNS	conj	O
and	CC	cc	O
Wnt	NN	compound	B-Gene_or_gene_product
-	:	punct	O
,	,	punct	O
Notch	NNP	conj	B-Gene_or_gene_product
-	HYPH	punct	O
,	,	punct	O
Hedgehog	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
and	CC	cc	O
NF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
kappaB	NN	nmod:npmod	I-Gene_or_gene_product
-	HYPH	punct	O
dependent	JJ	conj	O
pathways	NNS	nsubjpass	O
were	VBD	auxpass	O
found	VBN	ROOT	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
EMT	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

From	IN	case	O
in	FW	amod	O
vivo	FW	dep	O
experiments	NNS	nmod	O
using	VBG	acl	O
new	JJ	amod	O
methods	NNS	dobj	O
such	JJ	case	O
as	IN	mwe	O
the	DT	det	O
rabbit	NN	compound	B-Organism
cornea	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
it	PRP	nsubj	O
is	VBZ	aux	O
now	RB	advmod	O
becoming	VBG	ROOT	O
clear	JJ	xcomp	O
that	IN	mark	O
the	DT	det	O
growth	NN	nsubj	O
of	IN	prep	O
a	DT	det	O
capillary	JJ	pobj	B-Tissue
involves	VBZ	ccomp	O
an	DT	det	O
ordered	VBN	amod	O
sequence	NN	dobj	O
of	IN	case	O
events	NNS	nmod	O
that	WDT	nsubj	O
includes	VBZ	acl:relcl	O
lysis	NN	dobj	O
of	IN	case	O
the	DT	det	O
basement	NN	compound	B-Cellular_component
membrane	NN	nmod	I-Cellular_component
of	IN	case	O
a	DT	det	O
parent	NN	compound	O
venule	NN	nmod	B-Multi-tissue_structure
,	,	punct	O
directional	JJ	amod	O
migration	NN	appos	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cells	NNS	nmod	I-Cell
toward	IN	case	O
the	DT	det	O
angiogenic	JJ	amod	O
stimulus	NN	nmod	O
,	,	punct	O
lumen	NN	compound	B-Immaterial_anatomical_entity
formation	NN	conj	O
,	,	punct	O
development	NN	appos	O
of	IN	case	O
branches	NNS	nmod	B-Tissue
,	,	punct	O
and	CC	cc	O
anastomosis	NN	conj	O
of	IN	case	O
the	DT	det	O
tip	NN	nmod	O
of	IN	case	O
one	CD	nummod	O
tube	NN	nmod	B-Tissue
with	IN	prep	O
another	DT	pobj	O
to	TO	aux	O
form	VB	acl	O
a	DT	det	O
loop	NN	dobj	O
.	.	punct	O

In	IN	prep	O
3	CD	nummod	O
days	NNS	pobj	O
,	,	punct	O
1	CD	nummod	O
week	NN	npadvmod	O
,	,	punct	O
2	CD	nummod	O
weeks	NNS	appos	O
,	,	punct	O
3	CD	nummod	O
weeks	NNS	conj	O
and	CC	cc	O
4	CD	nummod	O
weeks	NNS	conj	O
after	IN	case	O
surgery	NN	nmod	O
,	,	punct	O
the	DT	det	O
MVD	NN	nsubj	O
of	IN	case	O
test	NN	compound	O
group	NN	nmod	O
was	VBD	cop	O
significantly	RB	advmod	O
higher	JJR	ROOT	O
than	IN	case	O
that	DT	nmod	O
of	IN	case	O
control	JJ	amod	O
group	NN	nmod	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Standard	NN	amod	O
therapy	NN	nsubj	O
with	IN	case	O
primary	JJ	amod	O
resection	NN	nmod	O
followed	VBN	acl	O
by	IN	case	O
adjuvant	JJ	amod	O
chemotherapy	NN	nmod	O
and	CC	cc	O
radiation	NN	conj	O
had	VBD	aux	O
failed	VBN	appos	O
in	IN	case	O
all	DT	det	O
patients	NNS	nmod	B-Organism
.	.	punct	O

Polyphenols	NNS	nsubj	B-Simple_chemical
are	VBP	ROOT	O
natural	JJ	amod	O
antioxidants	NNS	attr	O
that	WDT	nsubjpass	O
are	VBP	auxpass	O
thought	VBN	acl:relcl	O
to	TO	mark	O
contribute	VB	xcomp	O
to	TO	case	O
prevention	NN	nmod	O
of	IN	case	O
cardiovascular	JJ	amod	B-Anatomical_system
disease	NN	nmod	O
and	CC	cc	O
malignancy	NN	conj	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Thirty	CD	compound	O
-	HYPH	punct	O
two	CD	nsubj	O
of	IN	case	O
35	CD	nummod	O
patients	NNS	nmod	B-Organism
(	-LRB-	punct	O
median	JJ	amod	O
age	NN	dep	O
,	,	punct	O
62	CD	nummod	O
years	NNS	appos	O
)	-RRB-	punct	O
are	VBP	cop	O
evaluable	JJ	appos	O
for	IN	case	O
response	NN	nmod	O
.	.	punct	O

Epithelial	JJ	amod	B-Tissue
keratitis	NN	ROOT	O
,	,	punct	O
disciform	NN	compound	B-Pathological_formation
edema	NN	conj	I-Pathological_formation
,	,	punct	O
and	CC	cc	O
necrotizing	VBG	conj	O
keratitis	NN	dobj	O
with	IN	case	O
neovascularization	NN	nmod	O
of	IN	case	O
the	DT	det	O
cornea	NN	nmod	B-Multi-tissue_structure
developed	VBN	acl	O
in	IN	case	O
control	JJ	amod	O
animals	NNS	nmod	O
.	.	punct	O

Alteration	NN	ROOT	O
of	IN	case	O
homeobox	NN	compound	B-Gene_or_gene_product
gene	NN	compound	O
expression	NN	nmod	O
by	IN	case	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
transformation	NN	nmod	O
of	IN	case	O
PA	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	nummod	I-Cell
human	JJ	amod	I-Cell
teratocarcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

We	PRP	nsubj	O
used	VBD	ROOT	O
a	DT	det	O
series	NN	dobj	O
of	IN	case	O
cell	NN	compound	B-Cell
clones	NNS	nmod	I-Cell
from	IN	case	O
a	DT	det	O
human	JJ	amod	B-Organism
teratocarcinoma	NN	compound	B-Cell
cell	NN	compound	I-Cell
line	NN	nmod	I-Cell
,	,	punct	O
PA	NN	compound	B-Cell
-	:	punct	I-Cell
1	CD	appos	I-Cell
,	,	punct	O
to	TO	mark	O
study	VB	advcl	O
the	DT	det	O
effect	NN	dobj	O
of	IN	case	O
transformation	NN	nmod	O
by	IN	case	O
an	DT	det	O
activated	VBN	amod	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
ras	NN	compound	I-Gene_or_gene_product
oncogene	NN	nmod	O
on	IN	case	O
the	DT	det	O
expression	NN	nmod	O
of	IN	case	O
genes	NNS	nmod	O
involved	VBN	acl	O
in	IN	case	O
retinoic	JJ	amod	B-Simple_chemical
acid	NN	intj	I-Simple_chemical
(	-LRB-	punct	O
RA	NN	appos	B-Simple_chemical
)	-RRB-	punct	O
-	:	punct	O
induced	VBN	amod	O
differentiation	NN	dobj	O
and	CC	cc	O
growth	NN	compound	O
regulation	NN	conj	O
.	.	punct	O

New	JJ	amod	O
functions	NNS	ROOT	O
of	IN	case	O
epidermal	JJ	amod	B-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
:	:	punct	O
stimulation	NN	dep	O
of	IN	case	O
capillary	JJ	amod	B-Cell
endothelial	JJ	amod	I-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
matrix	NN	nmod:npmod	B-Cellular_component
dependent	JJ	amod	O
proliferation	NN	conj	O
.	.	punct	O

METHODS	NNS	ROOT	O
:	:	punct	O
Sixty	NNP	compound	O
-	HYPH	punct	O
two	CD	nummod	O
patients	NNS	nsubj	B-Organism
(	-LRB-	punct	O
62	CD	nummod	O
eyes	NNS	appos	B-Organ
)	-RRB-	punct	O
with	IN	case	O
PM	NN	nmod	O
underwent	VBD	appos	O
PDT	NN	dobj	O
according	VBG	prep	O
to	IN	prep	O
the	DT	det	O
guidelines	NNS	pobj	O
of	IN	prep	O
the	DT	det	O
Verteporfin	NNP	pobj	B-Simple_chemical
in	IN	prep	O
Photodynamic	NNP	compound	O
Therapy	NNP	compound	O
Study	NNP	pobj	O
.	.	punct	O

Here	RB	advmod	O
we	PRP	nsubj	O
report	VBP	ROOT	O
that	IN	mark	O
the	DT	det	O
distal	JJ	amod	O
region	NN	nsubj	O
of	IN	case	O
the	DT	det	O
hepatoma	NN	compound	B-Cancer
type	NN	compound	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
hexokinase	NN	compound	I-Gene_or_gene_product
promoter	NN	nmod	O
displays	VBZ	ccomp	O
consensus	NN	compound	O
motifs	NNS	dobj	O
for	IN	case	O
hypoxia	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
inducible	JJ	amod	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
HIF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
)	-RRB-	punct	O
that	WDT	nsubj	O
overlap	VBP	acl:relcl	O
E	NN	compound	O
-	HYPH	punct	O
box	NN	compound	O
sequences	NNS	dobj	O
known	VBN	acl	O
to	TO	mark	O
be	VB	cop	O
related	JJ	xcomp	O
in	IN	case	O
other	JJ	amod	O
gene	NN	compound	O
promoters	NNS	nmod	O
to	TO	case	O
glucose	NN	compound	B-Simple_chemical
response	NN	nmod	O
.	.	punct	O

Hedgehog	JJ	amod	B-Gene_or_gene_product
signaling	NN	ROOT	O
:	:	punct	O
networking	VBG	dep	O
to	TO	mark	O
nurture	VB	xcomp	O
a	DT	det	O
promalignant	JJ	amod	B-Cancer
tumor	NN	compound	I-Cancer
microenvironment	NN	dobj	O
.	.	punct	O

In	IN	case	O
this	DT	det	O
study	NN	nmod	O
,	,	punct	O
we	PRP	nsubj	O
have	VBP	aux	O
evaluated	VBN	ROOT	O
the	DT	det	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
of	IN	case	O
UFT	NN	nmod	B-Simple_chemical
against	IN	case	O
RENCA	NN	nmod:npmod	B-Cell
cell	NN	nmod:npmod	I-Cell
-	:	punct	O
induced	VBN	amod	O
angiogenesis	NN	nmod	O
by	IN	case	O
a	DT	det	O
dorsal	NN	amod	O
air	NN	compound	O
sac	NN	compound	O
assay	NN	nmod	O
.	.	punct	O

We	PRP	nsubj	O
previously	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
disruption	NN	nsubj	O
of	IN	case	O
TGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
signaling	NN	nmod	O
by	IN	case	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	nmod	I-Gene_or_gene_product
in	IN	case	O
a	DT	det	O
diffuse	JJ	amod	O
-	HYPH	punct	O
type	NN	compound	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	compound	I-Cancer
model	NN	nmod	O
accelerated	VBD	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
through	IN	case	O
induction	NN	nmod	O
of	IN	case	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	nmod	O
by	IN	case	O
decreased	VBN	amod	O
expression	NN	nmod	O
of	IN	case	O
the	DT	det	O
anti	JJ	compound	O
-	HYPH	punct	O
angiogenic	JJ	dep	O
factor	NN	compound	O
thrombospondin	NN	dep	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
TSP	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nmod	I-Gene_or_gene_product
.	.	punct	O

On	IN	prep	O
the	DT	det	O
contrary	NN	pobj	O
,	,	punct	O
the	DT	det	O
constitutive	JJ	amod	O
activation	NN	nsubjpass	O
of	IN	case	O
Nrf2	NN	nmod	B-Gene_or_gene_product
due	JJ	case	O
to	TO	case	O
mutations	NNS	nmod	O
in	IN	case	O
the	DT	det	O
keap1	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
is	VBZ	auxpass	O
characteristically	RB	advmod	O
observed	VBN	ROOT	O
in	IN	case	O
lung	NN	compound	B-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
,	,	punct	O
suggesting	VBG	xcomp	O
that	IN	mark	O
induced	VBN	amod	O
expression	NN	nsubj	O
of	IN	case	O
Nrf2	NN	compound	B-Gene_or_gene_product
target	NN	compound	O
genes	NNS	nmod	O
favors	VBZ	ccomp	O
the	DT	det	O
prevalence	NN	dobj	O
of	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

RNA	NN	nsubj	B-Organism
and	CC	cc	O
DNA	NN	compound	B-Organism
viruses	NNS	conj	I-Organism
can	MD	aux	O
be	VB	aux	O
transforming	VBG	ROOT	O
and	CC	cc	O
tumourigenic	JJ	amod	O
agents	NNS	conj	O
.	.	punct	O

Co	NN	compound	O
-	HYPH	punct	O
treatment	NN	ROOT	O
with	IN	case	O
inhibitors	NNS	nmod	O
of	IN	case	O
autophagy	NN	compound	O
results	VBZ	nmod	O
in	IN	case	O
marked	JJ	amod	O
enhancement	NN	nmod	O
of	IN	case	O
cell	NN	compound	B-Cell
death	NN	nmod	O
.	.	punct	O

Recent	JJ	amod	O
advances	NNS	nsubj	O
in	IN	case	O
stem	NN	compound	B-Cell
cell	NN	compound	I-Cell
biology	NN	nmod	O
added	VBD	ROOT	O
the	DT	det	O
new	JJ	amod	O
concept	NN	dobj	O
that	IN	mark	O
cancer	NN	nsubj	B-Cancer
originates	VBZ	ccomp	O
from	IN	case	O
a	DT	det	O
single	JJ	amod	O
cancer	NN	preconj	B-Cancer
-	HYPH	punct	O
initiating	VBG	amod	O
cell	NN	nmod	B-Cell
.	.	punct	O

In	IN	case	O
cultured	VBN	amod	O
cells	NNS	nmod	B-Cell
,	,	punct	O
this	DT	det	O
molecule	NN	nsubjpass	O
is	VBZ	auxpass	O
physically	RB	advmod	O
associated	VBN	ROOT	O
with	IN	case	O
focal	JJ	amod	B-Cellular_component
adhesions	NNS	nmod	I-Cellular_component
,	,	punct	O
which	WDT	nsubj	O
are	VBP	cop	O
well	RB	advmod	O
-	HYPH	punct	O
defined	VBN	amod	O
regions	NNS	acl:relcl	O
of	IN	case	O
intimate	JJ	amod	O
cell	NN	compound	B-Cell
-	:	punct	O
to	TO	advmod	O
-	HYPH	punct	O
substratum	NN	amod	O
adhesion	NN	nmod	O
.	.	punct	O

Brain	NN	compound	B-Cell
pericytes	NNS	nsubj	I-Cell
in	IN	case	O
culture	NN	nmod	O
had	VBD	ROOT	O
higher	JJR	amod	O
levels	NNS	dobj	O
of	IN	case	O
endosialin	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
TEM	NN	appos	B-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
than	IN	case	O
TEMs	NNS	nmod	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
3	CD	dep	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
4	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
5	CD	conj	I-Gene_or_gene_product
,	,	punct	O
-	SYM	punct	B-Gene_or_gene_product
7	CD	conj	I-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
-	SYM	punct	B-Gene_or_gene_product
8	CD	conj	I-Gene_or_gene_product
.	.	punct	O

The	DT	det	O
rabbits	NNS	nsubjpass	B-Organism
were	VBD	auxpass	O
sacrificed	VBN	ROOT	O
and	CC	cc	O
the	DT	det	O
specimens	NNS	nsubjpass	B-Multi-tissue_structure
were	VBD	auxpass	O
procured	VBN	conj	O
at	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
,	,	punct	O
1	CD	nummod	O
,	,	punct	O
2	CD	conj	O
,	,	punct	O
3	CD	conj	O
,	,	punct	O
4	CD	conj	O
and	CC	cc	O
6	CD	conj	O
weeks	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
for	IN	case	O
histological	JJ	amod	O
observation	NN	nmod	O
,	,	punct	O
Chinese	JJ	amod	O
ink	NN	compound	O
perfusion	NN	npadvmod	O
and	CC	cc	O
CD34	NN	compound	B-Gene_or_gene_product
immunohistochemistry	NN	conj	O
.	.	punct	O

Although	IN	mark	O
the	DT	det	O
importance	NN	nsubjpass	O
of	IN	case	O
VEGF	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
A	NNP	nmod	I-Gene_or_gene_product
has	VBZ	aux	O
been	VBN	auxpass	O
shown	VBN	advcl	O
in	IN	case	O
renal	JJ	amod	B-Cancer
carcinomas	NNS	nmod	I-Cancer
,	,	punct	O
the	DT	det	O
contribution	NN	nsubj	O
of	IN	case	O
these	DT	det	O
new	JJ	amod	O
ligands	NNS	nmod	O
in	IN	case	O
kidney	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
is	VBZ	cop	O
not	RB	neg	O
clear	JJ	ROOT	O
.	.	punct	O

It	PRP	nsubjpass	O
is	VBZ	auxpass	O
regulated	VBN	ROOT	O
by	IN	case	O
numerous	JJ	amod	O
angiogenic	JJ	amod	O
factors	NNS	nmod	O
,	,	punct	O
one	CD	appos	O
of	IN	case	O
the	DT	det	O
most	RBS	advmod	O
important	JJ	nmod	O
being	VBG	cop	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
VEGF	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
.	.	punct	O

VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	O
targeted	VBN	amod	O
therapy	NN	ROOT	O
:	:	punct	O
therapeutic	JJ	amod	O
potential	JJ	dep	O
and	CC	cc	O
recent	JJ	amod	O
advances	NNS	conj	O
.	.	punct	O

The	DT	det	O
development	NN	nsubj	O
and	CC	cc	O
progression	NN	conj	O
of	IN	case	O
colorectal	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
(	-LRB-	punct	O
CRC	NN	appos	B-Cancer
)	-RRB-	punct	O
is	VBZ	cop	O
a	DT	det	O
multi	NN	amod	O
-	HYPH	punct	O
step	NN	compound	O
process	NN	ROOT	O
,	,	punct	O
and	CC	cc	O
the	DT	det	O
Wnt	NN	compound	B-Gene_or_gene_product
pathways	NNS	nsubj	O
with	IN	case	O
its	PRP$	nmod:poss	O
two	CD	nummod	O
molecular	JJ	amod	O
gladiators	NNS	compound	O
adenomatous	JJ	amod	B-Gene_or_gene_product
polyposis	NN	compound	I-Gene_or_gene_product
coli	NN	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
APC	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
and	CC	cc	O
beta	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
catenin	NN	conj	I-Gene_or_gene_product
plays	VBZ	conj	O
an	DT	det	O
important	JJ	amod	O
role	NN	dobj	O
in	IN	mark	O
transforming	VBG	advcl	O
a	DT	det	O
normal	JJ	amod	B-Tissue
tissue	NN	dobj	I-Tissue
into	IN	case	O
a	DT	det	O
malignant	JJ	amod	B-Cancer
one	CD	nmod	I-Cancer
.	.	punct	O

Retrospective	JJ	amod	O
case	NN	compound	O
series	NN	ROOT	O
of	IN	case	O
juxtafoveal	NN	amod	B-Multi-tissue_structure
choroidal	NN	amod	I-Multi-tissue_structure
neovascularization	NN	nmod	O
treated	VBN	acl	O
with	IN	case	O
photodynamic	JJ	amod	O
therapy	NN	nmod	O
with	IN	case	O
verteporfin	NN	nmod	B-Simple_chemical
.	.	punct	O

Grape	NN	compound	B-Organism_substance
seed	NN	compound	I-Organism_substance
extract	NN	nsubj	I-Organism_substance
inhibits	VBZ	ROOT	O
angiogenesis	NN	dobj	O
via	IN	case	O
suppression	NN	nmod	O
of	IN	case	O
the	DT	det	O
vascular	JJ	amod	B-Gene_or_gene_product
endothelial	JJ	amod	I-Gene_or_gene_product
growth	NN	compound	I-Gene_or_gene_product
factor	NN	compound	I-Gene_or_gene_product
receptor	NN	compound	I-Gene_or_gene_product
signaling	NN	compound	O
pathway	NN	nmod	O
.	.	punct	O

Marked	JJ	amod	O
angiogenesis	NN	nsubjpass	O
is	VBZ	auxpass	O
induced	VBN	ROOT	O
by	IN	case	O
implantation	NN	nmod	O
of	IN	case	O
a	DT	det	O
chamber	NN	nmod	O
containing	VBG	acl	O
RENCA	NN	compound	B-Cell
cells	NNS	dobj	I-Cell
into	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Despite	IN	case	O
a	DT	det	O
small	JJ	amod	O
sample	NN	compound	O
size	NN	nmod	O
and	CC	cc	O
limited	JJ	amod	O
length	NN	conj	O
of	IN	prep	O
follow	NN	compound	O
-	HYPH	punct	O
up	RP	pobj	O
,	,	punct	O
this	DT	det	O
study	NN	nsubj	O
shows	VBZ	appos	O
that	IN	mark	O
visual	JJ	amod	O
acuity	NN	nsubj	O
on	IN	case	O
average	JJ	nmod	O
can	MD	aux	O
remain	VB	ccomp	O
stable	JJ	xcomp	O
for	IN	case	O
at	IN	case	O
least	JJS	nmod:npmod	O
12	CD	nummod	O
months	NNS	nmod	O
after	IN	prep	O
PDT	NN	pobj	O
of	IN	prep	O
juxtafoveal	JJ	amod	B-Pathological_formation
lesions	NNS	pobj	I-Pathological_formation
.	.	punct	O

N	NNP	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nsubj	I-Gene_or_gene_product
augments	VBZ	ROOT	O
death	NN	dobj	O
and	CC	cc	O
attenuates	VBZ	conj	O
protective	JJ	amod	O
effects	NNS	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nmod	I-Gene_or_gene_product
in	IN	case	O
trophically	RB	advmod	O
stressed	JJ	amod	O
neuroblastoma	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

In	IN	prep	O
control	JJ	compound	O
group	NN	pobj	O
,	,	punct	O
there	EX	expl	O
was	VBD	ROOT	O
no	DT	neg	O
vascular	JJ	amod	B-Multi-tissue_structure
bundle	NN	compound	I-Multi-tissue_structure
implantation	NN	nsubj	O
.	.	punct	O

Certain	JJ	amod	O
carcinostatic	JJ	amod	O
agents	NNS	nsubj	O
induce	VBP	ROOT	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
selectin	NN	nmod	I-Gene_or_gene_product
on	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
enhance	VBP	conj	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
carbohydrate	NN	amod	B-Simple_chemical
ligands	NNS	nmod	O
on	IN	case	O
cancer	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

However	RB	advmod	O
,	,	punct	O
in	IN	case	O
rap1GAPII	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
cells	NNS	nmod	O
,	,	punct	O
ephrin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
B1	NN	nsubj	I-Gene_or_gene_product
did	VBD	aux	O
not	RB	neg	O
induce	VB	ROOT	O
membrane	NN	compound	B-Cellular_component
spreading	NN	dobj	O
,	,	punct	O
probably	RB	advmod	O
due	JJ	case	O
to	TO	case	O
instability	NN	nmod	O
of	IN	case	O
the	DT	det	O
focal	JJ	amod	B-Cellular_component
complex	NN	nmod	I-Cellular_component
.	.	punct	O

Dopamine	NN	compound	B-Simple_chemical
pretreatment	NN	nsubj	O
increases	VBZ	ROOT	O
the	DT	det	O
translocation	NN	dobj	O
and	CC	cc	O
colocalization	NN	conj	O
of	IN	prep	O
Src	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
homology	NN	compound	I-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
domain	NN	intj	I-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
containing	VBG	amod	I-Gene_or_gene_product
protein	NN	compound	I-Gene_or_gene_product
tyrosine	NN	compound	I-Gene_or_gene_product
phosphatase	NN	pobj	I-Gene_or_gene_product
(	-LRB-	punct	O
SHP	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
2	CD	dep	I-Gene_or_gene_product
)	-RRB-	punct	O
with	IN	case	O
D2DR	NN	nmod	B-Gene_or_gene_product
at	IN	case	O
the	DT	det	O
cell	NN	compound	B-Cellular_component
surface	NN	nmod	I-Cellular_component
.	.	punct	O

PURPOSE	NN	ROOT	O
:	:	punct	O
To	TO	mark	O
evaluate	VB	dep	O
alterations	NNS	dobj	O
in	IN	case	O
the	DT	det	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculature	NN	nmod	I-Multi-tissue_structure
overlying	NN	acl	O
pigment	NN	amod	B-Pathological_formation
epithelial	JJ	amod	I-Pathological_formation
detachments	NNS	dobj	I-Pathological_formation
(	-LRB-	punct	O
PED	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
in	IN	case	O
exudative	JJ	amod	O
age	NN	compound	O
-	HYPH	punct	O
related	JJ	amod	O
macular	JJ	amod	B-Tissue
degeneration	NN	nmod	O
(	-LRB-	punct	O
ARMD	NN	appos	O
)	-RRB-	punct	O
using	VBG	acl	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
and	CC	cc	O
fluorescein	NN	conj	B-Simple_chemical
angiography	NN	dobj	O
.	.	punct	O

CONCLUSIONS	NNS	ROOT	O
:	:	punct	O
Retinal	JJ	amod	B-Multi-tissue_structure
vasculopathies	NNS	nsubjpass	O
may	MD	aux	O
be	VB	auxpass	O
observed	VBN	dep	O
in	IN	case	O
eyes	NNS	nmod	B-Organ
with	IN	case	O
PED	NN	nmod	B-Pathological_formation
and	CC	cc	O
are	VBP	cop	O
detectable	JJ	conj	O
by	IN	case	O
indocyanine	NN	amod	B-Simple_chemical
green	JJ	amod	I-Simple_chemical
and	CC	cc	O
fluorescein	NN	conj	B-Simple_chemical
angiography	NN	nmod	O
.	.	punct	O

In	FW	amod	O
vivo	FW	dep	O
assay	NN	nsubj	O
further	RB	advmod	O
showed	VBD	ROOT	O
that	IN	mark	O
GSE	NN	nsubj	B-Organism_substance
could	MD	aux	O
inhibit	VB	ccomp	O
tumor	NN	compound	B-Cancer
growth	NN	dobj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
of	IN	case	O
MDA	NN	compound	B-Cell
-	HYPH	punct	I-Cell
MB	NNP	compound	I-Cell
-	:	punct	I-Cell
231	CD	nummod	I-Cell
breast	NN	compound	I-Cell
cancer	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
in	IN	case	O
mice	NNS	nmod	B-Organism
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
also	RB	advmod	O
a	DT	det	O
direct	JJ	amod	O
correlation	NN	attr	O
between	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularization	NN	nmod	O
and	CC	cc	O
size	NN	conj	O
of	IN	case	O
the	DT	det	O
PED	NN	nmod	B-Pathological_formation
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dep	O
.	.	punct	O
03	CD	attr	O
)	-RRB-	punct	O
.	.	punct	O

An	DT	det	O
earlier	RBR	amod	O
study	NN	nsubj	O
showed	VBD	ROOT	O
that	IN	mark	O
thrombospondin	NN	nsubjpass	B-Gene_or_gene_product
is	VBZ	auxpass	O
expressed	VBN	ccomp	O
in	IN	case	O
benign	JJ	amod	B-Pathological_formation
prostatic	JJ	amod	I-Pathological_formation
hyperplasia	NN	nmod	I-Pathological_formation
(	-LRB-	punct	O
BPH	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
and	CC	cc	O
high	JJ	amod	O
-	HYPH	punct	O
grade	NN	compound	O
prostatic	JJ	amod	B-Pathological_formation
intraepithelial	JJ	amod	I-Pathological_formation
neoplasia	NN	conj	I-Pathological_formation
(	-LRB-	punct	O
PIN	NN	appos	B-Pathological_formation
)	-RRB-	punct	O
but	CC	cc	O
is	VBZ	cop	O
absent	JJ	conj	O
in	IN	case	O
prostate	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

Furthermore	RB	advmod	O
,	,	punct	O
transfection	NN	nsubj	O
of	IN	case	O
E	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
cadherin	NN	compound	I-Gene_or_gene_product
cDNA	NN	nmod	I-Gene_or_gene_product
into	IN	case	O
invasive	JJ	amod	O
NM	NN	compound	B-Cell
-	HYPH	punct	I-Cell
f	NN	compound	I-Cell
-	HYPH	punct	I-Cell
ras	NN	compound	I-Cell
-	HYPH	punct	I-Cell
TD	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
upregulation	NN	nmod	O
of	IN	case	O
syndecan	NN	amod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
association	NN	nmod	O
with	IN	case	O
decreased	VBN	amod	O
invasiveness	NN	nmod	O
.	.	punct	O

FAS	NNP	compound	B-Gene_or_gene_product
-	:	punct	O
1377	CD	nummod	O
G	NN	compound	O
/	:	punct	O
A	DT	compound	O
polymorphism	NN	ROOT	O
and	CC	cc	O
the	DT	det	O
risk	NN	conj	O
of	IN	case	O
lymph	NN	compound	B-Multi-tissue_structure
node	NN	compound	I-Multi-tissue_structure
metastasis	NN	nmod	O
in	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

There	EX	expl	O
was	VBD	ROOT	O
a	DT	det	O
significant	JJ	amod	O
correlation	NN	nsubj	O
between	IN	case	O
loss	NN	nmod	O
of	IN	case	O
CDC4	NN	nmod	B-Gene_or_gene_product
/	:	punct	O
FBXW7	NN	conj	B-Gene_or_gene_product
expression	NN	dep	O
and	CC	cc	O
upregulation	NN	conj	O
of	IN	case	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	nmod	I-Gene_or_gene_product
.	.	punct	O

Parental	JJ	amod	O
NIH	NNP	compound	B-Cell
3T3	NN	npadvmod	I-Cell
-	:	punct	I-Cell
derived	VBN	amod	I-Cell
cells	NNS	nsubj	I-Cell
had	VBD	ROOT	O
both	CC	cc:preconj	O
72	CD	nummod	B-Gene_or_gene_product
kDa	NN	dobj	I-Gene_or_gene_product
and	CC	cc	O
92	CD	nummod	B-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
gelatinase	NN	compound	I-Gene_or_gene_product
activities	NNS	conj	O
,	,	punct	O
and	CC	cc	O
LTA	NNP	nmod:npmod	B-Cell
-	HYPH	punct	O
derived	VBN	amod	O
cells	NNS	conj	B-Cell
had	VBD	aux	O
either	CC	cc:preconj	O
aberrantly	RB	advmod	O
sized	VBN	conj	O
approximately	RB	advmod	O
90	CD	nummod	B-Gene_or_gene_product
kDa	NN	compound	I-Gene_or_gene_product
activity	NN	dobj	O
alone	RB	advmod	O
or	CC	cc	O
neither	CC	cc:preconj	O
enzyme	NN	compound	O
activity	NN	conj	O
.	.	punct	O

Human	JJ	amod	B-Organism
cytomegalovirus	NN	nsubj	I-Organism
elevates	NNS	ROOT	O
levels	NNS	dobj	O
of	IN	case	O
the	DT	det	O
cellular	JJ	amod	B-Cell
protein	NN	compound	O
p53	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

We	PRP	nsubj	O
conditionally	RB	advmod	O
activated	VBD	ROOT	O
N	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
myc	NN	dobj	I-Gene_or_gene_product
in	IN	case	O
SH	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
EP	NN	compound	I-Cell
neuroblastoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
subjected	VBN	acl	O
to	TO	case	O
the	DT	det	O
trophic	JJ	amod	O
stress	NN	nmod	O
of	IN	case	O
serum	NN	compound	B-Organism_substance
or	CC	cc	O
nutrient	JJ	conj	O
deprivation	NN	nmod	O
while	IN	mark	O
changing	VBG	advcl	O
the	DT	det	O
expression	NN	dobj	O
of	IN	case	O
Bcl	NN	compound	B-Gene_or_gene_product
-	SYM	punct	I-Gene_or_gene_product
2	CD	nummod	I-Gene_or_gene_product
,	,	punct	O
survivin	NN	conj	B-Gene_or_gene_product
and	CC	cc	O
FLIP	NN	conj	B-Gene_or_gene_product
(	-LRB-	punct	I-Gene_or_gene_product
L	NN	appos	I-Gene_or_gene_product
)	-RRB-	punct	I-Gene_or_gene_product
,	,	punct	O
antiapoptotic	JJ	amod	O
molecules	NNS	nmod	O
often	RB	advmod	O
overexpressed	VBD	acl	O
in	IN	case	O
poor	JJ	amod	O
prognosis	NN	compound	O
neuroblastomas	NNS	nmod	B-Cancer
.	.	punct	O

Additional	JJ	amod	O
experiments	NNS	nsubj	O
revealed	VBD	ROOT	O
FT	NN	dobj	B-Simple_chemical
to	TO	mark	O
be	VB	cop	O
effective	JJ	amod	O
component	NN	xcomp	O
of	IN	case	O
UFT	NN	nmod	B-Simple_chemical
;	:	punct	O
uracil	NN	nsubj	B-Simple_chemical
remained	VBD	parataxis	O
ineffective	JJ	xcomp	O
in	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
angiogenesis	NN	nmod	O
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Mean	NN	compound	O
(	-LRB-	punct	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
SEM	NNP	appos	O
)	-RRB-	punct	O
graft	NN	compound	B-Multi-tissue_structure
survival	NN	nsubj	O
was	VBD	auxpass	O
significantly	RB	advmod	O
prolonged	JJ	appos	O
in	IN	case	O
animals	NNS	nmod	O
receiving	VBG	acl	O
spironolactone	NN	dobj	B-Simple_chemical
(	-LRB-	punct	O
14	CD	nummod	O
.	.	punct	O
9	CD	nmod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
2	CD	dep	O
.	.	punct	O
0	CD	nummod	O
days	NNS	ROOT	O
)	-RRB-	punct	O
compared	VBN	prep	O
with	IN	prep	O
both	DT	cc:preconj	O
PBS	NNP	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
treated	VBN	amod	O
(	-LRB-	punct	O
12	CD	nummod	O
.	.	punct	O
3	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	intj	O
.	.	punct	O
2	CD	nummod	O
days	NNS	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
007	CD	dobj	O
)	-RRB-	punct	O
and	CC	cc	O
untreated	JJ	amod	O
controls	NNS	conj	O
(	-LRB-	punct	O
13	CD	dep	O
.	.	punct	O
0	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
1	CD	npadvmod	O
.	.	punct	O
0	CD	nummod	O
days	NNS	npadvmod	O
,	,	punct	O
p	NN	nsubj	O
=	JJ	ROOT	O
0	CD	dobj	O
.	.	punct	O
01	CD	dobj	O
)	-RRB-	punct	O
.	.	punct	O

Four	CD	nummod	O
patients	NNS	nsubj	B-Organism
received	VBD	ROOT	O
bevacizumab	NN	dobj	B-Simple_chemical
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
m2	NN	appos	O
;	:	punct	O
irinotecan	NN	nsubjpass	B-Simple_chemical
was	VBD	auxpass	O
given	VBN	parataxis	O
at	IN	case	O
a	DT	det	O
dose	NN	nmod	O
of	IN	case	O
125	CD	nummod	O
mg	NN	nmod	O
/	:	punct	O
m2	NN	nmod	O
every	DT	det	O
week	NN	npadvmod	O
for	IN	prep	O
3	CD	nummod	O
weeks	NNS	pobj	O
.	.	punct	O

Fas	NN	compound	B-Gene_or_gene_product
and	CC	cc	O
FasL	NN	conj	B-Gene_or_gene_product
proteins	NNS	nsubjpass	O
were	VBD	auxpass	O
increased	VBN	ROOT	O
approximately	RB	advmod	O
twofold	RB	advmod	O
in	IN	case	O
the	DT	det	O
RM	NNP	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
-	HYPH	punct	I-Cancer
IL12	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
compared	VBN	case	O
with	IN	case	O
the	DT	det	O
RM	NN	compound	B-Cancer
-	HYPH	punct	I-Cancer
9	CD	nummod	I-Cancer
control	NN	compound	I-Cancer
tumors	NNS	nmod	I-Cancer
as	IN	mark	O
determined	VBN	advcl	O
by	IN	case	O
Western	NN	compound	O
blot	NN	nmod	O
and	CC	cc	O
immunohistochemical	JJ	amod	O
analyses	NNS	conj	O
(	-LRB-	punct	O
P	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
DSCR1s	NN	compound	B-Gene_or_gene_product
promoter	NN	nsubjpass	O
was	VBD	auxpass	O
similarly	RB	advmod	O
induced	VBN	ROOT	O
in	IN	case	O
the	DT	det	O
endothelium	NN	nmod	B-Tissue
of	IN	case	O
tumor	NN	compound	B-Cancer
xenografts	NNS	nmod	I-Cancer
.	.	punct	O

As	IN	mark	O
expected	VBN	advcl	O
,	,	punct	O
Ang	NN	conj	B-Gene_or_gene_product
II	CD	npadvmod	I-Gene_or_gene_product
-	HYPH	punct	O
induced	VBN	amod	O
sFlt	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
secretion	NN	nsubj	O
resulted	VBD	ROOT	O
in	IN	case	O
the	DT	det	O
inhibition	NN	nmod	O
of	IN	case	O
endothelial	JJ	amod	B-Cell
cell	NN	compound	I-Cell
migration	NN	nmod	O
and	CC	cc	O
in	FW	amod	O
vitro	FW	dep	O
tube	NN	compound	B-Tissue
formation	NN	conj	O
.	.	punct	O

Our	PRP$	nmod:poss	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
that	IN	mark	O
HCMV	NN	nsubj	B-Organism
elevates	VBZ	ccomp	O
cellular	JJ	amod	B-Cell
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	dobj	O
on	IN	case	O
the	DT	det	O
order	NN	nmod	O
of	IN	case	O
10	CD	nummod	O
-	HYPH	punct	O
to	IN	quantmod	O
20	CD	nummod	O
-	HYPH	punct	O
fold	JJ	nmod	O
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

To	TO	mark	O
address	VB	advcl	O
this	DT	det	O
question	NN	dobj	O
,	,	punct	O
we	PRP	nsubj	O
used	VBD	ROOT	O
the	DT	det	O
proteomic	JJ	amod	O
approach	NN	dobj	O
of	IN	case	O
tandem	JJ	amod	O
affinity	NN	compound	O
purification	NN	nmod	O
to	TO	mark	O
identify	VB	advcl	O
cellular	JJ	amod	B-Cell
proteins	NNS	dobj	O
that	WDT	nsubj	O
are	VBP	cop	O
in	IN	case	O
complex	NN	acl:relcl	O
with	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
and	CC	cc	O
identified	VBD	conj	O
the	DT	det	O
600	CD	compound	O
-	HYPH	punct	O
kDa	NN	compound	O
protein	NN	dobj	O
,	,	punct	O
p600	NN	appos	B-Gene_or_gene_product
,	,	punct	O
as	IN	case	O
a	DT	det	O
binding	VBG	amod	O
partner	NN	nmod	O
of	IN	case	O
E7	NN	nmod	B-Gene_or_gene_product
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
are	VBP	cop	O
potentially	RB	advmod	O
clinically	RB	advmod	O
relevant	JJ	ROOT	O
,	,	punct	O
because	IN	mark	O
HMGA2	NN	compound	B-Gene_or_gene_product
expression	NN	nsubjpass	O
is	VBZ	auxpass	O
reported	VBN	advcl	O
to	TO	mark	O
be	VB	auxpass	O
upregulated	VBN	xcomp	O
in	IN	case	O
a	DT	det	O
number	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
cancers	NNS	nmod	B-Cancer
as	IN	case	O
telomere	RB	compound	B-Cellular_component
maintenance	NN	nmod	O
is	VBZ	cop	O
essential	JJ	conj	O
for	IN	case	O
tumorigenesis	NN	nmod	O
.	.	punct	O

Adaptive	JJ	amod	O
landscapes	NNS	nsubj	O
and	CC	cc	O
emergent	NN	amod	O
phenotypes	NNS	conj	O
:	:	punct	O
why	WRB	advmod	O
do	VBP	aux	O
cancers	NNS	nsubj	B-Cancer
have	VBP	ROOT	O
high	JJ	amod	O
glycolysis	NN	dobj	O
?	.	punct	O

This	DT	det	O
treatment	NN	nsubj	O
also	RB	advmod	O
changed	VBD	ROOT	O
the	DT	det	O
mitochondrial	JJ	amod	B-Cellular_component
membrane	NN	compound	I-Cellular_component
potential	NN	dobj	O
in	IN	case	O
both	CC	cc:preconj	O
MG	NNP	compound	B-Cell
-	HYPH	punct	I-Cell
63	CD	dep	I-Cell
and	CC	cc	O
SaOS	NNP	compound	B-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
cells	NNS	nmod	I-Cell
within	IN	case	O
1h	NN	nmod	O
,	,	punct	O
caused	VBD	conj	O
chromatin	NN	compound	B-Cellular_component
condensation	NN	dobj	O
and	CC	cc	O
the	DT	det	O
formation	NN	conj	O
of	IN	case	O
apoptotic	JJ	amod	B-Cellular_component
bodies	NNS	nmod	I-Cellular_component
.	.	punct	O

Genotypes	NNS	nsubjpass	O
of	IN	case	O
155	CD	nummod	O
patients	NNS	nmod	B-Organism
with	IN	case	O
cervical	JJ	amod	B-Cancer
cancer	NN	nmod	I-Cancer
and	CC	cc	O
160	CD	nummod	O
healthy	JJ	amod	B-Organism
control	NN	compound	I-Organism
subjects	NNS	conj	I-Organism
were	VBD	auxpass	O
determined	VBN	ROOT	O
using	VBG	xcomp	O
polymerase	NN	compound	O
chain	NN	compound	O
reaction	NN	compound	O
-	HYPH	punct	O
based	VBN	amod	O
restriction	NN	compound	O
fragment	NN	compound	O
length	NN	compound	O
polymorphism	NN	dobj	O
(	-LRB-	punct	O
PCR	NN	compound	O
-	HYPH	punct	O
RFLP	NN	appos	O
)	-RRB-	punct	O
.	.	punct	O

This	DT	det	O
study	NN	nsubjpass	O
was	VBD	auxpass	O
designed	VBN	ROOT	O
to	TO	mark	O
evaluate	VB	xcomp	O
the	DT	det	O
potential	JJ	amod	O
implication	NN	dobj	O
of	IN	case	O
stromelysin	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
3	CD	nmod	I-Gene_or_gene_product
(	-LRB-	punct	O
ST3	NN	appos	B-Gene_or_gene_product
)	-RRB-	punct	O
,	,	punct	O
a	DT	det	O
newly	RB	advmod	O
identified	VBN	amod	O
member	NN	appos	O
of	IN	case	O
the	DT	det	O
matrix	NN	compound	O
-	HYPH	punct	O
degrading	VBG	amod	O
metalloproteinase	NN	compound	O
family	NN	nmod	O
,	,	punct	O
and	CC	cc	O
of	IN	case	O
BM	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
40	CD	nummod	I-Gene_or_gene_product
/	SYM	punct	O
SPARC	NNP	conj	B-Gene_or_gene_product
,	,	punct	O
a	DT	det	O
glycoprotein	NN	appos	O
associated	VBN	acl	O
with	IN	case	O
the	DT	det	O
extracellular	JJ	amod	B-Cellular_component
matrix	NN	nmod	I-Cellular_component
,	,	punct	O
during	IN	case	O
the	DT	det	O
progression	NN	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
colorectal	JJ	amod	B-Cancer
cancers	NNS	nmod	I-Cancer
.	.	punct	O

These	DT	det	O
results	NNS	nsubj	O
indicate	VBP	ROOT	O
the	DT	det	O
possibility	NN	dobj	O
that	IN	mark	O
activation	NN	nsubj	O
of	IN	case	O
angiogenic	JJ	amod	O
activity	NN	nmod	O
after	IN	case	O
resection	NN	nmod	O
of	IN	case	O
osteosarcoma	NN	compound	B-Cancer
tumors	NNS	nmod	I-Cancer
enhances	VBZ	ccomp	O
progression	NN	dobj	O
of	IN	case	O
pulmonary	JJ	amod	B-Organ
metastasis	NN	nmod	O
.	.	punct	O

CONCLUSION	NN	nsubj	O
:	:	punct	O
Immunostaining	NN	nsubj	O
with	IN	case	O
D2	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
40	CD	nmod	I-Gene_or_gene_product
significantly	RB	advmod	O
increased	VBD	ROOT	O
the	DT	det	O
frequency	NN	dobj	O
of	IN	case	O
detection	NN	nmod	O
of	IN	case	O
lymphatic	JJ	amod	B-Multi-tissue_structure
invasion	NN	nmod	O
compared	VBN	prep	O
to	TO	case	O
conventional	JJ	amod	O
H	NN	nmod	B-Simple_chemical
.	.	punct	I-Simple_chemical
E	NNP	compound	I-Simple_chemical
.	.	punct	I-Simple_chemical
-	HYPH	punct	O
staining	NN	ROOT	O
in	IN	case	O
early	JJ	amod	O
breast	NN	compound	B-Cancer
cancer	NN	nmod	I-Cancer
.	.	punct	O

The	DT	det	O
cohort	NN	nsubj	O
examined	VBN	acl	O
was	VBD	advcl	O
relatively	RB	advmod	O
small	JJ	acomp	O
and	CC	cc	O
with	IN	case	O
larger	JJR	amod	O
patient	NN	compound	B-Organism
numbers	NNS	nmod	O
,	,	punct	O
MDM2	NN	compound	B-Gene_or_gene_product
overexpression	NN	nsubj	O
may	MD	aux	O
emerge	VB	ROOT	O
as	IN	case	O
a	DT	det	O
more	RBR	advmod	O
significant	JJ	amod	O
covariate	NN	nmod	O
.	.	punct	O

Younger	NN	amod	O
patients	NNS	nsubj	B-Organism
and	CC	cc	O
eyes	NNS	conj	B-Organ
with	IN	case	O
higher	JJR	amod	O
refractive	JJ	amod	O
error	NN	nmod	O
appear	VBP	ROOT	O
more	RBR	advmod	O
likely	JJ	advmod	O
to	TO	mark	O
benefit	VB	xcomp	O
from	IN	case	O
PDT	NN	nmod	O
with	IN	prep	O
verteporfin	NN	pobj	B-Simple_chemical
.	.	punct	O

It	PRP	nsubjpass	O
was	VBD	auxpass	O
suggested	VBN	ROOT	O
that	IN	mark	O
UFT	NN	nsubj	B-Simple_chemical
has	VBZ	ccomp	O
a	DT	det	O
stronger	JJR	amod	O
angiogenesis	NN	compound	O
-	HYPH	punct	O
inhibitory	JJ	amod	O
effect	NN	dobj	O
than	IN	mark	O
did	VBD	advcl	O
other	JJ	amod	O
fluorinated	JJ	amod	B-Simple_chemical
pyrimidines	NNS	dobj	I-Simple_chemical
,	,	punct	O
partly	RB	advmod	O
due	JJ	case	O
to	TO	case	O
its	PRP$	nmod:poss	O
pharmacokinetic	JJ	amod	O
properties	NNS	nmod	O
characterized	VBN	acl	O
by	IN	case	O
maintaining	VBG	nmod	O
of	IN	case	O
higher	JJR	amod	O
and	CC	cc	O
long	RB	conj	O
-	HYPH	punct	O
lasting	VBG	amod	O
blood	NN	compound	B-Organism_substance
levels	NNS	nmod	O
of	IN	case	O
5	CD	nummod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
FU	NN	nmod	I-Simple_chemical
and	CC	cc	O
partly	RB	advmod	O
due	JJ	case	O
the	DT	det	O
inhibitory	JJ	amod	O
effects	NNS	conj	O
derived	VBN	acl	O
from	IN	case	O
gamma	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
hydroxybutyric	JJ	amod	I-Simple_chemical
acid	NN	nmod	I-Simple_chemical
and	CC	cc	O
gamma	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
butyrolactone	NN	conj	I-Simple_chemical
,	,	punct	O
UFT	NN	nmod:npmod	B-Simple_chemical
-	HYPH	punct	O
specific	JJ	amod	O
metabolites	NNS	conj	O
.	.	punct	O

Eligible	JJ	amod	O
patients	NNS	nsubj	B-Organism
had	VBD	ROOT	O
CNV	NN	nsubj	O
in	IN	case	O
which	WDT	nmod	O
the	DT	det	O
central	JJ	amod	O
boundary	NN	nsubj	O
of	IN	prep	O
the	DT	det	O
lesion	NN	pobj	B-Pathological_formation
was	VBD	cop	O
between	IN	case	O
1	CD	nummod	O
and	CC	cc	O
199	CD	conj	O
microm	NN	dobj	O
from	IN	case	O
the	DT	det	O
geometric	JJ	amod	O
center	NN	nmod	O
of	IN	case	O
the	DT	det	O
foveal	JJ	amod	B-Tissue
avascular	JJ	amod	I-Tissue
zone	NN	nmod	I-Tissue
(	-LRB-	punct	O
FAZ	NN	appos	B-Tissue
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
overall	JJ	amod	O
mutation	NN	compound	O
rate	NN	nsubj	O
of	IN	case	O
the	DT	det	O
MCR	NN	nmod	O
of	IN	case	O
the	DT	det	O
APC	NN	compound	B-Gene_or_gene_product
gene	NN	nmod	O
among	IN	case	O
86	CD	nummod	O
CRC	NN	compound	B-Cancer
cases	NNS	nmod	O
was	VBD	cop	O
12	CD	ROOT	O
.	.	punct	O
8	CD	ROOT	O
per	IN	case	O
cent	JJ	nmod	O
(	-LRB-	punct	O
11	CD	dep	O
of	IN	advmod	O
86	CD	nmod	O
)	-RRB-	punct	O
.	.	punct	O

The	DT	det	O
finding	NN	nsubjpass	O
of	IN	case	O
retinal	JJ	amod	B-Multi-tissue_structure
vasculopathy	NN	nmod	O
(	-LRB-	punct	O
32	CD	nummod	O
patients	NNS	dep	B-Organism
in	IN	case	O
group	NN	nmod	O
1	CD	nummod	O
and	CC	cc	O
two	CD	nummod	O
patients	NNS	conj	B-Organism
in	IN	case	O
group	NN	nmod	O
2	CD	nummod	O
)	-RRB-	punct	O
was	VBD	auxpass	O
directly	RB	advmod	O
correlated	VBN	ROOT	O
with	IN	case	O
the	DT	det	O
presence	NN	nmod	O
of	IN	case	O
choroidal	JJ	amod	B-Multi-tissue_structure
neovascularizations	NNS	nmod	O
(	-LRB-	punct	O
P	NN	dep	O
=	JJ	amod	O
0	CD	dobj	O
.	.	punct	O
002	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

Comparison	NN	nsubj	O
between	IN	case	O
RNA	NN	compound	O
/	:	punct	O
DNA	NN	compound	B-Cellular_component
sequence	NN	nmod	O
of	IN	case	O
viral	JJ	amod	B-Organism
oncogenes	NNS	nmod	O
and	CC	cc	O
normal	JJ	amod	O
human	JJ	amod	B-Organism
genome	NN	conj	O
of	IN	case	O
non	JJ	amod	O
-	HYPH	punct	O
transformed	VBN	amod	O
cells	NNS	nmod	B-Cell
revealed	VBD	ROOT	O
high	JJ	amod	O
sequence	NN	compound	O
similarities	NNS	dobj	O
in	IN	case	O
specific	JJ	amod	O
genomic	JJ	amod	O
areas	NNS	nmod	O
,	,	punct	O
which	WDT	nsubjpass	O
were	VBD	auxpass	O
named	VBN	acl:relcl	O
cellular	JJ	amod	B-Cell
proto	NN	compound	O
-	:	punct	O
oncogens	NNS	oprd	O
.	.	punct	O

The	DT	det	O
formation	NN	nsubj	O
of	IN	case	O
functional	JJ	amod	O
,	,	punct	O
mature	JJ	dep	O
blood	NN	compound	B-Multi-tissue_structure
vessels	NNS	nmod	I-Multi-tissue_structure
depends	VBZ	ROOT	O
on	IN	case	O
the	DT	det	O
interaction	NN	nmod	O
between	IN	case	O
endothelial	JJ	amod	B-Cell
cells	NNS	nmod	I-Cell
and	CC	cc	O
pericytes	NNS	conj	B-Cell
.	.	punct	O

The	DT	det	O
capillary	JJ	amod	B-Tissue
density	NN	nsubj	O
in	IN	case	O
group	NN	nmod	O
1	CD	nummod	O
(	-LRB-	punct	O
ischemia	NN	dep	O
+	CC	cc	O
L	NN	compound	B-Simple_chemical
-	HYPH	punct	I-Simple_chemical
NIL	NN	conj	I-Simple_chemical
)	-RRB-	punct	O
was	VBD	cop	O
significantly	RB	advmod	O
different	JJ	ROOT	O
from	IN	case	O
group	NN	nmod	O
2	CD	nummod	O
(	-LRB-	punct	O
ischemia	NN	dep	O
+	CC	cc	O
saline	NN	conj	B-Simple_chemical
)	-RRB-	punct	O
;	:	punct	O
group	NN	conj	O
1	CD	nummod	O
:	:	punct	O
360	CD	nummod	O
.	.	punct	O
33	CD	nummod	O
+	CC	cc	O
/	SYM	punct	O
-	SYM	punct	O
77	CD	nummod	O
.	.	punct	O
02	CD	nummod	O
,	,	punct	O
group	NN	ROOT	O
2	CD	nummod	O
:	:	punct	O
549	CD	dep	O
+	CC	cc	O
/	SYM	punct	O
-	:	punct	O
81	CD	nummod	O
.	.	punct	O
85	CD	nummod	O
/	SYM	punct	O
mm2	NN	appos	O
,	,	punct	O
p	NN	compound	O
<	CD	appos	O
0	CD	nummod	O
.	.	punct	O
05	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O
In	IN	case	O
addition	NN	nmod	O
,	,	punct	O
expression	NN	nsubjpass	O
of	IN	case	O
HIF1alpha	NN	nmod	B-Gene_or_gene_product
was	VBD	auxpass	O
significantly	RB	advmod	O
increased	VBN	ROOT	O
in	IN	case	O
ischemic	JJ	amod	O
groups	NNS	nmod	O
(	-LRB-	punct	O
p	NN	compound	O
<	CD	dep	O
0	CD	nummod	O
.	.	punct	O
05	CD	nummod	O
)	-RRB-	punct	O
.	.	punct	O

BACKGROUND	NN	ROOT	O
:	:	punct	O
The	DT	det	O
MDM2	NN	compound	B-Gene_or_gene_product
oncoprotein	NN	nsubj	O
promotes	VBZ	dep	O
p53	NN	compound	B-Gene_or_gene_product
degradation	NN	dobj	O
via	IN	case	O
ubiquitin	NN	nmod	B-Gene_or_gene_product
,	,	punct	O
establishing	VBG	advcl	O
negative	JJ	amod	O
feedback	NN	compound	O
control	NN	dobj	O
of	IN	case	O
p53	NN	nmod	B-Gene_or_gene_product
and	CC	cc	O
consequently	RB	advmod	O
affecting	VBG	conj	O
cell	NN	compound	B-Cell
cycle	NN	compound	O
arrest	NN	dobj	O
and	CC	cc	O
apoptosis	NN	conj	O
.	.	punct	O

Protruding	NN	nsubj	O
and	CC	cc	O
expansive	JJ	amod	O
ulcerating	VBG	amod	B-Cancer
carcinomas	NNS	conj	I-Cancer
developed	VBD	ROOT	O
at	IN	case	O
36	CD	nummod	O
weeks	NNS	nmod	O
and	CC	cc	O
had	VBD	conj	O
a	DT	det	O
microvascular	JJ	amod	B-Tissue
pattern	NN	dobj	O
similar	JJ	amod	O
to	TO	case	O
that	DT	nmod	O
of	IN	case	O
human	JJ	amod	B-Organism
adenocarcinoma	NN	nmod	B-Cancer
.	.	punct	O

RESULTS	NNS	ROOT	O
:	:	punct	O
Endometrial	JJ	amod	B-Multi-tissue_structure
glands	NNS	nsubj	I-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
proliferative	JJ	amod	O
and	CC	cc	O
early	JJ	conj	O
secretory	JJ	amod	O
phase	NN	nmod	O
expressed	VBD	appos	O
both	CC	cc:preconj	O
DCC	NN	dobj	B-Gene_or_gene_product
and	CC	cc	O
netrin	NN	conj	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
1	CD	conj	I-Gene_or_gene_product
,	,	punct	O
but	CC	cc	O
glands	NNS	conj	B-Multi-tissue_structure
in	IN	case	O
the	DT	det	O
late	JJ	amod	O
-	HYPH	punct	O
secretory	JJ	amod	O
phase	NN	nmod	O
tended	VBD	conj	O
to	TO	mark	O
silence	VB	xcomp	O
DCC	NN	compound	B-Gene_or_gene_product
expression	NN	dobj	O
.	.	punct	O

In	FW	amod	O
vitro	FW	dep	O
studies	NNS	nmod	O
,	,	punct	O
the	DT	det	O
results	NNS	nsubj	O
indicated	VBD	ROOT	O
that	IN	mark	O
DATS	NN	nsubj	B-Simple_chemical
induced	VBD	ccomp	O
morphological	JJ	amod	O
changes	NNS	dobj	O
and	CC	cc	O
induction	NN	conj	O
of	IN	case	O
apoptosis	NN	nmod	O
in	IN	case	O
CT26	NN	compound	B-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

These	DT	det	O
findings	NNS	nsubj	O
reveal	VBP	ROOT	O
a	DT	det	O
previously	RB	advmod	O
unrecognized	JJ	amod	O
regulatory	JJ	amod	O
role	NN	dobj	O
for	IN	case	O
Ang	NN	nmod	B-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
on	IN	case	O
sFlt	NNP	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
expression	NN	nmod	O
in	IN	case	O
murine	JJ	amod	B-Organism
and	CC	cc	O
human	JJ	conj	B-Organism
pregnancy	NN	nmod	O
and	CC	cc	O
suggest	VBP	conj	O
that	IN	mark	O
elevated	JJ	amod	O
sFlt	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
1	CD	nummod	I-Gene_or_gene_product
levels	NNS	nsubjpass	O
in	IN	case	O
preeclampsia	NN	nmod	O
may	MD	aux	O
be	VB	auxpass	O
caused	VBN	ccomp	O
by	IN	case	O
a	DT	det	O
dysregulation	NN	nmod	O
of	IN	case	O
the	DT	det	O
local	JJ	amod	O
renin	NN	compound	B-Gene_or_gene_product
/	:	punct	O
angiotensin	NN	compound	B-Gene_or_gene_product
system	NN	nmod	O
.	.	punct	O

Cediranib	NN	nsubj	B-Simple_chemical
(	-LRB-	punct	O
6	CD	nummod	O
mg	NN	compound	O
/	:	punct	O
kg	NN	compound	O
/	:	punct	O
day	NN	appos	O
)	-RRB-	punct	O
also	RB	advmod	O
blocked	VBD	ROOT	O
angiogenesis	NN	dobj	O
and	CC	cc	O
lymphangiogenesis	NN	conj	O
induced	VBN	acl	O
by	IN	case	O
adenoviruses	NNS	nmod	B-Organism
expressing	VBG	acl	O
VEGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
A	NNP	dobj	I-Gene_or_gene_product
or	CC	cc	O
VEGF	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NN	conj	I-Gene_or_gene_product
and	CC	cc	O
compromised	VBD	conj	O
the	DT	det	O
blood	NN	preconj	B-Organism_substance
and	CC	cc	O
lymphatic	JJ	conj	B-Multi-tissue_structure
vasculatures	NNS	dobj	I-Multi-tissue_structure
of	IN	case	O
VEGF	NNP	nmod:npmod	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
C	NNP	intj	I-Gene_or_gene_product
-	HYPH	punct	O
expressing	VBG	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Statistically	RB	advmod	O
significant	JJ	amod	O
differences	NNS	nsubjpass	O
were	VBD	auxpass	O
observed	VBN	ROOT	O
regarding	VBG	case	O
angiogenesis	NN	nmod	O
between	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
and	CC	cc	O
groups	NNS	conj	O
3	CD	nummod	O
and	CC	cc	O
4	CD	conj	O
.	.	punct	O

Metastasis	NN	nsubj	O
and	CC	cc	O
tumor	NN	compound	B-Cancer
angiogenesis	NN	conj	O
are	VBP	cop	O
invasive	JJ	amod	O
phenomena	NNS	ROOT	O
and	CC	cc	O
share	VB	conj	O
many	JJ	amod	O
common	JJ	amod	O
properties	NNS	dobj	O
at	IN	case	O
the	DT	det	O
physiological	JJ	amod	O
level	NN	nmod	O
and	CC	cc	O
some	DT	det	O
similarities	NNS	conj	O
at	IN	case	O
the	DT	det	O
molecular	JJ	amod	O
level	NN	nmod	O
.	.	punct	O

p21	NN	nsubj	B-Gene_or_gene_product
delays	VBZ	ROOT	O
tumor	NN	compound	B-Cancer
onset	NN	dobj	O
by	IN	case	O
preservation	NN	nmod	O
of	IN	case	O
chromosomal	JJ	amod	B-Cellular_component
stability	NN	nmod	O
.	.	punct	O

When	WRB	advmod	O
10	CD	nummod	O
(	-LRB-	punct	O
5	CD	dep	O
)	-RRB-	punct	O
cells	NNS	nsubjpass	B-Cell
were	VBD	auxpass	O
injected	VBN	ROOT	O
i	LS	dobj	B-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
v	LS	ccomp	I-Immaterial_anatomical_entity
.	.	punct	I-Immaterial_anatomical_entity
,	,	punct	O
median	JJ	amod	O
colony	NN	compound	B-Cell
value	NN	nsubj	O
was	VBD	ROOT	O
55	CD	attr	O
and	CC	cc	O
20	CD	conj	O
in	IN	case	O
higher	JJR	amod	O
expressor	NN	nmod	O
vs	CC	cc	O
.	.	punct	O
lower	JJR	amod	O
expressor	NN	ROOT	O
respectively	RB	advmod	O
(	-LRB-	punct	O
p	NN	dep	O
less	JJR	advmod	O
than	IN	case	O
0	CD	dep	O
.	.	punct	O
005	CD	appos	O
)	-RRB-	punct	O
.	.	punct	O

An	DT	det	O
extensive	JJ	amod	O
array	NN	nsubj	O
of	IN	case	O
compounds	NNS	nmod	O
is	VBZ	cop	O
currently	RB	advmod	O
in	IN	case	O
preclinical	JJ	amod	O
development	NN	ROOT	O
,	,	punct	O
with	IN	mark	O
many	JJ	pobj	O
now	RB	advmod	O
entering	VBG	advcl	O
the	DT	det	O
clinic	NN	dobj	O
and	CC	cc	O
/	SYM	punct	O
or	CC	cc	O
achieving	VBG	conj	O
approval	NN	dobj	O
from	IN	prep	O
the	DT	det	O
US	NNP	compound	O
Food	NNP	nmod	O
and	CC	cc	O
Drug	NNP	compound	O
Administration	NNP	pobj	O
.	.	punct	O

Similar	JJ	advmod	O
to	TO	case	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
dominant	JJ	amod	O
-	HYPH	punct	O
negative	JJ	amod	O
TGF	NN	compound	B-Gene_or_gene_product
-	:	punct	I-Gene_or_gene_product
beta	NN	compound	I-Gene_or_gene_product
type	NN	compound	I-Gene_or_gene_product
II	CD	nummod	I-Gene_or_gene_product
receptor	NN	dobj	I-Gene_or_gene_product
,	,	punct	O
histochemical	JJ	amod	O
studies	NNS	nsubj	O
revealed	VBD	ROOT	O
less	JJR	amod	O
fibrosis	NN	dobj	O
and	CC	cc	O
increased	VBN	amod	O
angiogenesis	NN	conj	O
in	IN	case	O
xenografted	JJ	amod	O
tumors	NNS	nmod	B-Cancer
expressing	VBG	acl	O
c	NN	compound	B-Gene_or_gene_product
-	HYPH	punct	I-Gene_or_gene_product
Ski	NN	dobj	I-Gene_or_gene_product
compared	VBN	case	O
to	TO	case	O
control	JJ	amod	O
tumors	NNS	nmod	B-Cancer
.	.	punct	O

Loss	NN	ROOT	O
of	IN	case	O
CDC4	NN	compound	B-Gene_or_gene_product
/	:	punct	O
FBXW7	NN	nmod	B-Gene_or_gene_product
in	IN	case	O
gastric	JJ	amod	B-Cancer
carcinoma	NN	nmod	I-Cancer
.	.	punct	O

RESULTS	NNS	nsubjpass	O
:	:	punct	O
The	DT	det	O
bone	NN	compound	B-Multi-tissue_structure
grafts	NNS	nsubjpass	I-Multi-tissue_structure
were	VBD	auxpass	O
found	VBN	ROOT	O
revascularization	NN	dobj	O
in	IN	case	O
3	CD	nummod	O
days	NNS	nmod	O
after	IN	case	O
surgery	NN	nmod	O
in	IN	case	O
the	DT	det	O
test	NN	compound	O
group	NN	nmod	O
,	,	punct	O
whereas	IN	dep	O
at	IN	case	O
2	CD	nummod	O
weeks	NNS	advcl	O
in	IN	case	O
the	DT	det	O
control	JJ	compound	O
group	NN	nmod	O
.	.	punct	O

This	DT	nsubj	O
is	VBZ	ROOT	O
the	DT	det	O
first	JJ	amod	O
report	NN	attr	O
of	IN	case	O
increased	VBN	amod	O
p53	NN	compound	B-Gene_or_gene_product
levels	NNS	nmod	O
caused	VBN	acl	O
by	IN	case	O
HCMV	NN	nmod	B-Organism
in	IN	case	O
infected	JJ	amod	O
fibroblasts	NNS	nmod	B-Cell
.	.	punct	O

Mechanisms	NNS	ROOT	O
for	IN	case	O
the	DT	det	O
magnolol	NN	npadvmod	B-Simple_chemical
-	HYPH	punct	O
induced	VBN	amod	O
cell	NN	compound	B-Cell
death	NN	nmod	O
of	IN	case	O
CGTH	NN	compound	B-Cell
W	NNP	compound	I-Cell
-	:	punct	I-Cell
2	CD	nummod	I-Cell
thyroid	NN	compound	I-Cell
carcinoma	NN	compound	I-Cell
cells	NNS	nmod	I-Cell
.	.	punct	O

